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SUMMARY
The quality of the nutrients provided to the developing embryo are of 
primary importance to ensure the proper functional development of the various 
organs. The brain and retina require large amounts of certain long chain 
polyunsaturated fatty acids (PUFA) during embryonic and neonatal life. 
Docosahexaenoic acid (DHA) is a major component of neural tissues. However, the 
mechanism of delivery of this fatty acid to the brain still has to be established. The 
chick embryo was used as model system in the present study. The amounts and 
proportions of the major fatty acids in the lipids of the yolk, whole embryo, blood 
plasma, adipose tissue, heart and brain were determined throughout chick embryo 
development. The results revealed a series of unique features associated with 
various stages of DHA transport from the yolk to the target tissues. Firstly, DHA 
was preferentially transferred from the lipids of the yolk complex to the embryo. 
Secondly, since DHA was present in the initial yolk as a component of phospholipid, 
but was released into the embryonic circulation in the form of plasma 
triacylglycerol; it was proposed that DHA is translocated from phospholipid to 
triacylglycerol in the yolk sac membrane. It was also proposed that the high activity 
of lipoprotein lipase in the developing adipose tissue promotes the hydrolysis of 
DHA from plasma triacylglycerol and the incorporation of this DHA into the 
triacylglycerol of the adipocytes. The pattern of change in the amount of DHA 
present in adipose triacylglycerol suggested that this fatty acid may be preferentially 
mobilised from this tissue to be released into the circulation as the free fatty acid. 
Experiments involving the incubation of adipose tissue pieces in vitro also provided 
evidence for the preferential mobilisation of DHA from the tissue. It was proposed 
that DHA in the form of plasma free fatty acid is readily taken up by the brain. The 
amount of DHA in brain phospholipid increased continuously during embryonic 
development but this increase occurred in parallel with the accretion of the other 
major fatty acids; i.e. there was no evidence for any preferential incorporation of 
DHA. Brain phospholipid classes were separated using an HPLC system and it was 
shown that phosphatidylethanolamine and phosphatidylserine were the major DHA- 
containing fractions in this tissue. Similar results were also obtained using duck 
embryo brain. On the basis of the findings of this study, a mechanism for the 
transfer of DHA from the yolk to brain is proposed; the key feature of this 
mechanism is the role of adipose tissue as a mediator of this process. The possible 
relevance of these findings to mammalian and human development is discussed.
LITERATURE REVIEW
It has been argued that the single most important adaptation during the evolution 
of terrestrial vertebrates was the development of an egg that could sustain the embryo 
away from the aquatic environment (Romer, 1968). The eggs of reptiles and birds are 
described as both amniote and cleidoic. The first term refers to the amniotic sac, within 
which the embryo develops in an aqueous environment, protected from desiccation. 
Cleidoic refers to the shell that encloses the egg and isolates the embryo from the 
external environment. Embryonic development within a cleidoic egg occurs, therefore, 
within an essentially closed system in which all the nutrients for the sustenance of the 
embryo are "pre-packaged" prior to laying, and where only 0 2, C 02 and H20-vapour 
are exchanged with the environment (White, 1991).
The synthesis and deposition of large amounts of nutrients, particularly in the 
form of yolk, into the egg prior to laying, represents a major metabolic effort by the 
maternal parent. The mechanisms of this process in the laying hen are described in 
section 1.1. In the avian embryo, the early stages of development as reviewed in section
1.2, proceed with only minimal utilisation of the yolk nutrients. However, the final 
trimester of avian embryogenesis is characterised by an extremely rapid uptake of yolk 
components, in which the metabolism of yolk lipids by the embryo assumes paramount 
importance (Noble and Cocchi, 1990) as described in section 1.3 . The major metabolic 
functions of the yolk lipids include energy provision to sustain growth and the supply of 
components for membrane biogenesis. However, a range of more specific functions 
have also been described including the essentiality of certain polyunsaturated fatty acids, 
particularly docosahexaenoic acid (22:6; DHA) for the functional maturation of the 
brain and retina. The importance of DHA during vertebrate development generally is 
discussed in section 1.4, and some particular advantages of using the avian embryo as a 
model system for studying the transport and metabolism of this fatty acid are suggested 
in section 1.5. These latter aspects formed the major focus of the present study.
1.1.SYNTHESIS AND ASSEMBLY OF EGG COMPONENTS BY THE 
PARENT BIRD
1.1.1.Lipids and proteins o f the yolk
The colloquial "yolk" of a bird's egg is a single massive cell, the oocyte, in which 
the cytoplasm proper is mainly restricted to a narrow layer, the germinal disc, which lies 
adjacent to the plasma membrane at one pole of the cell. By far the major portion of the 
yolk consists of a mass of lipid-rich droplets and dense proteinaceous granules which 
form the major nutritive source for the developing embryo. The mechanism of yolk
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formation has been described in detail in a series of reviews (Griffin et al, 1984; Griffin, 
1992; Burley et al, 1993; White, 1991; Noble and Cocchi, 1990), and the essential 
features are described below.
High speed centrifugation of yolk produces 3 fractions : (i) a floating fat layer 
consisting of triacylglycerol-rich lipoproteins, (ii) a pellet consisting of the granule 
fraction plus some associated lipid, (iii) an infranatant containing water-soluble proteins. 
Few, if any, of these components are synthesised in the ovary; the triacylglycerol-rich 
lipoproteins are initially synthesised by the liver in the form of a specialised type of very 
low density lipoprotein (VLDL), and the granules originate from a large precursor 
protein, vitellogenin, which is also synthesised by the liver. The VLDL and vitellogenin 
are secreted from the liver into the bloodstream, transported to the ovary and 
incorporated into the developing oocyte. An impressive feature of oocyte development 
in the ovary is the dramatic growth of the cell, typically from 0.07 to 37.0 mm in 
diameter in the hen. The uptake of the liver-derived yolk components occurs mainly in 
the latter phases of this process, during growth from about 4.0 to 37 mm. The ovary at 
peak performance usually contains at any one time, 5 or 6 oocytes which have attained 
this stage, in a graded size sequence.
Plasma lipoproteins of the VLDL-type, isolated from the plasma of mammals 
and birds, have a general common structure, with a core of triacylglycerol and 
cholesteryl ester and a surface layer of phospholipid, non-esterified cholesterol, and 
specific apoproteins. The specialised VLDL particles secreted by the liver of the laying 
bird are unusually small and regular in size, with a mean diameter of 30 ± 5 nm. The 
much larger VLDL particles present in the plasma of non-laying birds contain 6-9 
different apoproteins. In contrast, those of the laying bird contain only 2 apoproteins, 
namely apoB and apo-VLDL-II. ApoB, the main structural protein of the particle is 
enormous with a molecular weight of over 500,000 whereas apo-VLDL-II is a much 
smaller protein of subunit molecular weight 9,500 which exists as a dimer of about 
18,000. Hen vitellogenin is a dimer of about 480,000, consisting of 2 identical 
monomers. It is a highly phosphorylated protein and also contains some associated 
lipid, mainly phospholipid.
Vitellogenin, apo-VLDL-II, and the specialised "small" VLDL particles are 
essentially absent from the plasma of male birds, and from immature or non-laying 
females. With the approach of sexual maturity in the female and the onset of egg laying, 
a series of dramatic changes take place. The rate of synthesis of lipid from carbohydrate 
in the liver increases to such a high level that the total concentration of triacylglycerol in 
the liver increases some 3-fold. The secretion of this lipid results in an increase of some 
20-fold in the plasma VLDL concentration.
Moreover, this increase is accounted for entirely by the production of the 
"small", apo-VLDL-II containing particles typical of the laying bird. Similarly, the
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plasma concentrations of vitellogenin, and also some other yolk-specific proteins such as 
certain vitamin binding proteins, also increase dramatically at this time. All these 
changes occur in a co-ordinated fashion and are regulated by changes in plasma 
oestrogen concentration. Thus, hepatic expression of the genes coding for vitellogenin, 
apo-VLDL-II, vitamin-binding proteins, and lipogenic enzymes are induced or enhanced 
by oestrogen. The expression of these genes can also be induced in male and immature 
female birds by administration of oestrogen.
The VLDL particles produced by the laying bird possess properties which 
promote their delivery to the ovary and uptake into the oocyte. In particular the small 
size of these particles is apparently a modification to facilitate uptake into the oocyte. In 
the ovarian follicle, the growing oocyte is surrounded by several layers of supporting 
tissue. Blood capillaries permeate the outer, thecal layer. These capillaries are 
exceptionally permeable, enabling large particles such as lipoproteins to diffuse through 
to the next layer, the basal lamina. This is a connective tissue layer that surrounds the 
oocyte and acts as a filter, preventing the passage of large lipoproteins such as the 
intestinal portomicrons but permitting the transfer of the smaller apo-VLDL-II 
containing lipoproteins. The yolk precursors then pass between the granulosa cells 
which surround the oocyte. The binding of the VLDL particles to specific receptors on 
the oocyte plasma membrane is followed by receptor-mediated endocytosis and the 
delivery of the yolk precursors into the oocyte. The surface area of the oocyte is greatly 
enlarged by extensive convolutions of the plasma membrane, in order to promote the 
efficient bulk transfer of yolk precursors into the cell. The binding of the VLDL to the 
receptor occurs via the apo-B component and not via the apo-VLDL-II. However, the 
receptor is distinct from the LDL receptor present on other cell types. Interestingly, 
vitellogenin and VLDL are taken up by the oocyte via the same receptor. Birds with the 
restricted ovulator mutation lack this receptor on the oocytes and consequently 
accumulate VLDL and vitellogenin in the plasma as opposed to deposition in the yolk.
Following uptake into the oocyte, the protein components of the yolk precursors 
are proteolytically modified. Apo-B is cleaved to give a series of smaller proteins, the 
apovitellenins III, IV, V and VI, whereas the apo-VLDL-II subunit remains intact and is 
referred to as apovitellenin I. Vitellogenin is cleaved to give two proteins, phosvitin 
(molecular weight approximately 30,000) and lipovitellin (molecular weight 
approximately 340,000). 54 % of the amino acids of phosvitin are serine residues, with 
95 % of these phosphorylated. Thus phosvitin accounts for 80 % of the protein-bound 
phosphorus of the yolk whereas lipovitellin contains 15-20 % associated lipid. 
Following uptake, the endocytotic vesicles packed with yolk precursor particles undergo 
a series of fusions to form large, membrane bound yolk spheres. These consist of tightly 
packed lipoprotein particles plus granules consisting of aggregated phosvitin-lipovitellin 
complexes.
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In contrast to the modifications to the protein components, the lipids of the 
VLDL are deposited in the yolk essentially unaltered. Thus the fatty acid composition 
of the yolk lipid will reflect that of the VLDL lipid assembled in the liver. Dietary fat 
cannot be directly incorporated into the yolk since the portomicrons released from the 
intestine are too large to cross the basal lamina. The fatty acids incorporated into 
VLDL by the liver may be derived by hepatic lipogenesis from carbohydrate precursors, 
uptake of portomicron remnants, or mobilisation of adipose tissue triacylglycerol stores. 
The latter may be derived from a combination of de novo synthesis and dietary sources. 
Whereas the saturated and monounsaturated fatty acids of the VLDL may be derived 
from both de novo lipogenesis from carbohydrate and from the diet, the polyunsaturated 
components can only be provided from the diet. Thus the DHA content of the yolk lipid 
can only be derived from dietary fatty acid, either in the final form, or as the linolenic 
acid precursor. A number of studies (Anderson et al, 1989; Cherian and Sim, 1992, 
1993) have shown that feeding of oils enriched in either DHA or linolenic acid to the 
parent bird enhances the DHA content of the yolk lipid. The biosynthetic and / or 
dietary origins of the major fatty acids present in animals are outlined in Figure 1.1.
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Figure 1.1: The separate biosynthetic pathways for the 3 families of fatty 
acid share and compete for the same enzymes. Thus A6-desaturase can use either 
18:1 n-9, 18:2 n-6 or 18:3 n-3 as substrate. The conversion of 18:1 n-9 through to 
20:3 n-9 is usually only favoured when 18:2 n-6 and / or 18:3 n-3 are deficient. 
Likewise the synthesis of 22:4 n-6 and 22:5 n-6 often only occurs when n-3 fatty 
acids are deficient.
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1.1.2. Other yolk components
The protein content of the aqueous phase of the yolk are collectively known as 
livetins and are derived from the plasma. Livetins a-, P-, and y- correspond respectively 
to serum albumin, ot2 -glycoprotein and y-globulin (Burley et al, 1993; Griffin et al, 
1984).
In addition to lipid and protein for energy and growth, the embryo also needs to 
be supplied with all the vitamins, minerals and trace elements needed for development. 
Binding proteins for riboflavin, biotin and thiamin are synthesised in the parental liver in 
response to oestrogen stimulation and serve to transport these vitamins to the oocyte. 
The binding proteins and their associated vitamins accumulate in the aqueous phase of 
the yolk (Griffin et al, 1984; White, 1991). Vitamin A is present in the aqueous phase 
as a complex with retinol-binding protein and pre-albumen, and an identical complex is 
responsible for the plasma transport of this vitamin to the ovary (Griffin et al, 1984; 
Vieira and Schneider, 1993). Vitamin D is transported in the plasma and deposited in 
the yolk in association with a cholecalciferol-binding protein (Griffin et al, 1984). 
Vitamin E is probably supplied to the yolk as a component of the VLDL (Cohn et al, 
1992).
The high phosphate content of vitellogenin/phosvitin enables it to bind large 
amounts of Ca2+,and also Mg2+ and Fe3+. These and various other metal ions are 
consequently found complexed to the granule fraction (Griffin eta l, 1984).
1.1.3. Formation o f albumen, shell membranes and shell
In the hen, a single ovary and oviduct are located on the left hand side of the 
body; the respective organs on the right hand side having undergone degeneration 
during development. In a laying hen, oocytes of all sizes are present in the ovary, from 
microscopic to the fully formed yolk-rich ovum ready to escape from the follicle. 
Ovulation occurs at approximately daily intervals, when the ovum (i.e. the "yolk") 
escapes by rupture of the follicle and is picked up by the infundibulum (mouth) of the 
oviduct. The ovum is driven down the oviduct by peristaltic contractions. Fertilisation 
occurs in the upper part of the oviduct and the early cleavage divisions of the zygote 
occur before laying (Romanoff, 1960).
The egg remains in the infundibulum for 15-30 min and then spends the next 2-3 
hours passing down the portion of the oviduct called the magnum. Albumen proteins 
are synthesised and secreted by specialised cells of the endometrial glands of the 
magnum. The oviductal expression of the genes coding for the major albumen proteins 
(ovalbumen, ovotransferrin, ovomucoid, lysozyme and avidin) is induced by oestrogen.
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This hormone also promotes the differentiation of the endometrial glands in immature 
chicks. Thus the synthesis both of the yolk components by the liver and albumen 
components by the oviduct is coordinated by oestrogen. The twisting movement of the 
egg as it passes along the magnum result in the formation of layers of the albumen 
around the yolk (Palmer and Guillette, 1991). From the magnum, the egg enters the 
isthmus portion of the oviduct where it becomes surrounded by the shell membranes. 
These consist of a network of proteinaceous fibres secreted by the endometrial glands of 
the isthmus (Palmer and Guillette, 1991). The egg passes from the isthmus to the shell 
gland, where during the 4.5-24 hour period post-ovulation, mineral secretion and 
crystallisation occurs producing a shell consisting mainly of calcite (Board and Sparks, 
1991)
1.1.4. Composition o f the newly-laid egg
In an average newly-laid egg weighing approximately 60g, four principal parts 
may be described : the shell (6g), the shell membranes and air space, the albumen (34g) 
and the yolk (20g). The germinal disc or blastoderm which gives rise to the embryo and 
its associated membranes "floats" on the upper surface of the yolk (Romanoff, 1960).
The calcite shell has a well-defined system of pores which permit the exchange 
of respiratory gases and also the loss of a proportion of the egg's water content during 
incubation. A thin proteinaceous cuticle prevents bacterial penetration via the pores 
(Board and Sparks, 1991).
The albumen consists of 4 % (w/w) of solid matter in an aqueous environment. 
The solid matter is largely made up of proteins but as many of these are glycosylated 
there is also a significant carbohydrate content. At least 13 proteins have been identified 
with the major one, ovalbumen, making up 54% (w/w) of the total. Others include 
lysozyme, ovomucoid and ovotransferrin. Albumen provides a mechanical support for 
the yolk and also exerts a major antimicrobial function. The albumen is ingested orally 
by the embryo from about day 12 of development and therefore represents an important 
nutritional protein resource for the embryo (Palmer and Guillette, 1991).
Yolk consists of approximately 50 % (w/w) solids and 50 % water. Lipids make 
up about 66 % (w/w) of the solid matter, proteins about 33 %, and only a very small 
proportion of carbohydrate (Romanoff, 1960). Thus the average 60g egg contains 
about 6g of lipid. The majority of yolk lipid (> 90 %) is associated with the VLDL- 
derived fraction. The concentrations of the yolk major individual lipid fractions with 
their fatty acid composition are given in Table 1.1.
The data in this table are based on eggs from parents which have received a 
normal commercial diet.
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Table 1.1 : Yolk lipid and fatty acid composition before incubation (Noble 
and Cocchi, 1990).
CE* TG* PE* PS* PC* Sph* FC*
W. % of total lipid 
Fatty acids, w. % 
total
1.3
of
63.1 7.1 0.81 20.5 0.30 4.9
16:0 29.1 24.5 21.7 33.6 33.7 41.7
16:1 1.0 6.6 1.1 5.4 1.0 6.5
18:0 9.5 6.4 30.1 27.3 15.8 17.6
18:1 40.1 46.2 15.3 15.9 27.7 23.7
18:2 18.0 14.7 9.2 7.3 14.1 9.1
18:3 0.3 1.1 <0.5 <0.5 <0.5 <0.5
20:4 0.9 0.3 13.2 8.5 4.4 <0.5
22:6 0.5 <0.5 8.4 1.2 1.8 <0.5
*CE=cholesteryl ester; TG=triacylglycerol; PE=phosphatidylethanolamine; 
PS=phosphatidylcholine; Sph=sphingomyelin; FC=free cholesterol
The principal lipid fraction is triacylglycerol which is expected considering the 
high rate of synthesis of this fraction by the liver of the laying hen (see 1.1.). The 
second major component is the phospholipid fraction and the free cholesterol is the 
third. Oleic acid is the major fatty acid in the cholesteryl ester, triacylglycerol and total 
phospholipid fractions. Phospholipid fractions have substantial levels of long chain 
polyunsaturated fatty acids (arachidonic and docosahexaenoic acid).
This yolk composition is susceptible to modifications if the hen is under 
conditions of nutritional or environmental stress (Noble and Cocchi, 1990).
1.2.DEVELOPMENT OF THE CHICK EMBRYO
1.2.1. Fertilisation
The ovum of a bird is a single cell, but because of the large amount of yolk, the 
cell membrane is supplemented by the vitelline membrane for support. Fertilisation 
occurs in the infundibulum soon after ovulation, when the ovum interacts with sperm 
which have migrated up the oviduct. The sperm penetrate the vitelline membrane,
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facilitated by the release of hydrolytic enzymes from the acrosome. In birds, many 
sperm penetrate the vitelline membrane but only one fertilises the egg (Bellairs, 1992).
Recent studies suggest that lipids have important roles in sperm function. In 
most mammals (Lin et al, 1993) sperm phospholipids contain exceptionally high level of 
DHA, and there is evidence that adequate levels of this fatty acid are essential for 
maximal motility and fertility. However, chicken sperm appears to be deficient in DHA 
and instead contain high levels of 22:4 n-6 (Darin-Bennett et al, 1974). In mammalian 
sperm, the release of diacylglycerides and long-chain polyunsaturated fatty acids from 
membrane phospholipids appears to be a key stage in the signalling cascade which 
triggers the acrosome reaction (Roldan and Hamilton, 1993).
1.2.2. Early stages o f development
The cleavage divisions of the fertilised egg occur during passage down the 
oviduct. Because of the large yolk mass, cell division is restricted to the protoplasmic 
portion of the egg where the zygote nucleus is located. The daughter nuclei are 
separated by infoldings of the plasma membrane which eventually fuse to delineate the 
cells, forming a circular blastodisc initially one cell layer thick and later several cells 
thick. At the time of laying, the blastodisc consists of about 60,000 cells and is 2.5-5.8 
mm in diameter. Between 9 and 20 h after laying a condensation of cells known as the 
primitive streak forms along the central line of the blastodisc. A gastrulation process 
then occurs as cells of the blastodisc migrate to the streak and pass through it to become 
the mesodermal and endodermal layers, whilst those remaining at the surface form the 
ectoderm. By about one day of incubation, an infolding of the ectoderm along the mid­
line begins to produce the neural tube, the precursor of the central nervous system. The 
formation of the neural tube proceeds from anterior to posterior. By 36 h, the neural 
tube in the anterior region has closed to form 3 brain vesicles. Thus the ectoderm 
furnishes all the neural elements of the body. The early development of the embryo is 
described in detail in several articles (Romanoff, 1960; Bellairs, 1991, 1992; Slack, 
1991). The role of inductive interactions between the primary cell layers in the 
differentiation of specific structures such as the neural elements is discussed by Slack 
(1991). Shortly after the beginning of incubation the activity of the Hox (homeobox) 
genes in controlling the development of particular embryonic regions and the formation 
of the basic body pattern becomes apparent, and there is some evidence that gradients of 
retinoic acid may partly regulate this expression (Bellairs, 1992). Morphogenic 
gradients of retinoic acid also appear to regulate the pattern of digit formation in the 
developing limb buds (Ragsdale and Brockes, 1991).
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Although the blastoderm of the newly laid egg contains about 60,000 cells only 
about 500 will contribute to the embryo proper, the rest forming extraembryonic 
structures including the amnion, chorio-allantois, and yolk sac membrane (Slack, 1991). 
A major role for the yolk sac membrane is that of yolk lipid uptake and transfer and its 
development has been described by Noble and Cocchi (1990). This structure grows 
outwards from the embryo, spreading over the yolk surface to eventually envelop the 
entire yolk. The yolk sac membrane is divisible into 2 major structural areas : an outer 
mesoderm of flattened cells to form a supportive membrane and an inner endoderm of 
columnar cells which are responsible for yolk absorption. From about the fourth day of 
development, the yolk sac membrane begins to develop markedly with the formation of 
elaborate folds and a microvillus structure. At the same time, the yolk sac membrane 
undergoes extensive vascularisation through the development of a network of capillaries 
emanating from within the villi. The blood flowing from these capillaries passes into the 
portal system of the embryo via several major vitelline veins which enter the embryo 
through the yolk stalk. There is no evidence of any lymphatic system within the yolk sac 
membrane. Although anatomically the yolk sac membrane is essentially an extension of 
the embryo's hind gut, passage of yolk material directly into the intestine is prevented by 
a loop of tissue.
1.2.3 The embryo as a physiological system
The nutrition of the embryo during the early stages of development is poorly 
understood but it has been claimed that glucose and amino acids form the major energy 
source at this time. However, during the latter half of development which represents the 
major growth period, the energy metabolism of the embryo is overwhelmingly 
dominated by the utilisation of yolk lipid. In fact, the (3-oxidation of fatty acids derived 
from yolk lipid provides approximately 95 % of the energy needs of the embryo over the 
whole developmental period (Romanoff, 1967; Freeman and Vince, 1974; Noble and 
Cocchi, 1990). Consideration of the physiological and biochemical processes occurring 
within the egg from about the half way stage of development reveals a coordinated 
series of complex functions designed for the delivery of nutrients from the yolk to the 
embryo, the utilisation of additional nutrients from the albumen and shell, the exchange 
of respiratory gases, and the disposal of waste products. The extraembryonic 
membranes play a key role in these inter-relationships. The role of the yolk sac 
membrane in the transfer of lipids and also proteins, vitamins and minerals from the yolk 
to the embryo has already been mentioned (section 1.2.2). Gaseous exchange occurs 
through the pores of the calcite shell and transport of O2 and CO2 between the shell and 
the interior is mediated by the blood vessels of the highly vascularised chorioallantoic
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membrane which lies beneath the shell membranes and which therefore fulfills the 
functions of a lung. The rates of O2 uptake and CO2 release by the egg increase 
dramatically from about day 10, reaching a plateau level by day 18 of incubation. These 
respiration characteristics largely reflect the rates of P-oxidation of yolk derived lipids 
by the embryonic tissues (Romanoff, 1967; Freeman and Vince, 1974). A second major 
role of the chorioallantoic membrane is the mobilisation of the calcium of the shell to 
supply the needs of the embryo. The mechanism of this process involves the conversion 
of respiratory CO2 to carbonic acid by the action of carbonic anhydrase, the 
solubilisation of shell calcium by this acid and the translocation of this calcium into the 
circulation involving the action of a chorioallantoic Ca2+ binding protein (Tuan et al,
1987).
The newly laid egg does not contain a major store of carbohydrate. Thus the 
synthesis of glucose by the gluconeogenic pathway, probably using amino acids as 
precursors, assumes a major importance in the embryo. The key gluconeogenic 
enzymes are expressed in the embryo's liver from around the 7th day and increase to a 
maximal value by day 17. Much of the gluconeogenic effort is directed towards 
glycogen production, and both the liver and the yolk sac membrane are major sites of 
glycogen storage (Freeman and Vince, 1974).
1.2.4. The hatching process
The major features of hatching have been described by Freeman and Vince 
(1974). The onset of pulmonary respiration probably starts from the time the beak 
penetrates the inner shell membrane and enters the air space (internal pipping). It has 
been suggested that increases in the arterial concentration of CO2 act as a stimulus for 
this process. During the period of approximately 25 h between internal pipping and 
hatching, the responsibility for respiration is gradually switched from the chorioallantois 
to the lungs.
Immediately prior to the initiation of breathing there is a profound mobilisation 
of glycogen stores from both the liver and the yolk sac membrane, stimulated by 
glucagon and catecholamines. The adipose tissue of the embryo also develops 
sensitivity to the lipolytic effects of glucagon during the hatching period. Thus 
mobilisation of the stores of both lipid and carbohydrate accumulated by the embryo 
appear to contribute to the energy needs of hatching.
Some 9 h after internal pipping, the beak fractures the shell over the air space. 
This external pipping process is apparently stimulated by a rise of pCC>2 in the air space 
and is facilitated by the previous thinning of the shell during calcium mobilisation.
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From about Day 19 of incubation, the yolk sac and its residual yolk content are 
progressively withdrawn into the abdominal cavity. There is evidence that yolk sac 
retraction is stimulated by thyroid hormones (Decuypere et al, 1991). The nutrient 
content of the retracted yolk sac is sufficient to maintain the hatchling for several days. 
The chick emerges from the shell some 16 h after external pipping. O2 consumption 
increases during this 16 h period, and then increases more dramatically in the 10 h after 
emergence.
1.3.TRANSPORT AND METABOLISM OF LIPIDS IN THE CHICK EMBRYO
1.3.1. Introduction
The almost total reliance on yolk lipids for energy metabolism, in addition to the 
provision of lipid components for cell membrane biogenesis and the existence of more 
specific roles such as the essentiality of DHA for adequate neural development, 
emphasises the crucial role of lipid metabolism in avian embryo development. In general 
terms the utilisation of yolk lipids by the embryo can be described by the following 
sequence of events : (i) the uptake and processing of yolk lipids by the yolk sac 
membrane; (ii) the assembly, within the yolk sac membrane, of the yolk derived lipid 
component into lipoproteins particles; (iii) the release of these lipoproteins into the 
circulation and their delivery to the embryo's tissues via the bloodstream; (iv) the uptake 
and metabolism of the lipid components of the lipoproteins by the tissues. However, 
within this overall scheme there is also a requirement for the specific delivery, or 
targeting, of particular lipid moieties, to the different tissues at defined stages of 
development; e.g. the specific incorporation of DHA by the brain and retina, and the 
delivery of cholesterol to the gonads and adrenals for steroid hormone synthesis. Early 
studies by Noble and Moore (1967a) showing that the liver lipids at day 12 of 
development consisted of triacylglycerol containing up to 20 % DHA, phospholipid 
containing more than 20 % arachidonic acid and cholesteryl ester containing up to 80 % 
oleate (i.e. in drastic contrast to the original yolk lipid composition, see Table 1.1; 
percentages refer to w/w of total fatty acid acids) provided a dramatic illustration that 
the lipid utilisation process did not simply consist of bulk transfer and non-specific f3- 
oxidation, but instead involved major tissue-specific rearrangements of the proportions 
and compositions of the lipid classes. It was suggested (Noble and Cocchi, 1990) that 
the high level of DHA in liver triacylglycerol was somehow related to the mechanism 
and route of transfer of this fatty acid from the yolk to the neural tissues, and more 
recent studies (Speake et al, 1993) lend support to this view.
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1.3.2. Uptake and processing o f yolk lipid by the yolk sac membrane
The yolk sac membrane of the avian embryo is in some respects analogous to the 
mammalian placenta in its role in the provision of nutrients to the embryo, although 
some of the aspects of lipid processing and secretion show some comparability with the 
function of the small intestine in dietary lipid uptake. However neither of these 
analogies provide an accurate picture of yolk sac membrane function, which exhibits a 
range of unique and characteristic features.
The mean weights of total lipid associated with the yolk contents, yolk sac 
membrane and tissue of the chick embryo at various stage of incubation are shown in 
Figure 1.2.
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Figure 1.2 The relative movement of lipid from the yolk contents into the chick 
embryo via the yolk sac membrane. Weights of total lipid in the yolk contents, yolk sac 
membrane and embryonic tissues during the last week of incubation (Noble and Cocchi, 
1990).
Net lipid loss from the yolk of a 60 g egg during the first 13 days of development 
only amounts to a couple of hundreds of mg (Table 1.2). However, between days 13 
and 21, the loss of lipid increases substantially such that during the last two days of 
incubation, the yolk lipid is removed at its highest rate. The amount of yolk lipid 
decreases from around 4 g at day 13 to 1 g at day 21 (hatching), i.e. an overall loss of 
400 mg per day. A preferential absorption of lipid relative to other components from
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the yolk contents over this period is indicated by a decrease in the percentage of total 
lipid in the dry matter, from 65% on day 13 of incubation to 54 and 44% respectively on 
day 15 and 21. Between days 13 and 17 of incubation, loss of lipid from the yolk 
contents is accompanied by its rapid accumulation in the yolk sac membrane, such that 
by day 17 the membrane contains as much lipid as the contents (Noble and Moore, 
1967b). Just prior to hatching, there is a rapid loss of lipid from the membrane, from 
82% at day 17 to 68% at day 21 (% w/w of lipid in its dry matter; Noble and Cocchi, 
1990).
Table 1.2: Lipid changes in the yolk during incubation (Noble and Cocchi, 1990).
Yolk content
Day of incubation 0 13 21
Total lipid, g 6.11 4.93 0.80
Lipid
composition, w %
of total
CE 1.3 0.42 0.50
CHOL 4.9 6.11 5.00
TG 63.1 71.8 75.9
PL 29.7 21.4 18.2
Phospholipid
composition, w %
of total
PE 23.9 14.0 8.30
PS 2.7 1.21 3.43
PC 69.1 75.4 71.7
Sph 1.0 1.79 2.67
Within the phospholipid fraction of the yolk there is a preferential removal of 
phosphatidylethanolamine (PE) relative to the other major fractions (Noble and Moore, 
1967b). Thus whereas the PC/PE ratio of the unincubated egg yolk is about 3.0, it rises 
to around 8.6 in the yolk contents by day 21 of incubation. The weights of PC in the 
yolk decreases by about 74 % (from about 1.25 g to 0.32 g) from day 0 to day 17 while 
that of PE decreases by some 90 % (from 433 mg to 44 mg) (Table 1.2).
Morphological and biochemical evidence has established that the yolk lipid 
uptake by the yolk sac membrane occurs through non specific phagocytosis. Plates la 
and lb present two pictures from electron microscopy showing the sequential 
engulfment of intact lipid droplets and their appearance at the apical surface of the
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Plates la  and lb show electron microscopic pictures of the yolk sac 
membrane at day 15 of incubation showing engulfment of the yolk material by 
the microvilli (see Noble and Cocchi, 1990). Plate la: yolk interface at the top of 
the picture. Plate lb: yolk lipid droplets (dark vesicles) being taken up by the 
yolk sac membrane microvilli.
Plate la
Plate lb
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endodermal cells. Yolk lipid droplets are trapped by the apical microvilli (Figure 1.3) 
and they are then enclosed within apical vesicles. These vesicles containing the 
absorbed lipid are transferred away from the apical surface to the basal surface where as 
a result of merger during transfer, they display physically different properties. 
Intracellular lipid droplets have been identified at quite early stages of development (6th 
day of incubation), their level increasing until about the 14th day onwards they form the 
principal inclusion of the endodermal cell (Noble et al, 1988).
There is no real evidence for extracellular digestion playing a part in the uptake 
of the major lipids into the membrane. Very low levels of lipid breakdown products 
(e.g. free fatty acids, partial glycerides) are found within the yolk during the most 
intense period of lipid uptake. However, there is considerable evidence that yolk lipid 
undergoes a range of modifications and re-arrangements within the yolk sac membrane. 
Perhaps the most drastic modification concerns the esterification of yolk-derived 
cholesterol, within the yolk sac membrane, to form cholesteryl ester. Whereas 
approximately 80 % of yolk cholesterol is present as the unesterified sterol, with only 20 
% as the ester, these proportions are effectively reversed (Table 1.3) within the yolk sac 
membrane where over 80 % of the total cholesterol content is present as the esterified 
form (Shand et al, 1993). Very high levels of acylCoA:cholesterol acyltransferase 
(ACAT), the enzyme responsible for cholesterol esterification, were detected in the 
microsomal fraction of the yolk sac membrane throughout the latter half of the 
developmental period (Shand et al, 1993).
Table 1.3 : Lipid composition of yolk and yolk sac membrane at day 14 of 
development. Each lipid class is expressed as percentage (w/w) of total lipid. Total lipid 
content is expressed as percentage (w/w) of wet tissue. bp<0.001, significant differences 
(Student's t-test) between lipid compositions of yolk and yolk sac membrane.
Lipid class Yolk Yolk sac membrane
Cholesterol 5.4 ± 0.2b 1.3 ±0.1
Cholesteryl ester 1.3 ± 0 .lb 5.6 ±0.3
Triacylglycerol 67.4 ±0.4 67.8 ± 1.2
Phospholipid 25.2 ±0.3 23.8 ±  1.1
Free fatty acid 0.7 ±0.1 1.1 ±0.1
Total lipid content 31.3 ±0.2 30.8 ±0.9
The activity of ACAT, measured using the cholesterol endogenous to the 
microsomes as substrate, was already high at day 9 of incubation, but this value 
increased nearly 3-fold by day 16 and then decreased by day 20. The levels of ACAT 
activity correlated with the rate of uptake of yolk lipid by the yolk sac membrane.
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Figure 1.3 : Proposed mechanism of yolk lipid assimilation by the yolk sac 
membrane.
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Furthermore, Reinhart et al (1993) demonstrated the presence of a protein in the yolk 
sac membrane which is similar to mammalian sterol carrier protein (SCP2 ); this protein is 
implicated in the transport of sterols through the cytoplasm and is known to stimulate 
ACAT. The activity of ACAT was increased by the addition of exogenous cholesterol 
to the microsomes with the greatest stimulation obtained at day 9 and 12, while less 
stimulation was observed for the later stages of development (Table 1.3). This suggests 
that the enzyme in the microsomes may be approaching saturation with substrate as 
development processes. This view was supported in the same study (Shand et al, 1993) 
by the fact that the concentration of endogenous microsomal cholesterol increased 
almost 4 fold between days 9 and 20 of development. In fact, ACAT activity was found 
to be highly correlated with the microsomal cholesterol concentration between days 9 
and 16 but poorly correlated prior to hatching at day 20. On the basis of these studies, 
Shand et al (1993) suggested that the increased potential for cholesterol esterification in 
the yolk sac membrane between days 9 and 12, and the decrease between days 16 and 
20, were due primarily to alterations in the total level of ACAT present, whereas the 
increase between days 12 and 16 was due predominantly to increased levels of 
cholesterol substrate in the microsomes (Table 1.4).
Table 1.4 : ACAT activities in microsomes isolated from yolk sac membranes of 
embryos during development. Exogenous cholesterol added to give a final concentration of 
250 pg/ml. bp<0.001; CP<0.01 (Shand et al, 1993).
Days of development
Cholesteryl oleate formed (pmol/min/mg protein)
Endogenous cholesterol Exogenous cholesterol
9 326 ±42b 696 ± 72c
12 550± 71b 1100± 115
14 720 ± 57c 1023 ±77
16 929 ± 56 1162 ±49
20 592± 13b 693 ± 40c
The activities of ACAT within the yolk sac membrane are high in comparison 
with previously published values for mammalian tissues, i.e. activities in mammary 
gland, heart, brain and pancreas are generally less than 1 % of the activity observed in 
the yolk sac membrane at day 16 (Shand and West, 1991 a,b). Even mammalian tissues 
which are actively involved in cholesterol metabolism such as liver, intestine, ovary and 
adrenal cortex, typically express levels of ACAT which are less than 20 % of those 
reported for the yolk sac membrane (Billheimer et al, 1981; Erickson et al, 1980; 
Cadigan et al, 1988). Furthermore the activity of cholesteryl ester hydrolase (CEH), an 
enzyme with the potential to reverse the effects of ACAT, within the yolk sac membrane
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is less than 2 % of the maximum ACAT activity throughout the developmental period. 
High levels of a cytosolic CEH-inhibitor protein are also present in this tissue (Shand et 
al, 1993). All these factors are a combination well suited to promote an essentially 
unidirectional conversion of cholesterol to cholesteryl ester. Thus, Shand et al (1993) 
concluded that the relevant enzymic systems in the yolk sac membrane are very strongly 
directed towards cholesterol esterification, with very little propensity to reverse this 
process. It should also be noted that the cholesteryl ester synthesised in the yolk sac 
membrane was predominantly in the form of cholesteryl oleate (Table 1.5). It appears 
that the ACAT system in this tissue may have a high specificity for oleoyl CoA, or 
alternatively oleate may be the major acyl group provided to the esterification system 
(Shand etal, 1993).
Analyses of the yolk contents during incubation, have shown that within the 
phospholipid fraction there is a preferential removal of phosphatidylethanolamine species 
enriched in DHA (Noble and Moore, 1967b). Thus there is a preferential uptake of 
DHA by the yolk sac membrane. In addition, the proportion of arachidonic acid in the 
phospholipids of the yolk sac membrane is much greater than in the yolk, due to the 
conversion of linoleic to arachidonic acid by the action of the A6 desaturase and other 
enzymes in this tissue (Noble and Cocchi, 1990). Table 1.5 illustrates the proportional 
increase of polyunsaturated fatty acids within phospholipid classes between yolk and 
yolk sac membrane.
Table 1.5 : Fatty acid composition (w percent of total) of the Cholesteryl Ester, 
Phosphatidylethanolamine and Phosphatidylcholine fractions of the yolk contents and yolk 
sac membrane at day 21 of incubation (Noble and Moore, 1967 b).
CE PE PC
Yolk
content
Yolk sac 
membrane
Yolk
content
Yolk sac 
membrane
Yolk
content
Yolk sac 
membrane
16:0 11.7 4.27 25.7 13.7 32.2 28.2
16:1 2.71 1.77 1.04 1.19 1.08 1.32
18:0 3.67 3.71 26.5 36.6 16.6 18.3
18:1 55.9 75.9 25.9 13.4 29.3 27.8
18:2 21.8 12.9 12.0 10.8 16.4 16.6
18:3 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5
20:4 1.26 0.63 5.07 15.7 2.68 4.35
22:6 2.46 0.30 1.79 6.44 1.14 2.55
Both the incorporation of oleate into cholesteryl ester and the conversion of 
linoleic to arachidonic acid described above, will require the prior hydrolysis of fatty
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acids from the complex lipids derived from the yolk. In addition, the electron 
microscopy studies of Lambson (1970) provided evidence that extensive modifications 
of the lipid droplets occur in the yolk sac membrane, resulting in the re-modelling of the 
contents to form lipoprotein particles which are secreted by exocytosis from the basal 
surface of the endodermal cells. Taken together, the evidence suggests that the lipids 
taken up from the yolk may be extensively hydrolysed in the yolk sac membrane, 
possibly by lysosomal action, followed by re-esterification at the endoplasmic reticulum 
and packaging into lipoprotein particles which enter secretory system (i.e. endoplasmic 
reticular lumen, Golgi, secretory vesicles) of the cell. This scheme is illustrated in 
Figure 1.3.
1.3.3. Assembly and release o f plasma lipoprotein by the yolk sac membrane
Evidence from electron microscopy (Plate la) has demonstrated that lipoprotein 
particles are secreted from the basal surface of the yolk sac membrane endodermal cells 
into the adjacent capillary system. Thus, via the extensive vascular system of the yolk 
sac membrane, it may be envisaged that these lipoproteins will enter the embryo's 
circulation system.
The rapid conversion of yolk-derived cholesterol to cholesteryl ester may be an 
obligatory stage in the assembly of stable lipoproteins (Griffin, 1992; Shand et al, 1993). 
Cholesteryl esters are synthesised by ACAT at the cytoplasmic face of the endoplasmic 
reticulum. They are extremely hydrophobic and have been shown to accumulate initially 
between the leaflets of the endoplasmic reticulum bilayer (Olofsson et al, 1987). Studies 
using hepatocytes have indicated that nascent apo-B, the major structural apoprotein, 
binds co-translationally to the luminal leaflet of the same subcellular organelle, and it has 
been proposed that it is only released into the cisternal space following interaction with 
cholesteryl ester (Olofsson et al, 1993). Thus it appears that the assembly of stable 
lipoprotein particles may be directly linked to the production of cholesteryl ester, and 
therefore ACAT activity, suggesting that in the yolk sac membrane, cholesterol 
esterification may be an important determinant of lipid transfer to the embryo. 
Additional studies using hepatocytes have also suggested that triacylglycerol synthesis in 
the microsomes may also have an important role in the early stages of lipoprotein 
assembly (Boren et al, 1993). The synthesis of triacylglycerols from yolk-derived acyl 
components in the yolk sac membrane and their assembly into the embryonic lipoprotein 
have yet to be investigated. It is likely that the lipoprotein released from the yolk sac 
membrane will be enriched in both DHA and arachidonic acid due to the selective 
uptake of some phospholipid classes within the yolk and A6-desaturation in the yolk sac 
membrane as described above. Yolk lipid absorption is associated with increasing
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lipid levels within the plasma of the embryo. Between days 13-18 of incubation, the 
plasma lipid concentration increases continuously with a slight fall occurring just prior to 
hatching (Yafei and Noble, 1990). The increased lipid level is largely accounted for 
initially by an accumulation of triacylglycerol-rich very low density lipoprotein. 
However, as incubation proceeds, the level of triacylglycerol in this lipoprotein fraction 
is decreased and that of cholesteryl ester increased, such that just prior to hatching, 
cholesteryl ester accounts for more than half of the total lipid present (Yafei and Noble,
1990).
1.3.4. Utilisation ofplasma lipid by the tissues. The role o f Lipoprotein lipase
In adult vertebrates, triacylglycerol-rich plasma lipoproteins from dietary or 
hepatic sources are processed by the action of lipoprotein lipase. This enzyme is present 
at the luminal surface of the blood capillaries of specific tissues where it catalyses the 
hydrolysis of triacylglycerols present in plasma chylomicrons and very low density 
lipoproteins. The fatty acids thus released can be taken up and utilised by the adjacent 
tissues (Cryer, 1987). The presence of this enzyme in specific tissues of the chick 
embryo would be consistent with the operation of a similar mechanism for the utilisation 
of the triacylglycerol rich lipoproteins released by the yolk sac membrane, and this 
possibility was investigated by Speake et al (1993). Table 1.6 shows the lipase activities 
found in several different organs.
Table 1.6 : Lipase activity characteristics of chick embryo tissues at day 14 of 
incubation (Speake et al, 1993).
Lipase activity (units/g tissue)
Standard assay ±NaCl -apoC-II
Adipose tissue 87.4 ±0.3 3.4 ±0.3 7.1 ±0.2
Heart 30.2 ±0.4 2.5 ±0.2 2.1 ±0.1
Thigh muscle 5.8 ±0.2 2.1 ±0.1 2.0 ±0.1
Breast muscle 1.3 ±0.2 0.8 ±0.1 0.8 ±0.1
Liver 6.0 ±0.1 5.5 ±0.1 4.6 ±0.3
Brain 4.6 ±0.2 4.7 ±0.2 4.5 ±0.1
Lipoprotein lipase is characterised and identified by its sensitivity to inhibition by 
NaCl and its requirement for apoC-II as an activator (Olivecrona and Bengtsson- 
Olivecrona, 1987). Thus the fact that the activities expressed in extracts of adipose 
tissue and heart were inhibited by the presence of NaCl or the absence of apoC-II by
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more than 90 % confirmed the identity of the enzyme as lipoprotein lipase. It is clear 
from these results that the activity of the enzyme in adipose tissue is exceptionally high. 
Although some lipase activity was exhibited by extracts of liver and brain in the assay, 
little or no reduction in this activity was brought about by the addition of NaCl or the 
omission of apoC-II. It would therefore appear that lipoprotein lipase is absent from 
liver and brain, with one or more lipases being responsible for the activities expressed in 
the assay. It was suggested by Speake et al (1993) that the lipase activity in the liver 
may be due to the expression of hepatic lipase, an enzyme which is located in vascular 
system of the liver and which functions in the metabolism of lipoprotein remnants. The 
lack of lipoprotein lipase in the brain may be of particular relevance when considering 
the mechanism of DHA uptake by this tissue.
The study of Speake et al (1993) indicated that the initial expression of 
lipoprotein lipase activity in adipose tissue, and indeed the early development of the 
tissue itself, was observed at around day 12 of incubation coincident with the beginning 
of intensive yolk lipid uptake. Furthermore, it was shown that the activity of the enzyme 
in heart also increased at this time. Thus it appears that the transfer of lipid from the 
yolk to the circulation, and the induction of lipoprotein lipase are coordinately regulated. 
The inducing stimulus is, as yet, unknown, although increased plasma levels of certain 
hormones occur at this stage (Freeman and Vince, 1974; Scanes et al, 1987).
It is likely that the growth of adipose tissue during chick embryo development is 
almost entirely a consequence of lipoprotein-mediated uptake of plasma lipid, since the 
rate of lipogenesis from carbohydrate precursors is extremely low (Goodridge, 1973). 
Moreover the mobilisation of fatty acids from the tissue is very limited until the hatching 
period (Langslow, 1973), suggesting that the amount of adipose tissue lipid during 
embryo development may be a reflection simply of the functional activity of lipoprotein 
lipase in the tissue and the plasma concentration of its lipoprotein substrate (Speake et 
al, 1993). The activity of lipoprotein lipase in adipose tissue decreased transiently over 
the hatching period, then increased dramatically with the onset of feeding (Speake et al, 
1993).
An earlier study by Langslow (1972) indicated that the lipolytic sensitivity of 
chicken adipose tissue to glucagon increases dramatically over the hatching period. It 
was shown that this hormone stimulates glycogen mobilisation from the liver and fatty 
acid mobilisation from adipose tissue at this time.
The composition of the tissue lipids of the chick embryo is striking in that the 
proportion of long-chain polyunsaturated fatty acids therein is very high in comparison 
with the original yolk contents. The phospholipids of the liver and heart are enriched in 
arachidonic acid whereas those of the brain and retina are especially high in DHA 
(Noble and Cocchi, 1990). Furthermore the triacylglycerols of adipose tissue, heart and 
liver are notable for the presence of high levels of DHA, a feature which is not exhibited
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by the yolk contents, and which is unusual in tissues of terrestrial adult birds and 
mammals (Speake et al, 1993).
Studies of the lipid compositions of individual tissues of the chick embryo during 
development show a range of unique features when compared with comparable tissues 
from other animal species. The most extreme of these tissue lipid changes is displayed 
by the liver. Noble (1986) showed that 5 % (w/w) of the lipid taken up from the yolk by 
the embryo is accumulated by the liver by day 19 of incubation. However, as can be 
seen in Table 1.7, its composition bears no resemblance to that of the lipid absorbed 
from the yolk.
Table 1.7 : Lipid and fatty acid changes in the liver during the last week of 
incubation (Noble and Cocchi, 1990).
CE TG PL
Day of incubation 13 21 13 21 13 21
Lipid concentration, mg 
per liver
1.63 122.0 1.07 5.39 3.63 21.5
Lipid distribution, % 
Fatty acid composition, 
wt % of total
23.3 80.2 15.1 3.58 51.4 14.2
16:0 2.31 1.95 23.4 23.0 22.4 17.8
16:1 0.91 0.97 1.41 1.52 <0.5 <0.5
18:0 2.04 2.74 8.81 11.1 24.6 28.4
18:1 77.2 79.6 30.4 35.7 7.29 7.97
18:2 12.7 12.5 8.32 8.23 9.94 13.8
18:3 <0.5 <0.5 <0.5 <0.5 1.21 1.07
20:4 2.24 1.47 3.52 2.92 26.2 20.0
22:6 1.91 0.42 20.1 11.6 6.45 9.12
The accumulation of lipid in liver during the last week of development is almost 
wholly accounted for by cholesteryl ester which represents 80% of the total lipid of the 
liver and 30% of the dry matter (Noble and Moore, 1967a). The triacylglycerol and 
phospholipid which normally predominate in any liver tissue barely rise in concentration 
and by the time of hatching amount to only 1 and 7%, respectively, of the total lipid 
present. A further feature of the accumulated cholesteryl esters is their extremely high 
content of oleic acid.
Table 1.7 also shows that during embryonic development the fatty acid 
composition of the liver phospholipids are characteristically different from that of the 
yolk as they display considerably more stearic, arachidonic and docosahexaenoic acids
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and considerably less palmitic and oleic acids (Noble and Cocchi, 1990). These 
characteristic differences are a reflection of both differences in the proportions of the 
various phospholipid moieties and in their fatty acid compositions. Phosphatidylcholine 
is the major phospholid class: 55% of the total at day 13 but decreasing towards the end 
of incubation; while the proportion of phosphatidylethanolamine and phosphatidylserine 
remains constant at about 30 and 12% respectively (Noble and Cocchi, 1990). The two 
last phospholipid fractions display very much higher levels of arachidonic and 
docosahexaenoic acids (Noble and Moore, 1967a) than in the yolk during the last week 
of incubation. The most pronounced changes in the fatty acid composition of the liver 
phospholipids during embryo development occur in the phosphatidylcholine fraction and 
involve alterations to both saturated and unsaturated acids (Noble and Moore, 1967a). 
These analyses show that at some stage during the transfer from yolk to embryo, the 
phospholipids undergo extensive breakdown and that new phospholipids are synthesised 
in the embryonic tissues.
The surprising feature of the triacylglycerols found within the liver of the embryo 
during incubation is the very high concentration of DHA, as this fatty acid is more 
commonly associated with phospholipids (Noble and Cocchi, 1990). At day 13 of 
incubation, the level of DHA in the triacylglycerol fraction of the liver is considerably 
greater than in the phospholipids. Speake et al (1993) proposed a theory about the role 
of lipoprotein lipase in tissue specific lipid uptake (Figure 1.4) which would explain 
tissue lipid compositions.
The intense level of lipid catabolism via p-oxidation is associated with a 
significant accumulation of ketone bodies in the plasma. Rapid changes occur in the 
lipid oxidative abilities of several major tissues, e.g. heart and liver, during the second 
half of the incubation period (Noble et al, 1986). However such changes may not 
necessarily be solely due to alterations in oxidizable lipid substrate supply; in the case of 
the liver, the specific apolar nature of the unusual lipid accumulation may affect 
subcellular function. The requirements and mechanisms of the oxidative processes, 
which can be observed from about the 8th day of incubation, are similar to those for 
fatty acid oxidation in mammalian tissues (Koerker and Fritz, 1970). The extent of lipid 
oxidation can be measured by the rapid increase in the concentration of carbon dioxide 
within the enlarging air space that develops latterly between the inner and outer shell 
membranes; thus, whereas at day 13 of incubation, carbon dioxide accounts for only 
about 1.7% of the total gas present in the air space, just prior to hatching the carbon 
dioxide concentration exceeds 5% (Freeman and Vince, 1974, Tullett and Noble, 1988).
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Figure 1.4 : Proposed model for the role of lipoprotein lipase in tissue- 
specific lipid uptake. This hypothesis attempts to explain tissue lipid 
compositions in terms of the distribution and substrate specificity of lipoprotein 
lipase. Lipoproteins released into the embryonic circulation from the yolk sac 
membrane are initially processed by the action of lipoprotein lipase located in the 
capillaries of adipose tissue, muscle and heart. The proportion of 22:6 in the fatty 
acids thus released is less than originally present in the lipoprotein triacylglycerol 
due to the relative resistance of esters of this fatty acid to hydrolysis by 
lipoprotein lipase. This reduced proportion of 22:6 in the free fatty acids 
available for tissue uptake and re-esterification is reflected in the composition of 
triacylglycerol deposited in adipose tissue, etc. The action of lipoprotein lipase 
results in the conversion of the lipoproteins to smaller remnants consisting mainly 
of cholesteryl ester. The residual triacylglycerols of the remnant are enriched in 
22:6, again due to the relative resistance of esters of this fatty acid to lipoprotein 
lipase. Remnant uptake by the liver results in the accumulation in this tissue of 
triacylglycerols rich in 22:6 as well as cholesteryl ester. YSM : yolk sac 
membrane; TG : triacylglycerol; FFA : free fatty acid; CE : cholesteryl ester; 
LPL : lipoprotein lipase; HL : hepatic lipase; RME : receptor-mediated 
endocytosis. The proportions (% w/w of total fatty acids) of 22:6 in 
triacylglycerol and free fatty acid fractions are indicated. These are approximate 
values for the early lipid uptake period. The values for the free fatty acid and 
remnant are assumed to be equivalent to those for adipose and liver 
triacylglycerol, respectively (Speake et al, 1993).
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1.3.5. Deposition o f cholesterol ester in embryo's liver
It may be envisaged that the action of lipoprotein lipase on the lipoproteins 
released from the yolk sac membrane, will deplete the lipoproteins of their 
triacylglycerol content, resulting in the formation of much smaller remnant particles 
consisting largely of cholesteryl ester (Figure 1.4). By analogy with other system 
(Goldstein and Brown, 1977) it may be proposed that the remnant lipoprotein will be 
taken up by the liver, by a receptor-mediated endocytotic process. The deposition of 
large amount of cholesteryl ester in the embryo's liver (Table 1.7) would be consistent 
with such mechanism.
The preponderance of cholesteryl oleate in the liver sterol esters (Table 1.7) is 
consistent with the view that the lipid deposited in the liver originates from that 
assembled in the yolk sac membrane (Noble and Cocchi, 1990). Cytoplasmic lipid 
droplets are discernible in the liver at day 13 of incubation but they are few in number at 
this time and similar in size to the adjacent mitochondria. However by day 19 a marked 
accumulation of lipid occurs in the liver cells, with large lipid droplets occupying the 
bulk of the cytoplasm. In fact, between days 12 and 20, the amount of cholesteryl ester 
in the liver increased 37-fold, when expressed on the basis of tissue fresh weight (Shand 
et al, 1994). The study of Shand et al (1994) indicated that the ACAT activity in the 
liver follows the same pattern as that displayed in the yolk sac membrane: i.e. an 
increase to a maximal value at day 16 followed by a decrease by day 20 of incubation. 
The activities of the enzyme in the liver were markedly lower (by approx. 4-fold) than 
those in the yolk sac membrane. Work in other systems has shown that receptor- 
mediated uptake of lipoprotein remnants by the liver is followed by lysosomal hydrolysis 
and the release of free cholesterol and fatty acids, initially into the cytoplasm (Goldstein 
and Brown, 1977). The presence of significant levels of ACAT activity in the liver of 
the chick embryo (Shand et al, 1994) would appear to provide a potential mechanism 
for the rapid re-esterification of this cholesterol, and its subsequent storage as droplets 
of cholesteryl ester in the cytoplasm.
The activity of microsomal cholesteryl ester hydrolase in the chick embryo was 
very low, and even at its maximal value (day 20 ) represented only 25% of the activity 
found in the liver of the adult rat (Shand et al, 1994). This activity will be decreased by 
the action of the CEH-inhibitor protein present at all stages; the embryonic liver seems 
therefore to display very little capacity for the mobilisation of the accumulated 
cholesteryl ester (Shand et al, 1994).
Although there is no definitive evidence for any mechanism by which the embryo 
may reduce the hepatic accumulation of cholesteryl esters, excretion through the bile 
into the small intestine may be one possible pathway as the liver lipids of chick embryo 
show accumulation of cholesteryl oleate at the same time of the appearance of
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substantial quantities of this component within the bile (Noble and Cocchi, 1990). 
Similarly, the presence of high levels of arachidonic acid in the bile phospholipids 
parallels the accumulation in the liver of phospholipids with unusually high levels of 
arachidonic acid. Subsequent to the liver and bile changes, an increase has been 
observed in the ratio of esterified:free cholesterol in the yolk content (Noble and Moore, 
1967b), the occurrence of which could not be explained by any association with the 
metabolic changes in the yolk sac membrane. Also, following the injection of 14C- 
cholesterol into the yolk, autoradiographic analysis over the incubation period has 
detected substantial and increasing levels of radioactivity within the gall bladder and 
gastrointestinal tract of the embryo (Jain et al, 1972). Sufficient evidence exists, 
therefore, to suggest that, during the latter part of development, the bile may provide a 
limited means of homeostatic control over the lipid accumulation in the liver (Noble and 
Cocchi, 1990).
1.3.6.Lipid metabolism and the emerged chick
About a quarter of the lipid that was originally present in the yolk (1-2 g) 
remains unabsorbed at the time of hatching when the yolk sac membrane and its residual 
contents are retracted into the body cavity (Noble and Moore, 1964; Noble and Moore, 
1967b). Following hatching, there is a rapid uptake of the residual yolk material from 
the retracted yolk sac such that by the 5th 0r 6th day after hatching, only a vestigial 
amount remains (Entenman et al, 1940, Noble and Ogunyemi, 1989, Romanoff, 1960). 
The lipid metabolism of the newly hatched chick undergoes a series of rapid changes. 
The massive stores of cholesteryl ester in the liver are dramatically depleted within a few 
days after hatching and, in the absence of a supply of yolk lipid, the liver develops the 
enzymic capacity to synthesise fatty acids and triacylglycerol from dietary carbohydrate 
(Noble and Cocchi, 1990).
1.4. THE ROLE OF N-3 POLYUNSATURATED FATTY ACIDS DURING 
VERTEBRATE DEVELOPMENT
In many animal cell types, polyunsaturated fatty acids of both the n-6 and n-3 
series have a number of important roles, mainly related to the structure and function of 
cell membranes and the production of eicosanoids. An adequate provision of essential 
polyunsaturates is especially important during early development, since DHA in 
particular is required by the brain and retina during critical periods of differentiation.
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1.4.1. General effects o f DHA on embryonic growth and survival
n-3 fatty acids appear to be essential for the survival of embryos and emergent 
larvae of certain fish species. The consistent occurrence of high levels of these fatty 
acids in the lipids of fish eggs, and their preferential incorporation into membrane 
phospholipids as opposed to oxidation for energy, suggests that relatively large amounts 
of n-3 polyunsaturates may be necessary during the early stages of fish development. 
Deficiency of n-3 fatty acids in the yolk lipid of trout embryos was associated with high 
levels of embryonic mortality, and adequate levels of these fatty acids were required to 
support normal growth rates in embryos and larvae of a range of fish species 
(Henderson and Tocher, 1987).
Current evidence also suggests that an adequate supply of DHA may be essential 
for the survival of alligator embryos. Reduced levels of DHA in the yolk lipids of eggs 
from alligators currently reared in captivity were associated with a high degree of 
embryonic mortality in comparison with eggs from wild alligator (Noble et al, 1993).
The effects of DHA-deficiency during embryogenesis of the higher vertebrates 
may be less drastic. In a study by Anderson et al (1989), reduced levels of n-3 fatty 
acids in the yolk lipids of chicken eggs resulted in greatly decreased levels of DHA in 
the brain of the newly-hatched bird but no increase in embryo mortality. Similarly, in 
mammals DHA-deficiency is not normally associated with increased embryonic mortality 
(Neuringer et al, 1988). In humans, maternal dietary intakes of arachidonic acid and 
DHA were positively correlated with placental weight, birthweight and head 
circumference (Crawford et al, 1989)
1.4.2. DHA and retinal function
Very high levels of DHA are present in the photoreceptor cells of the retina. 
Rod photoreceptor outer segments consist of stacks of disks, each composed of a pair 
of membrane bilayers. These membranes have an unusually low cholesterol content 
(<10 mol % of total lipid) and an exceptionally high content of phospholipid (80-90 mol 
%). These phospholipids contain extremely high levels of polyunsaturated fatty acids, 
with DHA comprising up to 65% of the total fatty acids of phosphatidylethanolamine 
and phosphatidylserine. In the 2-position of these phospholipids, DHA accounts for 75- 
100% of the total fatty acids. The 1-position also contains up to 25% DHA, resulting in 
the formation of suprenoic molecular species with DHA in both positions. Rod outer 
segment phosphatidylcholine also contains significant levels of very long chain 
polyunsaturated fatty acids containing 24-36 carbon atoms (Neuringer et al, 1988).
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The presence of polyunsaturated fatty acids in membrane phospholipids 
produces increased membrane fluidity, compressibility, and permeability. Although 
DHA with six double bonds, is unique in its high degree of polyunsaturation, its 
incorporation into membrane phospholipids does not necessarily result in high fluidities. 
Studies using artificial phospholipid membranes with different fatty acids in the 2- 
position have shown that the presence of DHA compared to 18:2 n-6 does not cause a 
further increase in fluidity (Coolbear et al, 1983). Thus DHA's role in retinal function 
may involve properties other than fluidity, such as the physical flexibility or 
compressibility of the membrane.
The rod outer segment is responsible for transducing photons to electrical 
signals. This process is mediated by rhodopsin, an integral membrane protein which 
accounts for 90% of the protein in the disk membrane. Activation of rhodopsin results 
in a major conformational change which must be accommodated by the membrane 
bilayer. It has been proposed that the presence of DHA in phospholipids results in a 
membrane that is relatively thin but is able to expand in response to rhodopsin 
activation. The basis of this property may be related to the postulated ability of DHA in 
the membrane to undergo a transition between helical and uncoiled conformations 
(Dratz et al, 1987; Neuringer et al, 1988; Sanders, 1988). It has also been suggested 
that the high DHA content may increase the permeability of the disk to ions involved in 
neural signalling (Sanders, 1988).
1.4.3. DHA and brain development
In cerebral grey matter, DHA makes up approximately 30% of the fatty acid 
content of phosphatidylethanolamine and phosphatidylserine. The highest levels of 
DHA are present in synaptosomes, synaptic vesicles, mitochondria and microsomes. In 
contrast, white matter and its myelin fraction contain very little DHA (Neuringer et al,
1988).
Brain development in cellular terms, consists of a sequence of events including 
neuronal multiplication followed by cell stretching and neurite extension, synapse 
formation and myelination. The timing of these processes differs among mammalian 
species. In rats, mice and rabbits, myelination commences 10-15 days after birth and is 
completed several months later, whereas in the guinea pig myelination is largely 
completed prior to birth. In humans and primates, myelination occurs both pre- and 
post-natally. DHA accumulation in the neurones largely occurs in the phase 
immediately prior to myelination, and is associated with the periods of neurite extension 
and axonal formation. Thus in the rat, the level of DHA in the brain increases rapidly 
between birth and 16 days of age whereas in the guinea pig DHA accumulation is largely
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pre-natal. During human brain development the DHA content increases 3-5 times in the 
last trimester of foetal life, and a further 3-5 times during the first 12 post-natal weeks. 
Similarly, in rhesus monkeys, the percentage of DHA in the cerebral cortex at birth is 
approximately half the adult value (Neuringer et al, 1988; Burdge and Postle, 1994; 
Kamazawa et al, 1991; Davison, 1965).
The precise role of DHA in brain development remains to be ascertained. The 
timing of DHA accumulation is consistent with the incorporation of this fatty acid into 
the membranes of maturing neurones prior to, and in support of, neurite extension and 
axon formation (Burdge and Postle, 1994). Addition of DHA to neuronal cell cultures 
stimulates neurite extension (Burdge, G.C., personal communication) and has also been 
reported to promote neuronal cell division (Bourre et al, 1983). The period of most 
rapid accumulation of DHA generally precedes the onset of electrical activity and the 
expression of neurite growth cone associated protein (Burdge and Postle, 1994). The 
presence of high levels of DHA in the excitable membranes of the nervous system may 
affect a range of parameters including the biophysical and structural properties of the 
membrane-bound enzymes associated with neurotransmission, membrane permeability, 
and the synthesis of eicosanoids and docosanoids (Neuringer et al, 1988).
1.4.4. Consequences o f DHA deprivation during development on neural and 
retinal function
The incorporation of DHA into neural lipids at a defined stage of differentiation 
suggests that an adequate provision of this fatty acid is specifically required during a 
particular developmental period. Consequently, a number of studies have been 
undertaken to investigate the possibility that an inadequate DHA supply during the 
developmental period may lead to irreversible impairments of neural and retinal function. 
The major conclusions of these studies have been described in reviews by Neuringer et 
al (1988) and Sanders (1988) and are discussed below.
Initial studies in which rats were fed diets deficient in n-3 but rich in n-6 fatty 
acids indicated that the brain and retina were very resistant to DHA depletion compared 
to other tissues. Furthermore, the brain subfractions which normally contain high levels 
of DHA, such as synaptosomes, showed less proportionate DHA depletion than 
oligodendrocytes, myelin and peripheral nerves, which normally have low DHA levels. 
Dietary depletion for 2 or more generations reduced DHA levels in the brain and retina 
to 8-20 % of control values. These decreases in DHA were compensated by increases in 
22:577-6 and to a lesser extent 22 An-6 so that the total level of C22-polyunsaturated 
fatty acids remained almost constant, and the degree of polyunsaturation decreased only 
slightly. Normally, 22.Sn-6 and 22 An-6 are present at very low levels in animal tissues,
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and their appearance is an indication of DHA deficiency. It is possible that these fatty 
acids are able to fulfill, at least partially, some of the roles of DHA and their synthesis 
may represent a homeostatic mechanism for maintaining neural membrane function. 
DHA-deficient rats were, however, found to exhibit a degree of visual impairment as 
quantified by electroretinogram studies on the physiological response evoked from the 
retina by brief flashes of light. Such rats also suffered to some extent from behavioural 
impairments, as reflected in reduced exploratory behaviour and in maze-leaming tasks.
Similar studies on non-human primates have also been described (Neuringer et 
al, 1988; Sanders, 1988). Feeding of diets low in n-3 but high in n-6 fatty acids to 
rhesus monkeys throughout pregnancy resulted in offspring in which, at the time of 
birth, DHA levels were reduced to 25% of control in the brain and 50% of control in the 
retina. Continuation of this n-3 deficient diet to the mothers during suckling prevented 
any further increase in neural DHA levels, in contrast to controls where the levels 
doubled. By 2 years of age, DHA levels in both tissues were 15-20 % of normal. As in 
rats, there was a quantitative substitution of 22:5n-6 for DHA. Visual acuity and 
electroretinogram function were found to be substantially impaired in the DHA-deficient 
monkeys, although tests on behavioural ability were less conclusive. The reversibility of 
n-3 deficiency was studied in 10-24 month old monkeys, after the deficiency was well 
established and brain growth was virtually complete. Supplementation of the diet with 
n-3 fatty acids resulted in an increase in cerebral DHA to control levels within 12 weeks, 
while levels of 22:5n-6 declined. However, the visual acuity and electroretinogram 
impairments did not improve, suggesting that DHA-deficiency during early development 
irreversibly alters retinal function.
These studies on rodents and primates have been confirmed and extended by 
more recent investigations (Wainwright et al, 1991; Kanazawa et al, 1991; Enslen et al,
1991). Until recently, information regarding humans has been limited, although Holman 
et al (1982) described a case of n-3 deficiency in a 6-year old child characterised by 
peripheral neuropathy and blurred vision. Evidence has, however, been accumulating 
over the last few years emphasising the importance of adequate DHA provision for the 
human foetus and neonate. Studies on premature infants have indicated that the ability 
to synthesise DHA from 18:3n-3 is inadequate to meet the demands of the nervous 
system (Carlson et al, 1987; Uauy et al, 1990). Thus DHA must be provided by the 
mother to the foetus or neonate respectively via the placenta or the milk. Indeed 
Sinclair (1975) has shown that, in rats, DHA is incorporated into the brain at 10-times 
the rate of 18:3/2-3. Post-mortem analysis of brain lipid composition in victims of 
Sudden Infant Death Syndrome indicated that infants who had been fed artificial bottle 
milk lacking in DHA exhibited deficiencies in brain DHA compared to breast-fed babies 
(Farquharson et al, 1992). Furthermore, a study on the effects of post-natal feeding on 
premature babies found that those infants who received breast milk had significantly
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higher IQ's at 8 year of age compared to those who were bottle fed (Lucas et al, 1992), 
and it was suggested that these effects were related to DHA provision. The importance 
of an adequate supply of DHA to the human foetus and neonate has been stressed in a 
recent report by the British Nutrition Foundations' Task Force (1992).
1.4.5. The route and mechanism o f DHA-delivery to the neural tissues.
In species such as the rat, where DHA accumulation is restricted to the post­
natal period, polyunsaturated fatty acids are obtained from milk lipids during suckling. 
In contrast, in the guinea pig where neuronal differentiation is essentially pre-natal, 
polyunsaturated fatty acids are delivered to the foetus via the placenta. In the human, 
where DHA accumulation in the brain occurs both pre- and post-natally, delivery of 
polyunsaturated fatty acids will initially be a placental and later a lactational function. 
However the mechanisms whereby DHA and other long chain polyunsaturates are 
delivered to the developing brain, either pre- or post-natally, are not known (Neuringer 
et al, 1988). Several mechanisms have been proposed regarding the form in which 
polyunsaturated fatty acids are taken up by the brain. On the basis of a series of detailed 
studies, Dhopeshwarkar and Mead (1973) suggested that plasma free fatty acids bound 
to albumin (or a-foetoprotein) are the preferred source, and a report by Anderson and 
Connor (1988) lent support to this view. In contrast, recent evidence that cells of the 
central nervous system express receptors for a range of lipoproteins (Pitas et al, 1987; 
Handelman et al, 1992) raises the possibility of neural uptake of polyunsaturates as 
components of plasma lipoproteins. It is of interest that receptor-mediated uptake of 
lipoproteins by foetal rabbit brain cells was found to promote neurite growth, extension 
and branching (Handelman et al, 1992). An alternative mechanism of DHA supply to 
the neonatal brain was proposed by Scott and Bazan (1989) on the basis of 
investigations using suckling rats. These studies suggested that dietary DHA from the 
milk is initially incorporated into phospholipids of the neonate's liver, and then secreted 
as the phospholipid component of very low density lipoprotein for delivery to the brain. 
A similar role for the neonatal liver as a mediator of DHA transport to the retina was 
proposed by Li et al (1992). However the means by which, in this scheme, DHA could 
be transferred from the VLDL phospholipid to the neural cells is not clear.
With regard to possible mechanisms of delivery of DHA to the foetal brain, the 
role of the placenta in the supply of lipid components from the maternal to the foetal 
circulation assumes paramount importance. In most species studied, it is clear that free 
fatty acids from the maternal plasma are able to traverse the placenta and enter the foetal 
circulation (Noble and Shand, 1981; Noble and Cocchi, 1989). In addition, the 
hydrolysis of maternal plasma triacylglycerol by placental lipoprotein lipase also results
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in the transfer of the derived free fatty acids into the foetal circulation (Noble and 
Shand, 1981; Faulkner and Jones, 1979). This transfer of free fatty acid across the 
placenta appears to be mediated by a plasma membrane fatty acid binding protein 
(Dutta-Roy, personal communication). In many species, the concentrations of 
arachidonic acid, DHA and other polyunsaturates in the foetal circulation are 
significantly higher than in the maternal circulation, and the existence of selective 
transfer and desaturation/elongation mechanisms have been demonstrated (Noble and 
Cocchi, 1989).
The delivery of DHA across the placenta in the free fatty acid form into the 
foetal circulation would be compatible with the possibility of subsequent uptake of this 
non-esterified DHA by the foetal brain in line with the views of Dhopeshwarkar and 
Mead (1973). It has been suggested, at least in the case of the guinea pig, that the foetal 
liver is not involved in the mediation of this transfer (Burdge and Postle, 1994), raising 
the likelihood that DHA is transported, in the free fatty acid form, direct from the 
placenta to the foetal brain. The period of DHA acquisition by the foetal and neonatal 
brain is accompanied by dramatic changes in the maternal hepatic DHA metabolism and 
the concentrations of DHA in the maternal plasma lipids in rats (Hunt et al, 1991), 
humans (Postle et al, 1994) and guinea pigs (Burdge and Postle, 1994).
1.5.THE CHICK EMBRYO AS A MODEL FOR N-3 FATTY ACID 
METABOLISM
The chick embryo presents several advantages as a model system for studying 
DHA transport to the neural tissues during development. Yolk lipids are the primary 
nutritive source supporting embryogenesis and the embryo exists essentially as a closed 
system within the egg utilising the pre-packaged nutrients. Consequently there is a 
temporal separation of the maternal and embryonic phases of lipid translocation. This 
contrasts with the situation in mammals where studies may be complicated by the 
continuous interaction between maternal and foetal/neonatal metabolism.
The large lipid flux through the laying hen allows for rapid diet-induced 
modulation of the fatty acid profile of the egg lipids. Anderson et al (1989) reported 
that the laying hen/newly hatched chick is a convenient model for the study of n-3 fatty 
acid metabolism and for the development of n-3 deficiency. This study indicated that 
the levels of n-3 fatty acids in the yolk, and subsequently in the plasma, brain and retina 
of the newly hatched chick can be quickly and conveniently modified over more than 10- 
fold range by feeding appropriate diets to the laying hen. Deficiency of DHA in the 
brain of the chick was associated with increased levels of 22\Sn-6. Cherian and Sim 
(1992, 1993) have also demonstrated that appropriate feeding of the parent bird is very
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effective in modulating the amount of n-3 fatty acids in the yolk and in the embryonic 
tissues. In addition, it may be envisaged that the amount of yolk lipid, and consequently 
the absolute amount of DHA available to the embryo, may be modulated simply by using 
eggs of different sizes, since the amount of yolk is proportional to egg size (Noble and 
Cocchi, 1990).
The particular features of lipid metabolism exhibited by the chick embryo may 
also help to provide insights into the characteristics of DHA transport; for example, the 
preferential uptake of yolk phospholipid species enriched in DHA and the distribution of 
considerable amounts of this fatty acid into tissue triacylglycerols (Noble and Cocchi, 
1990; Speake et al, 1993). Also, the fact that de novo synthesis of fatty acids from 
carbohydrate does not occur to any extent in the tissues of the embryo facilitates the 
interpretation of studies on the mass transfer of fatty acids from the yolk to the embryo 
(Goodridge, 1973).
An additional advantage of the avian system, as pointed out by Anderson et al 
(1989), is that in contrast to mammals where several generation of nutritional restriction 
are needed to produce major changes in brain DHA content, alterations in the levels of 
n-3 fatty acids in the yolk lipids dramatically affect the amount of DHA in the chick 
brain within a single generation, enabling the possibility to study the behavioural and 
other consequence of n-3 deprivation. Recent studies using this avian system have also 
identified a critical period in the development of the chicken when the composition of 
brain phospholipids is responsive to changes in fatty acid supply, and it was 
demonstrated that the plasticity of the embryonic and neonatal chick brain to the 
provision of DHA does not extent beyond 3 weeks after hatching (Anderson et al, 1992; 
Anderson, 1994).
As a final consideration, the variability in yolk fatty acid composition between 
different avian (and also reptilian) species (Noble, 1991) may provide an additional 
means of investigating the relationship between DHA supply and the brain fatty acid 
profile.
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MATERIALS AND METHODS
2.1.ANALYSIS OF THE LIPID COMPOSITION OE YOLK. WHOLE 
EMBRYOS. PLASMA AND TISSUES DURING DEVELOPMENT
2.1.1. Embryos
Fertile eggs from Ross 1 broiler-breeder parents (Gallus gallus), fed on a 
standard commercial diet were obtained from a commercial poultry supplier (Ross 
Poultry Farm Ltd, Inverurie, Scotland) and incubated at 37.8°C and 60% relative 
humidity in a force draught incubator (Brinsea Products, Banwell, England) with 
automatic egg turning. Hatching occurred after 21 days of incubation and the chicks 
were maintained for either 1 day with access to drinking water biut no food provision, or 
for 4 days with a commercial broiler starter diet provided from the second day.
2.1.2. Sample collections
At each developmental stage studied, 4 embryos were excised from the eggs and 
carefully separated from their associated yolk complexes (i. e. yolk plus yolk sac 
membrane). The intact embryos and yolk complexes were stored at - 20°C for up to 3 
weeks to await lipid analysis. The data from the analyses on these samples were used to 
evaluate the transfer of total lipid and of specific lipid components from the yolk to the 
embryo. An additional group of embryos at each stage were dissected to provide 
samples of specific embryonic tissues - i.e. brain, liver, heart and adipose tissue. Lipid 
analyses were performed on 4 replicate samples of these tissues; at each stage; in order 
to provide sufficient material for analysis, tissue samples from up to 10 embryos 
depending on the developmental stage were pooled to form each replicate sample. Thus 
tissues from up to 40 embryos were used at each time point. In the case of adipose 
tissue, the subcutaneous fat pads from the upper thigh area and along the sides of the 
abdomen and thorax (lateral thoracic and lateral ventral regions) was quantitatively 
dissected. The combined tissue from these sites from both sides of a single embryo is 
hereafter referred to as a "depot". Other, more diffuse sites o f  adipose tissue, such as 
those in the neck region and the ventromedial area, were not included in this study. 
Blood samples during embryogenesis were obtained from the major blood vessel of the 
chorioallantoic membrane which lies just beneath the shell. Blood samples from the 
post-hatch chick were obtained after decapitation. At each stage, 4 replicate blood 
samples were collected, with each replicate sample comprising blood from up to 10 
embryos / chicks. EDTA was used as the anticoagulant, and the plasma was obtained by 
centrifugation at 3000 r.p.m. for 20 min. The samples of brain, liver, heart, adipose 
tissue and plasma were stored at -20°C for up to 3 weeks to await lipid analysis. The
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data from these analyses were used to evaluate the distribution of lipid moieties between 
different embryonic tissues.
2.1.3. Lipid extraction
The lipid extraction method followed was that described by Folch et al (1957). 
Samples were minced with scissors and then homogenised in chloroform/methanol (2:1, 
v/v). The homogenates were then filtered through a Whatman filter paper (reference 
n°l, Whatman Labscales Ltd, Kent, UK) into measuring cylinders. The deposits on the 
filter papers were washed with an excess of the solvent.
Such chloroform/methanol extracts are known to contain sugars, urea, salts and 
amino acids in addition to lipids (Christie, 1982). In order to remove these non-lipid 
compounds an addition of a KC1 solution (0.88%, w/v) was made in a 1:4 (v/v) 
proportion to the chloroform/methanol extracts. After shaking, the mixture was left to 
stand for at least 12 hours; two phases were clearly visible : the upper "aqueous phase" 
was discarded and the lower one containing the lipids was evaporated in a round bottom 
flask on a rotary evaporator (in a water bath at 65°C).
The deposit of total lipids was then dissolved in a known volume of chloroform 
(10 ml); an addition of few milliliters of methanol was sometimes needed if a small 
amount of water was present in the samples. In such cases samples were dried again, 
and the operation was repeated until the lipid extract in chloroform was perfectly clear. 
A portion (usually half) of the chloroform extract was dried in weighed round bottom 
flasks on a rotary evaporator as mentioned above. By weighing the round bottom flasks 
plus the lipid deposit, the amount of total lipid in the sample was calculated. Portions of 
the remainder of the lipid extract (i.e. that which was not dried for gravimetric 
determination) were used for the determination of the fatty acid composition of the total 
lipid and of the individual lipid classes as isolated by thin layer chromatography.
2.1.4. Separation o f lipid classes by thin layer chromatography
20 x 20 cm glass plates were cleaned with cotton wool dampened with hexane. 
The stationary phase was Kieselgel 60 G (Merck, ATG, Darmstadt, Germany). This 
phase was applied to the plates using an aluminium spreader which was adjusted to 
deliver a layer of silica gel of defined thickness (0.25 mm). Plates were allowed to dry 
for 30 min at room temperature and were then activated in an oven for a minimum 
period of half an hour at 110°C. Plates were left to cool at room temperature before 
sample application.
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The eluting solvent was hexane/diethyl ether/formic acid (80:20:1, v/v/v), 
prepared freshly before use. 200 ml of the eluting solvent was added to the chromatank, 
which was lined with filter paper and sealed with a glass cover, and the system was 
allowed to equilibrate for 30 min before beginning the chromatography.
Lipid extracts were dried under a nitrogen stream (oxygen free). 5 mg of total 
lipid dissolved in chloroform was applied to the plate at 1 cm from the base, using a 500 
pi glass syringe. The applications were allowed to dry at room temperature before the 
plates were placed carefully in the chromatank. When the solvent front reached 1 cm 
from the top of the plate (after approximately 45 min.) the plates were removed from 
the chromatank and air dried for a few seconds. They were then sprayed with 2'7' 
dichloro-fluorescein (0.1 %, w/v in methanol) and the bands representing the lipid 
classes were visualised under ultraviolet light. The following diagram shows the lipid 
class separation obtained under these conditions:
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Figure 2.1: Separation of lipid classes by thin layer chromatography.
Bands were scraped from the plates with a spatula and all lipid classes were 
extracted by diethyl ether except for the phospholipid band where methanol was used. 
This operation was repeated 3 times each using 2-3 ml of solvent and the lipid extract 
was separated from the silica by centrifugation at 3000 r.p.m. for 3 min.
After each centrifugation, the solvent phase was poured into a round bottom 
flask. Each of the lipid classes were methylated as described in the following paragraph 
except for free cholesterol which was stored in solution in glass vial at - 20°C until 
analysis (see 2.1.7).
2.1.5.Methylation o f fatty acids
The methylation was carried out using 5 mg of total lipid or on lipid class 
extracts which had been isolated by thin layer chromatography. 1 ml of a standard
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solution of 15:0 (0.322 mg/ml in methanol) was added to all extracts. A diluted solution 
of 15:0 (0.0322 mg/ml) was used for samples with low levels of lipid (e.g. the free fatty 
acid class). 15:0 was used as internal standard as it is not found naturally in animal 
tissues (Christie, 1982). Samples were dried in round bottom flasks on a rotary 
evaporator; 4 ml of methanol/toluene/sulphuric acid (20:10:1, v/v/v) was added and the 
samples were refluxed for 35 min at 60°C. The samples were then allowed to cool and 
10 ml of water and 10 ml of hexane were added. After being shaken vigourously, 2 
layers formed quickly, the top hexane layer was pipetted off and added to a test tube 
containing a few mg of drying reagent (sodium sulphate/sodium hydrogen carbonate; 
4:1, w/w) and left for 30 minutes at least. The samples were dried down at 60°C under 
a flux of nitrogen (oxygen free), dissolved in few drops of hexane and injected onto the 
gas chromatography column.
2.1.6. Determination o f fatty acid composition by gas liquid chromatography
The samples were injected on an AMS 94 gas chromatograph linked to a Spectra 
Physics Chromjet integrator. The chromatograph was fitted with dual packed columns. 
The columns used were packed with 15% CP Sil 84 on Chromosorb W-HP 
(Chromopak UK. Ltd., Middelburg, Netherlands). The characteristics were programmed 
as follows:
Injector temperature 220°C
Detector temperature 225°C
Oven temperature 190°C
Time of analysis 45min.
N2  flow rate 20ml/min.
H2  flow rate 25ml/min.
Air flow rate 250ml/min.
Amount injected 1.5 - 2pi
The retention times of the relevant fatty acid methyl esters were determined 
using standards. The output from the integrator displayed the shorthand names of fatty 
acids, their retention times, their concentration as percentages of total fatty acids and the 
areas of each fatty acid peak. The total amount of fatty acid methyl ester (pg) in the 
sample was also given by the integrator. From this value, the amount of each lipid class 
in a given sample was calculated after multiplication by a correction factor relating the 
molecular mass of the lipid class to that of the constituent fatty acid (Christie et al., 
1970). Figure 2.2 shows a chromatogram with peak identification.
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Figure 2.2: Typical chromatogram showing fatty acid methyl esters and their
retention times, RT : retention time; I.S. : internal standard.
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2.1.7. Determination o f free cholesterol
Boehringer commercial test kits (Cat No 139050) were used for free cholesterol 
determination (Lewes, East Sussex, England). A microplate method was devised and is 
described below.
A colorimetric method was used. Cholesterol is oxidized by cholesterol oxidase 
to cholestenone (1). In the presence of catalase, the hydrogen peroxide produced in this 
reaction oxidizes methanol to formaldehyde (2). The latter reacts with acetylacetone 
forming a yellow lutidine-dye in the presence of NH4+ ions (3).
,,, „ cholesterol oxidase .4 , , , TT ^(1) Cholesterol + CL-----------------------------> A -cholestenone + F L 02
(2) Methanol + H20 2 —cata a^^ g_> formaldehyde + 2 H ,0
(3) Formaldehyde + NH* + 2 acetylacetone > lutidine - dye + 3 H20
The concentration of the lutidine-dye (3,5 diacetyl-1,4-dihydrolutidine) formed is 
stoichiometric with the amount of cholesterol and is measured by the increase of 
absorbance in the visible range at 405 nm.
40 samples were analysed per microplate. Free cholesterol extracts were dried 
down at 60°C under a nitrogen flux. A precise volume of propan-2-ol (IPA) was added 
as a function of expected cholesterol concentration (from 2 ml for the highest to 0.5 ml 
for the lowest concentration). Standard solutions of cholesterol in IP A were prepared, 
ranging in concentration from 0.1 to 1 mg/ml. 20 pi aliquots of standards and samples 
were placed into the microplate wells using a Gilson P20 pipette. The color reagent was 
added using an 8 way pipettor which delivered a volume of 250 pi into each well. The 
microplate was shaken for 15 sec. using the plate reader (Dynatech MR 5000 linked to a 
star LC-10 printer). Incubation time and temperature were as recommended by the 
manufacturer (60 - 75 min at 37 - 40°C). The optical densities (X = 405 nm) were 
measured using the plate reader and the sample concentrations were calculated using a 
linear regression obtained from the standard solutions. All standards and samples were 
measured in duplicate.
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2.2.A N A L Y SIS OF PH O SPH O LIPID  C L A SSE S B Y  H IG H  PE R FO R M A N C E
LIQ U ID  C H R O M A T O G R A PH Y  AND G A S C H R O M A T O G R A PH Y
2.2.1. Sample preparation
The total lipid extract of brain, mainly composed of phospholipid, was obtained 
as described above. The extract of phospholipids was evaporated under a nitrogen 
stream (oxygen free) in a dry block at 60°C. An appropriate amount of hexane was 
added to obtain a concentration of 40 mg/ml.
2.2.2.High performance liquid chromatography.
The system consisted of an SP 8800 ternary High Performance Liquid 
Chromatography pump (Spectra Physics Analytical Ltd., San Jose, California), an 
evaporative light scattering detector (Varex, Maryland, USA) and a Shimadzu C-R6A 
Chromatopac integrator (Dyson Instruments Ltd., Houghton-le-Spring, UK). A 10cm x 
5mm column packed with Spherisorb™ 3 p. Silica (Phase Separations Ltd., Clwyd, UK) 
was used. The mobile phase comprised a ternary solvent system of gradually increasing 
polarity:
Solvent A : hexane : tetrahydrofiiran 99:1 (v/v)
Solvent B : isopropanol : chloroform 4:1 (v/v)
Solvent C : isopropanol : water 1:1 (v/v)
Solvent were degassed with helium. The conditions were programmed as
follows :_______________________________________________________________
Time (min) % Solvents
A B C
0 100 0 0
5 80 20 0
5.1 42 52 6
25 32 52 16
25.1 30 70 0
30 100 0 0
35 100 0 0
Maximum pressure 4500 psi
Minimum pressure 1 psi
Solvent flow rate 2 ml/min
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The use of a stream splitter made the collection of the separated phospholipid 
species possible (4 fractions, Figure 3.20), splitting the flow by a ratio of approximately 
1:10 (detected:collected). After adding 100 pi of pentadecaenoic acid standard (0.322 
mg/ml) using a positive displacement pipette, the fractions were dried down in a dry 
block under nitrogen at 60°C and 0.5 ml of methylating reagent was added 
(methanol/toluene/sulphuric acid 20:10:1). Following the reflux for 30 min in the dry 
block at 60°C and then cooling, the methyl esters were extracted by addition of distilled 
water:hexane 1.5:1 (v/v) and then shaken. The upper layer (organic solvent) was 
removed using a Pasteur pipette and evaporated as described above. The lipid deposit 
was redissolved with a suitable volume of hexane (approximately 20 pi) in order to be 
injected on a gas chromatograph.
2.2.3. Gas liquid chromatography
The samples were analysed in the gas chromatography system described in 2.1.6. 
The amounts of each phospholipid class were subsequently obtained from the gas 
chromatograph data since the light scattering mass detector can only be used for 
quantitation after extensive calibration. Figure 3.20 shows a chromatograph of the 
phospholipid species separation on HPLC. Peaks were identified by injections of 
standards onto the HPLC system: phosphatidyl-ethanolamine, phosphatidyl-serine, 
phosphatidyl-inositol, phosphatidyl-choline (Sigma, Dorset, England). These 
identifications were confirmed by analysis of the peaks isolated by HPLC on High 
Performance Thin Layer Chromatography (HPTLC) plates.
2.2.4.Identification o f  phospholipid classes by HPTLC
Precoated HPTLC silica gel 60 plates (10x10 cm) were obtained from Whatman 
International Ltd, Maidstone, England. Phospholipid extracts and the phospholipid 
classes isolated by HPLC were dried down under nitrogen and redissolved in 80 pi of 
chloroform:methanol (2:1, v/v). The HPTLC plates were predeveloped fully in 
hexane:diethyl ether (1:1, v/v) to remove impurities. After drying at room temperature, 
the top 1 cm was scraped off. The plate was activated at 110°C for 1 hour. 1 pi of lipid 
sample was applied as a spot at 1 cm from the bottom of the plate. The plates were run 
at room temperature in saturated tanks designed for 10x10 cm HPTLC plates. The 
solvent used for the separation of phospholipid classes was methyl acetate : isopropanol 
: chloroform : methanol : 0.25% KC1 (25:25:25:10:9 by volume). After evaporation of 
the solvent, the plates were dried in a vacuum dessicator for 30 min. Separated 
phospholipid classes were detected by spraying the plate with 3% cupric acid (w/v) in
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8% phosphoric acid (v/v), followed by charring at 160°C for 15 min (Olsen et al, 1989). 
Figure 2.3 shows an example of the separation with identification of the various 
components according to Olsen and Henderson, 1989. The individual phospholipid 
classes chromatographed on the plate were those isolated by HPLC.
2.3.COMPARATTVE MOBILISATION OF DIFFERENT FATTY ACIDS FROM 
ADIPOSE TRIACYGLYCEROL DURING INCUBATION OF ADIPOSE 
TISSUE IN  VITRO
2.3.1. Incubation o f adipose tissue
Samples of adipose tissue were obtained from embryos and chicks at appropriate 
stages of development as described in 2.7. The freshly dissected tissue portions were 
initially collected into Dulbecco's Modified Eagle's Medium (Hepes buffered) 
supplemented with 1% (v/v) of antibiotic-antimycotic solution (penicillin / streptomycin 
/ amphotericin) and 2% (w/v) of bovine serum albumin (BSA, fatty acid free) maintained 
at 30°C. The tissue portions were chopped into small pieces (approximately 2 mm3) 
and for each replicate incubation approximately 300 mg of the tissue pieces were 
incubated in 1 ml of collection medium for 1 h at 37°C in a stoppered test tube with 
gentle shaking. Initially, polypropylene test tubes were used but because of problems 
caused by plasticisers interfering with the lipid analyses, these were replaced by glass 
tubes. Glucagon (porcine) was, where indicated, included in the incubation medium at 
final concentrations of 100 ng/ml or 1 pg/ml.
All components of the incubation media were obtained from Sigma Chemical 
Co. (Poole, Dorset, UK), except the serum albumen which was obtained from Advanced 
Protein Products Ltd (Bromsgrove, UK).
2.3.2. Fatty acid analysis
The aim was to compare the fatty acid composition of the mobilised free fatty 
acids released into the medium with that of the tissue triacylglycerol from which they 
were derived. Portions of unincubated tissue and of tissue and medium after incubation 
were extracted with a suitable excess of chloroform / methanol / HC1 (10:5:1, v/v/v) 
following the method described in 2.1.3. Triacylglycerol and free fatty acid fractions 
were isolated by thin layer chromatography (section 2.1.4.), and their fatty acid 
compositions were determined by gas chromatography (section 2.1.6.).
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Figure 2.3: Separation by HPTLC of phospholipid classes. PE : 
phosphatidylethanolamine, P I : phosphatidylinositol, PS : phosphatidylserine and 
PC : phosphatidylcholine. 1 and 6 : total phospholipid extract, 2 : PE, 3 : PI, 4 : 
PS and 5 : PC.
1 2 3 4 5 6
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2.4.STUDIES ON EMBRYOS OF OTHER AVIAN SPECIES
During the course of this study, a single experiment was carried out using 
embryos of the duck {Anas platyrhynchos). Fertile duck eggs were obtained from a 
commercial producer. The incubation conditions were as described for the chicken 
except that a higher degree of humidity was maintained by spraying the eggs twice a day 
with water using an aerosol can. The incubation time of duck eggs is 28 days. Samples 
of duck embryo brain were obtained at appropriate developmental stages. Also a single 
experiment was performed using eggs of the wild pheasant {Phasianus colchicus). The 
parent birds were free-living in a shooting estate in Galloway Scotland, laying the eggs 
in ground nests. The eggs were collected within 24 hours of laying with landowner's 
permission. The eggs were incubated at 37.5°C and 60% relative humidity. The 
incubation period for pheasant eggs is 24-26 days, and samples of adipose tissue were 
obtained at 16 days.
2.5.STATISTICAL ANALYSIS
Where indicated, statistical comparisons were performed using a 2 tail Student's 
t test or analysis of variance.
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RESULTS
3.1.TRANSFER OF DHA FROM THE YOLK TO THE TISSUES OF THE
EMBRYO
In this study, the changes during development in the amount of DHA in the lipids 
of the yolk, whole embryo, plasma, adipose tissue, liver, heart, and brain were 
quantified. The intention was to evaluate the rate of transfer of this fatty acid from the 
yolk and its subsquent distribution into specific tissue lipids, with the aim of obtaining 
information regarding the mechanism and route by which DHA is delivered to the brain.
3.1.1. Characteristics o f eggs prior to incubation.
In order to study the effect of variations in the amount of lipid available to the 
embryo, and in particular the consequences of differences in the supply of DHA from the 
yolk, 2 experiments were performed using batches of eggs which differed in initial 
weight and therefore in initial yolk lipid content. These batches are henceforth referred 
to as "small" (experiment 1) and "normal" size (experiment 2) eggs and were obtained 
from laying birds of 23 and 33 weeks of age respectively.
The results in Table 3.1 indicate that the initial amount of total lipid was 1.5-fold 
greater in the "normal" compared to the "small" eggs. The results in Tables 3.2 and 3.3 
indicate that the percentage composition of fatty acids in triacylglycerol and 
phospholipid were very similar in the 2 experiments, and that most of the initial yolk 
DHA was present as a component of phospholipid.
3.1.2. Changes in lipid composition and DHA content o f  the yolk complex 
during development
The changes in the total lipid content of the yolk complex (i.e. yolk plus yolk sac 
membrane) during development are depicted in Figure 3.1. In both experiments, there 
was very little removal of yolk lipid during the initial period of incubation, followed by a 
very rapid mobilisation during the final week, in agreement with previous work (see 
section 1.3.2). In the "small" egg experiment, the proportion of cholesteryl ester in the 
total lipid increased dramatically by the end of the embryonic period with corresponding 
decreases in the proportion of triacylglycerol and phospholipid (Table 3.4). However, 
development within the "normal" size eggs was characterised by a relative constancy in 
the proportions of the lipid classes (Table 3.5, Figure 3.2). The percentage fatty acid 
composition of the total lipid of the yolk complex showed very little change throughout 
development in both experiments. For example, the proportionate levels of the major 
fatty acids present, i.e. 16:0, 18:0, 18:1, 18:2, at day 22 (i.e. one day post hatch) were
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not significantly different from the initial yolk values. In contrast, the proportion of 
DHA was significantly reduced during development in both experiment, by 66 % and 
53% in the "small" and "normal" size eggs respectively (Tables 3.6 and 3.7). This 
observation suggests that DHA may be transferred preferentially from the lipids of the 
yolk. The percentage fatty acid compositions of the TG, PL and CE of the yolk 
complexes throughout development for the "normal" size egg incubation are shown in 
Tables 3.8, 3.9 and 3.10 respectivelly. There were no significant changes in the fatty 
acid composition of the TG fraction during development. However, the fatty acid 
composition of the PL fraction did show some changes; in particular the proportion of 
DHA decreased some 8-fold between day 12 and 22, consistent with previous evidence 
that PL-species enriched in DHA are preferentially taken up from the yolk (section 7.5). 
The fatty acid composition of the CE fraction changed dramatically during development; 
the proportion of 18:1 increased significantly with corresponding decreases in the 
proportions of 16:0 and 18:2. These changes are consistent with the specific synthesis 
of cholesteryl oleate by the ACAT reaction in the yolk sac membrane, as previously 
documented (section 1.3.2).
The amount (mg/yolk) of the major fatty acyl components of the total lipid of the 
yolk complex during development are given in Tables 3.11 and 3.12. In order to 
express these changes on the same scale, the amounts of each fatty acid are depicted as a 
% of the respective amount in the initial yolk (Figures 3.3 a and b). For purposes of 
clarity, only the values for 16:0, 18:1 and DHA are shown. The results in Figure 3.3 
indicate that the 2 most abundant fatty acyl components of yolk lipid, 18:1 and 16:0, 
exhibited identical transfer kinetics. In addition (data not shown), the transfer of 18:0, 
18:2, 18:3 and 20:4 followed a pattern identical to that of 18:1 and 16:0. In contrast, 
during the final week of embryogenesis, DHA in both experiments was transferred from 
the yolk complex at a significantly higher rate than exhibited by the other fatty acids.
3.1.3. Changes in the lipid composition and DHA content o f the whole embryo 
during development
The major parameters relating to the lipid composition of the whole embryo 
during development are presented in Tables 3.13 and 3.14 and the changes in the 
amount of total lipid per embryo are depicted in Figure 3.4. It can be seen from these 
results that the total lipid content per embryo was 1.5-fold greater by the time of 
hatching when development occurred in the "normal" size eggs compared to the "small" 
eggs; i.e. closely reflecting the differences in the initial amounts of yolk lipids.
The changes in the proportions of TG and PL in the whole embryos are 
illustrated in Figure 3.5. During the first half of development, PL was by far the major 
lipid class present in the embryo. However during the final week of development the 
proportion of PL declined in parallel with a dramatic increase in the proportion of TG
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with the "crossover point" occurring around day 14. The amounts (mg/embryo) of the 
different lipid classes in the whole embryo during development are depicted in Figure
3.6. The final week of development was characterised by a dramatic rise in the amount 
of TG in the embryo, co-incident with the phase of rapid lipid transfer from the yolk, 
followed by a decrease in the TG content over the hatching period. The amount of TG 
deposited during development reflected the amount present in the initial yolk, whereas 
the amounts of PL, CHOL and CE in the newly-hatched chick were less affected by the 
initial yolk lipid content (Figure 3.6 a and b). The fatty acid composition (% w/w of 
total fatty acids) of the major lipid classes are presented in Tables 3.15, 3.16, 3.17, 3.18, 
3.19 and 3.20. A consistent pattern was observed in which the proportions of DHA and 
also AA, in TG and CE were relatively high at around day 12 and then decreased as 
development proceeded towards hatching. The proportion of DHA in PL was also high 
at around day 12 but decreased only slightly thereafter. In experiment 1 where 
measurements were taken as early as day 6, it was noticeable that the proportion of 
DHA in all 3 lipid classes was very high even at this early stage.
In order to express the changes in the levels (mg/embryo) of each fatty acid on 
the same scale, and to facilitate comparisons with the changes in the yolk, the values are 
depicted in Figure 3.7 in terms of the amount of the fatty acid per embryo as a 
percentage of the amount present in the lipids of the initial yolk. For clarity, only the 
results for DHA, AA and 18:1 are shown. It is clear from Figure 3.7 that the rate of 
DHA and AA accumulation in the embryo lipids during the early part of the final week 
of embryogenesis was especially high in comparison to 18:1. Furthermore (data not 
shown), the accumulation of 16:0, 18:0, 18:2 and 18:3 followed a pattern essentially 
identical to that of 18:1.
The results in Figure 3.7 also indicate that the amount of DHA which 
accumulated in the embryo, expressed as a percentage of the initial yolk level of this 
fatty acid, was considerably less during incubation of the "normal" size eggs in 
comparison to the "small" eggs. This suggests that a greater proportion of the 
transferred DHA was oxidised for energy provision during incubation of the "normal" 
size eggs. Table 3.21 depicts the levels of the major fatty acids recovered in the lipids of 
the day-old as percentages of the amounts transferred from the yolk by this stage. This 
results suggest that AA and DHA are relatively resistant to p-oxidation in the embryo in 
comparison to the C16 and C l8 fatty acids, and that these differences on oxidative 
susceptibility were more pronounced during development within the "small" eggs.
Comparison of the levels of TG and PL recovered in the day-old chick with the 
amounts transferred from the yolk indicates that major proportions of both lipid classes 
were utilised for energy purposes during development (Table 3.22). These results also 
suggest that a greater proportion of the transferred TG was oxidised during incubation 
of the "small" eggs, whereas the reverse was the case for PL.
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The distributions of DHA and 18 :1 between TG and PL of the whole embryo for 
experiment 2 are illustrated in Figure 3.8. The amount of 18:1 (mg/embryo) in the TG 
fraction increased continuously until hatching, whereas much lower levels were present 
in PL. In contrast, the incorporation of DHA into TG followed a different pattern, 
reaching a plateau level by day 15 which was maintained until day 19, then decreasing 
dramatically over the hatching period. The incorporation of DHA into PL increased 
continuously from day 13 so that by day 19 this fatty acid was almost equally distributed 
between PL and TG.
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Table 3.1: Characteristics of ’’small” (experiment 1) and
’’normal”.(experiment 2) size eggs prior to incubation. Values are the means ± 
S.E.M. of measurements on 4 eggs with the exception of egg weights where n=10. 
The amounts (mg/yolk) of DHA and of other major fatty acids in the total lipids of 
the yolk are shown. Significant differences for values on the same line (between 
experiments) are illustrated with superscript character aP<0.05, bp<0.01, 
CP<0.001, nP>0.05 not significant.
Experiment
2
Age of parental flock 
(weeks)
23 33
Egg weight (g) 
Total lipid (g/yolk)
46.3 ±0.4 
3.8 ± 0.1
62.2 ± 0.7 c 
5.7 ± 0.1 c
Lipid class % (w/w) 
of total lipid
CE
FFA
TG
PL
CHOL
80.4 ±6.2
13.0 ±3.0 
4.7 ± 1.2
2.0 ± 1.1 
3.6 ± 1.0
70.5 ± 0.4 n
20.5 ± 0.8 n 
6.6 ± 0.6 n 
1.7 ± 0.1 n
0,86 ± 0.07 a
mg fatty acid/yolk
16:0
18:0
18:1
18:2
18:3
20:4
22:6
681.2 ±34.0 
267.1 ± 14.9 
1144.8 ±77.6 
469.5 ±31.0 
30.2 ±2.9 
61.1 ±7.0 
32.9 ±3.0
1086.5 ±27.3 c 
413.8 ± 12.0 c 
1757.7 ± 61.6 c 
689.6 ±71.1 a
54.1 ±6.2 a
73.1 ± 3.8 n 
93.8 ± 4.7 c
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Table 3.2: Fatty acid composition of yolk triacylglycerol (% w/w of total 
fatty acid). Details are as described in Table 3.1.
1
Experiment
2
16:0 24.7 ±0.3 25.1 ± 0 .7 n
18:0 6.2 ±0.2 6.9 ± 0.4 n
18:1 40.6 ±0.5 45.7 ± 0.1 c
18:2 21.0 ± 0.4 15.3 ± 1.4 b
18:3 1.9 ± 0.1 1.4 ± 0.2 n
20:4 0.42 ±0.03 0.27 ± 0.02 b
22:6 0.39 ±0.03 0.22 ± 0.02 b
Table 3.3: Fatty acid composition of yolk phospholipid (% w/w of total 
fatty acid). Details are as described in Table 3.1.
1
Experiment
2
16:0 27.3 ±0.3 27.9 ± 0.3 n
18:0 17.6 ±0.3 16.8 ± 0.4 n
18:1 21.3 ±0.4 24.6 ± 0.8 a
18:2 16.7 ±0.2 16.0 ± 0.5 n
18:3 0.33 ±0.1 0.40 ±0.03 n
20:4 6.5 ±0.2 5.5 ± 0.1 b
22:6 8.1 ±0.2 6.3 ±0.3 b
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Figure 3.1: Transfer of total lipid from the yolk complex during 
development. The values for the "small" ( • )  and "normal" size (O) eggs are 
shown. The results represent the mean ± S.E.M. of measurement on 4 yolk 
complexes. Hatching occurred on day 21, i.e. day 22 refers to 1 day after 
hatching.
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Table 3.4: Lipid classes of the yolk complexes from experiment 1 (% w/w of 
total lipid). Statistical comparison refers to day 22 vs day 18; symbols (a, b, c, n) 
as in Table 3.1.
Dav 6 11 13 15 18 22
TG 65.1 ± 0 . 7 67.9 ±0 .7 69.4 ±3 .8 64.0 ± 6 .0 65.2 ±2.2 n 42.1 ±1.6a
PL 25.1 ± 1.6 19.3 ± 1.4 16.7 ± 1.0 25.0 ± 6 .7 20.2 ± 1.7 14.5 ±0.3a
CHOL 5.3 ±0 .6 4.6 ±0 .3 4.6 ±0 .5 4.2 ± 0 .4 4.1 ± 0 . 2 4.4 ± 0.6n
CE 2.6 ±0 .5 3.3 ± 1.0 3.5 ± 0 . 7 4.2 ±0 .4 9.1 ±0 .8 35.1 ±2.3a
FFA
Amount
1.9 ± 0.2 5.0 ±2 .2 6.0 ±2 .6 2.8 ± 1.7 1.4 ±0 .2 2.8 ± 1.1
of total 
lipid 
(g/yolk)
3.2± 0.2 3.3± 0.6 3.0 ±0.3 2.7 ±0.3 1.3 ±0.1 0.24±0.08
Table 3.5: Lipid classes of the yolk complexes from experiment 2 (% w/w of 
total lipid). Statistical comparison refers to day 22 vs day 18; symbols (a, b, c, n) 
as in Table 3.1.
Dav 12 13 14 15 18 19 22
TG 71.3 ±2 .3 70.1± 2.2 70.6± 2.0 68.7± 0.5 72.8± 0.4 72.4± 0.7 77.9 ±0.9b
PL 19.9 ±1 .6 20.4± 1.6 21.1 ±1.0 22.8 ±1.7 24.1 ±1.0 20.1± 0.6 13.2± 1.6b
CHOL 4.4 ±0 .6 3.9 ±0 .5 5.3 ±2 .4 3.6± 0.1 2.6 ± 0 . 7 3.9 ±0 .6 6.6 ± 1 8n
CE 1.6 ±0 .2 1.2 ±0 .2 2.5 ±0 .3 2.5 ± 0 . 7 1.7 ±  1.0 3.1± 0.4 1.8 ± 0.8n
FFA 1.5 ±0 .6 2.8 ±0.1 1.5 ± 0.2 1.7 ± 0.1 0.8 ±0 .3 0.9 ±0 .4 1.7± 0.8n
Amount of
total lipid 5.2 ±0 .3 4.8 ±0 .2 4.8 ±0 .2 4.4 ±0.1 2.9 ±0 .2 2.4 ±0.1 0.5 ±0 .3
(a/yolk)
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Figure 3.2: Distribution of lipid classes of yolk complexes. The amounts 
(mg/yolk) of TG (•), PL (O), CHOL (■) and CE(D) were determined from 
experiment 1 (graphs a and b) and experiment 2 (graphs c and d) throughout 
development. Results are means of 4 replicate tissue samples and in all cases the 
SE's were less than 10 % of the means.
xaidiAioo >hoa d3d ssvno aidn do Bui
xdidwoo >hoa aad ssvno aidn do Biu
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Table 3.6: Fatty acid percentage composition of yolk total lipid during 
development (experiment 1). Results are % w/w of total fatty acids. Statistical 
comparison refers to day 22 vs day 0; symbols (a, b, c, n) as in Table 3.1.
Day 0 6 11 13 15 18 22
16:0 25.4 ±  1.3 24.7 ± 1.0 24.0 ±0 .8 25.1 ±2 .3 25.0 ± 2 .0 24.1 ± 2 .6 20.1 ±2.5n
18:0 9.9 ±0 .6 9.3 ±0 .4 8.7 ±0 .6 9.2 ±0 .6 9.1 ±0 .6 9.7 ± 1.1 9.9 ±  1.4n
18:1 42.6 ±2 .9 44.3 ± 3.5 42.3 ± 1.1 41.8 ±  3.3 42.7 ±3 .3 44.0 ± 3 . 7 49.1 ±5.7n
18:2 17.5 ± 1.1 16.8 ±2.1 20.0 ± 2 . 8 18.6 ±  1.9 18.6 ±1.1 17.6 ±2 .1 17.7 ± 1 ,7n
18:3 1.1 ±0.1 1.1 ±0 .2 1.3 ± 0.2 1.4 ±0 .2 1.2 ± 0.1 2.1 ±0 .2 0.9 ±  0.2n
20:4 2.3 ±0 .3 2.5 ±0 .2 2.3 ±0 .2 2.6 ±0 .2 2.4 ±0 .2 2.5 ±0 .3 1.9 ± 0.1n
22:6 1.2 ± 0.1 1.4 ±0.1 1.4 ± 0.1 1.3 ± 0.1 1.0 ± 0.1 0.9 ±0 .1 0.4 ±  0.1b
Table 3.7: Fatty acid percentage composition of yolk total lipid during 
development (experiment 2). Results are % (w/w) of total fatty acids. Statistical 
analysis performed on values of 22 against values of day 0.
Day 0 12 13 14 15 16 18 19 22
16:0 26.1 ±1.3 25.8 ±1.6 26.4 ±1.2 25.9 ±0.9 25.4 ±0.9 26.3 ±2.0 25.4 ±0.3 25.7 ±1.6 24.2± 6.5n
18:0 9.9 ±0 .6 9.7 ±0 .9 10.0 ±0.4 9.4 ±0 .5 9.8 ±0 .4 9.4 ± 1.6 10.6 ±0.3 9.7 ±1.1 10.7± 2.3n
18:1 42.2 ±3.0 43.0 ±3.4 41.9 ±1.8 42.9 ±1.3 42.5 ±2.1 44.0 ±5.0 42.3 ±2.9 43.3 ±3.6 45.4±13.0n
18:2 16.5 ±3.4 16.4 ±0.8 16.7 ±1.2 16.7 ±0.5 17.6 ±1.4 16.0 ±1.5 17.3 ±0.8 17.3 ±1.8 16.2± 1.7n
18:3 1.3 ±0 .3 1.4 ±0.04 1.38±0.06 1.35±0.06 1.3 ±0.1 1.2 ± 0.1 1.2 ± 0.1 1.4 ±  0.1 1.2 ±0.111
20:4 1.8 ± 0.2 1.7 ± 0.1 1.8 ± 0.2 1.8 ± 0.1 1.7 ±0.1 1.6 ±0 .3 1.9 ±0 .2 1.6 ±0 .2 1.2 ±0.1a
22:6 2.3 ± 0 .2 2.0 ±0.1 1.8 ±0.2 2.0 ±0 .2 1.8 ±0 .2 1.4 ±0 .2 1.2 ±0.1 1.1 ±0.1 1.1 ±0.0b
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Table 3.8: Fatty acid composition of triacylglycerol of the yolk complex 
during embryonic development for experiment 2 (% w/w of total fatty acids). 
Statistical comparison refers to day 22 vs day 12; symbols (a, b, c, n) as in Table 
3.1.
Acid D12 13 14 15 18 19 22
16:0 26.5 ± 0 . 7 26.7 ±0 .9 25.9 ±0 .6 24.9 ±0 .3 26.1 ± 0 . 7 27.0 ± 0.6 26.4 ±0.8n
18:0 6.6 ±0 .3 6.9 ±0 .2 6.4 ±0 .3 6.7 ±0 .5 6.4 ±0 .3 6.4 ±0.1 8.4 ± 0.9n
18:1 48.1 ±0 .6 47.3 ± 1.8 46.5 ± 1.4 48.3 ±  1.0 48.0 ± 1.0 46.3 ±  1.7 46.6 ±1.4n
18:2 11.8 ± 0.5 11.9 ± 0.8 13.3 ± 0.8 12.1 ±0 .8 12.3 ±0 .2 12.7 ± 1.2 12.40± 0.03n
18:3 0.81 ±0.03 0.85 ±0.03 0.97 ±0 .05 0.88 ±0 .05 0.84 ±0 .05 1.1 ±0 .3 0.83± 0.01n
20:4 0.33 ±0 .07 0.33 ±0 .02 0.35 ±0 .06 0.42 ±0.06 0.33 ±0.02 0.37 ±0 .05 0.42± 0.03n
22:6 0.48 ±0 .16 0.58 ±0 .02 0.78 ±0.11 0.74 ±0 .05 0.44 ±0 .08 0.61 ±0 .08 0.60± 0.06n
Table 3.9: Fatty acid composition of phospholipid of yolk complex during 
embryonic development for experiment 2 (% w/w of total fatty acids). Statistical 
comparison refers to day 22 vs day 12; symbols (a, b, c, n) as in Table 3.1.
Acid D12 13 14 15 18 19 22
16:0 29.5 ±0 .3 31.3 ± 1.0 29.4 ±0.3 31.7 ± 0.4 29.4 ±0 .5 31.1 ±0 .8 28.3 ±0.7n
18:0 18.3 ±0 .2 16.7 ±0 .8 18.1 ±0.3 15.2 ± 0 .4 17.1 ±0 .4 16.8 ± 1.0 20.1 ±1.0n
18:1 25.9 ±0 .4 27.8 ± 1.1 28.1 ±0 .2 28.3 ± 1.0 30.4 ±0 .5 29.6 ± 0.9 30.9 ± 0 . 4 °
18:2 12.4 ±0 .5 13.0 ±0 .5 13.4 ± 0.6 13.3 ± 0.2 13.5 ±0 .2 13.5 ± 0 .6 13.8 ± 0.3n
18:3 0.24 ±0.01 0.27 ±0.01 0.29 ±0.01 0.30 ±0 .05 0.33 ±0.04 0.29 ± 0.02 0.29 ±0.06n
20:4 5.4 ±0.1 4.9 ±0 .3 ND 4.3 ±0.1 4.5 ±0 .2 3.9 ±0 .6 4.0 ± 0.1c
22:6 6.03 ±0.11 5.0 ±0 .3 4.87 ±0 .04 4.3 ± 0 .3 2.4 ±0 .3 2.20 ±0 .08 0.76±0.09c
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Table 3.10: Fatty acid composition (% w/w of total fatty acids) of yolk 
cholesteryl ester during embryonic development for experiment 2. Statistical 
comparison refers to day 22 vs day 12; symbols (a, b, c, n) as in Table 3.1.
D12 13 14 15 18 19 22
16:0 16.5 ±  1.1 18.4 ±  2.0 15.9 ±  1.4 12.8 ±  1.4 13.5 ±  2.3 8.6 ±  0.9 5.5 ±  1.0°
18:0 7.7 +  0.8 7.5 + 0.3 8.9 ±  1.3 7.6 ±  0.5 5.9 ±  0.3 5.7 ±  0.6 5.7 ±  0.5n
18:1 51.5 + 1.4 56.2 ± 2.9 52.7 + 2.9 60.2 ±  1.9 63.1 ±  3.7 67.4 ±  1.1 73.8 +  1. l c
18:2 15.6 ±  0.5 13.3 ±  1.7 13.5 ±  1.2 13.2 ± 1.0 7.4 ±  0.7 10.7 ±  0.7 9.3 ±  0.2°
18:3 ND 0.32 ±  0.2 0.1 ±  0.1 0.4 ±  0.2 0.5 + 0.1 0 .54±0 .08 0.7 ±  0.4
20:4 1.9 ±  0.9 ND 2.4 ± 0.7 1.4 ±  0.4 1.2 ±  0.7 0.9 ±  0.1 0 .8 ±0 .03 n
22:6 2.4 ±  0.3 ND 4.0 ±  1.0 5.2 ±  5.2 2.1 ± 0.3 2.0 ±  0.2 1.8 ±  0.1n
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Table 3.11: Fatty acid composition (mg/yolk) of yolk total lipid during 
embryonic development for experiment 1.
DayO 6 11 13 15 18 22
16:0 681 ±  34 559 +  22 516 ±  18 540 +  50 451 +  36 226 +  24 19.9 ±  2.5
18:0 267 ±  15 211 ±  10 186 +  12 198 ±  12 164 ±  10 91 +  10 9.8 +  1.4
18:1 1145 ±  78 1003 ±  80 908 ±  23 900 ±  70 770 ±  60 412 +  35 48.6 +  5.6
18:2 470 ±  31 381 ±  49 430 ±  60 400 ±  40 335 + 20 165 ±  20 17.5 +  1.7
18:3 30 ±  3 24 ±  4 29 ±  4 30 ±  4 22 +  2 11 ±  2 0.9 ±  0.2
20:4 61 ±  7 57 + 4 50 + 4 57 +  4 43 +  3 23 +  3 1.9 + 0.1
22:6 33 ±  3 3 1 + 3 30 + 2 28 +  3 18 +  1 8 ±  1 0.4 ±  0.1
Table 3.12: Fatty acid composition of yolk (mg/yolk) during embryonic 
development for experiment 2.
Dav 0 12 13 14 15 18 19 22
16:0 1087 + 27 1067 ± 52 1038 + 56 1008 ±  19 972 ±  33 714 +  5 624 ±  14 182.9+4.0
18:0 414 ±  12 370 ±  22 349 ±  19 336 .9±3 .2 319 ±  18 248 ±  12 195 ±  3 68.6 ±  2.3
18:1 1758 + 62 1782 ±  75 1680 +121 1673 ±  88 1625 ±  89 1260 + 40 1008 ±  41 346.7 + 7.4
18:2 690 ±  71 538 ±  32 478 ±  14 529 ±  29 471 ±  18 357 +  8 306 ±  23 100 ±  3
18:3 54 +  6 55.4+12.7 31.2 + 0.9 35.5 ±  1.5 31.0 ±  1.3 24.6 ±  0.4 19.8 + 0.9 6.2 ±  0.2
20:4 73.1 ±  3.8 69.8 +  4.1 58.8 ±  4.0 59.0 +  3.6 51.3 ±  2.0 40.9 ±  2.8 31.9 ±  1.4 8.9 ±  0.4
22:6 93.8 + 4.7 98.5 ±  6.2 81.8 + 6.3 84.6 ±  8.7 68.4 ±  1.3 39.1 ±  2.6 31.7 ±  2.2 10.9 ±  1.9
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Figure 3.3: Transfer of fatty acids from the lipids of yolk complex. Changes 
in the level of oleic acid (O), palmitic acid (•)  and DHA (□ ) are shown during 
incubation of "small" (a) and "normal" (b) size eggs. Values are expressed as 
percentage of the amounts in the initial yolks prior to incubation and are the 
means of 4 replicates. Comparison between oleic acid and DHA values : 
bP<0.002, CP<0.02, dP<0.05.
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Table 3.13: Lipid composition and fatty acid content of whole embryos 
during development (experiment 1). The amount (mg) of each major fatty acid as 
a component of the total lipid per embryo is shown. Day 22 refers to 1 day after 
hatching. Results are the means ± S.E.M. of measurements on 4 embryos per 
time-point. Statistical analysis to the comparison between days 6 and 22 or 18 on 
the same line, same as Table 3.1.
D a v 6 11 13 15 18 22
Embryo wt (g) 0.36 ±0 .02 3.5 ±0 .6 8.2 ±0 .6 13.9 ± 0.4 23.8 ±0 .6 36 ± 5
Total lipid /
embryo or 2.9 ±0 .2 45.3 ±0 .5 128 ± 15 359 ± 39 1080 ± 9 0 1080 ± 21 0
chick (mg)
Lipid class %
(w/w) of total
lipid
CE 14.1 ± 1.5 16.8 ±2 .3 14.1 ±4 .5 9.2 ± 1.9 8.9 ±0 .4 16.6 ± 4.6n
TG 16.6 ±3 .4 14.2 ± 1.3 23.2 ± 3.2 45.2 ± 5.6 65.7 ± 3.5C 33.7 ± 7.6n
FFA 13.1 ±0 .3 4.7 ±0 .4 4.8 ± 2.5 9.1 ±0 .9 6.6 ± 0.8 17.3 ± 2 . 7n
PL 51.9 ± 2.8 49.8 ±7.1 42.5 ±4 .0 27.9 ±4 .6 10.2 ± 1.7 19.3 ± 2 .9 °
CHOL 14.2 ±4 .4 14.5 ±1.1 15.6 ± 1.9 8.6 ±3 .9 9.4 ± 1.4 13.1 ± 1.9n
mg fatty acid /
embryo or
chick
16:0 0.51 ±0 .03 5.30 ± 1.40 17.5 ± 2 .8 60.1 ±6 .8 201 ±  19 136±32
18:0 0.24 ±0.01 3.10 ± 0.85 9.6 ± 4.6 25.0 ±2 .2 68 ± 6 68 ± 9
18:1 0.35 ±0.02 4.43 ± 1.41 17.8 ± 3 . 7 75.4 ± 11.5 269 ± 30 208 ± 42
18:2 0.09 ±0.01 1.33 ± 0.41 8.2 ± 1.7 39.5 ± 4.6 134 ± 14 114 ± 25
18:3 0.01 ±0.001 0.04 ± 0.02 0.5 ±0 .53 2.3 ±0 .2 6 ± 1 5 ± 3
20:4 0.18 ±0.01 3.61 ±0 .25 8.2 ±  1.4 16.4 ± 1.0 31 ± 1 44 ± 5
22:6 0.88 ±0.01 1.78 ±0 .57 5.7 ± 0.9 12.2 ± 1.0 16 ± 1 20 ± 2
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Table 3.14: Lipid composition and fatty acid content of whole embryos 
during development (experiment 2). The amount (mg) of each major fatty acid as 
a component of the total lipid per embryo is shown. Day 22 refers to 1 day after 
hatching. Results are the means ± S.E.M. of measurements on 4 embryos per 
time-point. Statistical analysis to the comparison between days 12 and 22 on the 
same line.
Day 12 13 14 15 16 19 22
Embryo / 6.1 ±0 .9 8.9 ±0 .2 13.9 ±1 .0 16.2 ± 1.0 20.5 ±0 .6 31.9 ± 3.2 39.0 ±2 .8
chick wt (g)
Total lipid / 
embryo or
91.3 ±2 .4 110.6 ±  12.2 241.8 ± 16.1 408.5 ± 3.4 703.3 ±65.3 1557.6 ±  
235.7
1448.3 ± 
156.7
chick (mg) 
Lipid class % 
(w/w) of  total 
lipid
CE 8.1 ± 1.2 7.2 ±0 .8 4.9 ±0 .2 5.7 ±0 .3 5.9 ±0.1 6.1 ±0 .3 10.7 ± 0.4n
TG 18.3 ±2 .3 34.1 ±5 .4 52.7 ±1 .7 60.4 ± 4.0 66.4 ± 4.4 75.5 ± 1.5 59.3 ± 2 . 9C
FFA 3.4 ±0 .4 3.6 ±0 .8 3.3 ±0 .2 3.0 ±0 .3 2.3 ±0 .5 2.6 ±0 .5 5.4 ±  0.9n
PL 53.2 ±3 .5 41.8 ±5 .9 30.1 ±0 .6 25.1 ± 1.6 19.0 ± 3.3 11.8 ±  1.1 14.0 ±2 .9 °
CHOL 16.5 ±4 .4 12.7 ± 2.8 9.1 ± 1.2 8.5 ± 0 .2 6.3 ±0 .8 4.6 ±0 .3 10.7 ± 4.3n
mg fatty acid 
/ embryo or 
chick
16:0 11.9 ± 0.3 15.7 ± 1.9 40.0 ± 3.0 71.3 ± 0 .6 108.5 ± 12.5 303.0 ±47.1 255.3 ±  17.8
18:0 6.65 ± 0.09 8.1 ±0 .6 16.7 ±  1.3 30.8 ±0 .5 43.6 ±4 .5 94.4 ± 12.5 101.1 ±6 .2
18:1 10.2 ±0 .3 13.9 ± 1.9 42.8 ±3 .5 82.6 ±0 .5 128.3 ± 18.3 365.5 ±47 .2 365.7 ±3 .7
18:2 4.5 ±0 .5 6.0 ± 1.0 21.4 ±2 .4 44.1 ±2 .9 68.6 ±6 .2 157.9 ± 6 .9 169.0 ±20 .4
18:3 0.25 ± 0.03 0.35 ±0.07 1.5 ±0 .2 2.9 ±0 .3 4.8 ±0 .7 9.5 ± 0 . 7 10.7 ±2 .2
20:4 4.9 ±0 .2 5.9 ±0.3 9.7 ±0 .4 15.0 ±0.5 19.6 ± 1.3 21.6 ± 1.6 34.8 ±6 .2
22:6 5.71 ±0 .04 6.5 ±0 .4 12.6 ± 0.3 21.9 ± 1.9 23.2 ±2 .3 21.5 ± 2.8 28.4 ±5.1
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Figure 3.4: Changes in the amount of total lipid (mg) per embryo. The 
values for embryos from "small" (• )  and "normal" (O) size eggs are shown. 
The results represent the mean of measurements on 4 embryos. Hatching 
occured on day 21, i.e. day 22 refers to 1 day after hatching.
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Figure 3.5: Proportions of major lipid classes in the whole embryo 
throughout development. The proportions (% of total lipid) of TG (O) and PL 
( • )  from experiment 1 (a) and experiment 2 (b) are shown. The results 
represent the mean of measurements on 4 embryos and are based on the data in 
Tables 3.13 and 3.14. Hatching occurred on day 21, i.e. day 22 refers to 1 day 
after hatching.
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Figure 3.6: Levels of the major lipid classes in the embryo during 
development. The amounts (mg/embryo) of TG (•), PL (O), CE (□ ) and 
CHOL (■) are shown during incubation of "small” (a) and "normal" (b) eggs. 
Values are the mean of measurements on 4 embryos and are based on the data 
in Tables 3.13 and 3.14.
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Table 3.15: Fatty acid composition (% w/w of total fatty acid; means ± 
S.E.M. of 4 embryos) of whole embryo triacylglycerol from experiment 1.
Dav 6 11 13 15 18 22
16:0 24.7±1.0 24.2±0.9 25.6±0.6 27.4±1.0 26.2±0.9 28.1±0.2
18:0 11,2±0.5 12.2±0.6 8.2±0.3 7.6±0.3 8.8±1.5 7.3±0.4
18:1 34.5±1.0 28.0±1.6 33.9±1.0 37.1i l .5 38.3±0.1 38.3±1.7
18:2 12.1±1.2 11.2±0.2 18.4±0.1 18.3±0.5 20.3±0.5 18.8±1.4
18:3 0.9±0.07 0.77±0.006 1.24±0.08 1.07±0.09 1,00±0.08 1.02±0.1
20:4 4.3±0.7 7.7±1.2 3.6±0.2 2.2±0.3 1.5±0.2 1.7±0.3
22:6 8.9±0.6 9. l i l . 9 4.8±0.6 2.6±0.3 0.6±0.2 1.0±0.3
Table 3.16 : Fatty acid composition (% w/w of total fatty acid; 
S.E.M. of 4 embryos) of whole embryo phospholipid from experiment 1.
means ±
Dav 6 11 13 15 18 22
16:0 32.7±1.4 30.5±0.3 26.9±0.5 27.0±0.5 27. l i l  .5 29.2±0.4
18:0 14.5±0.3 16.0±0.6 16.7i0.4 18.1±0.3 21.6i0.5 17.9i0.6
18:1 19.6±0.5 18.8±0.3 18.0i0.4 17.6±0.3 17.4i0.4 14.7±1.5
18:2 3.4±0.2 4.7i0.2 6.8i0.2 9.4i0.09 11.8i0.6 9.8±0.9
18:3 0.35±0.01 0.20±0.07 0.32i0.02 0.34i0.04 0.36±0.04 0.20±0.07
20:4 12.9±0.3 16.4±0.8 17.3±0.4 15.3±0.2 14.2±1.1 16.1i0.7
22:6 13.3±0.2 10.Oi l . 0 9.8±0.3 9.5±0.2 7.2i0.5 9.0i0.4
Table 3.17 : Fatty acid composition (% w/w of total fatty acid; means ± 
S.E.M. of 4 embryos) of whole embryo chick cholesteryl ester from experiment 1.
Dav 6 11 13 15 18 22
16:0 17.9i l . 8 17.8i2.4 11.3±1.5 8.5±0.7 7.0±0.7 9 . 5 i l . l
18:0 12.3i0.3 7.7i0.6 5.5±0.3 4.2±0.2 5.2±0.8 5.7i0.5
18:1 35.3±0.9 41,3±4.7 49.3±1.6 59.2±2.6 64.7±1.2 58 .6 i l . 4
18:2 14.7i0.6 16.9±1.0 21,4±0.7 21.2±0.6 15.l i l . I 17. I i 0.8
18:3 0.2±0.1 0.30±0.07 0.57±0.06 0.50±0.09 0.47i0.09 0.70i0.01
20:4 9.6i0.6 9.1 ±0.4 6.6±1.2 5.2±0.3 4.2i0.2 5 .2 i l . l
22:6 14.5i0.7 6.5±1.8 3.2±0.4 1.2±0.3 1,0i0.4 1 , 8 i0 . 1
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Table 3.18: Fatty acid composition (% w/w of total fatty acid; means ± 
S.E.M. of 4 embryos) of whole embryo triacylglycerol from experiment 2.
Dav 12 13 14 15 18 19 22
16:0 27 .0±  1.1 29.6 ±0 .6 28.1 ±0 .6 28.8 ±0 .8 29.8 ± 0 . 6 29.6 ± 1.2 29.5 ±0 .5
18:0 9.2 ±0 .4 8.3 ±0 .2 3.2 ±0.1 7.6 ±0 .3 7.3 ±0 .3 7.0 ±0 .2 7.9 ±  0.1
18:1 31.7 ± 1.2 33.8 ±0 .8 35.0 ± 1.2 36.9 ±0 .8 39.8 ±0 .8 39.4 ± 1.5 41.4 ±0 .8
18:2 11.0 ± 0.7 11.9 ± 0.8 13.6 ± 0 . 7 13.0 ±  0.5 13.5 ±0 .3 13.8 ±1 .0 14.3 ±0 .2
18:3 0.79±0.08 0.71±0.02 0.8 ±0.02 0.82±0.05 0.92±0.03 0.8 ±0 .09 0.81±0.05
20:4 3.0 ±0 .4 2.5 ±0.1 2.1 ±0 .2 1.9 ±  0.2 1.10±0.08 1.0 ±  0.1 0.91±0.05
22:6 10.0 ± 1.5 8.5 ±0 .4 8.2 ±0 .4 6.4 ±0.5 2.7 ± 0 . 7 2.4 ±0 .2 1.1 ±0.1
Table 3.19 : Fatty acid composition (% w/w of total fatty acid; 
S.E.M. of 4 embryos) of whole embryo phospholipid from experiment 2.
means ±
Dav 12 13 14 15 18 19 22
16:0 29.6 ±0.1 29.7 ±0 .4 29.3 ±0 .3 32.8 ± 1.4 31.3 ± 0 .6 31.3 ±0 .7 29.1 ± 1.5
18:0 15.4 ±0 .2 15.8 ±0 .2 16.1 ±0.3 18.0 ± 1.3 17.0 ± 1.1 16.7 ± 0.2 21.2 ± 0 .9
18:1 18.9 ±0 .2 18.8 ±0 .4 19.2 ±0 .6 18.5 ±0 .4 19.0 ±0 .9 18.4 ±0 .6 19.4 ±0 .4
18:2 5.2 ± 0.3 5.9 ±0 .3 7.4 ±0 .2 7.5 ± 0 .7 9.0 ± 1.0 10.7 ± 0.8 10.0 ±0 .2
18:3 0.25±0.01 0.26±0.01 0.33±0.08 0.30±0.03 0.27±0.02 0.19±0.02 0.28±0.02
20:4 12.5± 0.3 12.1± 0.2 11 8± 0.5 9.5 ± 0 .9 9.9 ±0 .2 10.2± 0.3 9.1 ±0 .5
22:6 13.0 ±0 .3 12.6 ±0.2 11.6 ± 0.3 11.6 ± 0.2 10.0 ±0 .4 9.4 ±0 .04 8.6 ±0 .2
Table 3.20 : Fatty acid composition (% w/w of total fatty acid; means ± 
S.E.M. of 4 embryos) of whole embryo cholesteryl ester from experiment 2.
Dav 12 13 14 15 18 19 22
16:0 17.0 ± 1.0 14.7 ±0 .6 13.7 ± 1.3 12.6 ±0 .7 10.2 ±0 .5 8.8 ±0 .6 5.7 ±0 .3
18:0 6.2 ± 1.1 6.4 ± 0.5 4.9 ±0 .2 6.2 ± 0.2 6.6 ±0 .8 5.5 ±0 .3 4.6 ±0 .2
18:1 40.7 ±0.3 43.0 ± 0.6 52.0 ± 1.8 56.5 ±0 .9 60.5 ± 1.9 62.6 ±2 .4 69.2 ±2 .3
18:2 16.6 ±0 .8 16.6 ±0 .7 19.1 ± 1.2 16.0 ±0 .7 13.6 ±0 .6 13.7 ± 1.1 11.9 ±0 .2
18:3 0.45±0.07 0.48±0.02 0.50±0.06 0.6±0.07 0.51±0.05 0.46±0.06 0.38±0.02
20:4 7.8 ± 1.1 5.4 ±0.5 3.6 ±0 .2 3.2 ±0 .4 1.9 ±0 .2 2 .17±0.05 2.03 ±0 .2
22:6 8.2 ±0 .6 9.7 ± 1.7 6.0 ±0 .3 2.6 ±0 .6 4.2 ±  1.0 2.1 ±0 .4 2.5 ±0 .8
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Figure 3.7: Accumulation of fatty acids in the lipid of the whole embryo. 
The changes in the levels of oleic acid (O), AA (•)  and DHA (□ ) are shown 
during incubation of the "small” (a) and "normal" (b) eggs. Values are 
expressed as percentage of the amounts in the initial yolks prior to incubation 
and are the means of 4 replicates. Comparison between oleic and DHA values : 
aP<0.001, bP<0.002, CP<0.02.
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Table 3.21 : Recovery o f yolk lipids o f the newly hatched chick. The  
am ount o f each fatty acid present in total lipid per day-old chick is expressed as a 
percentage o f the am ount transferred from the initial yolk  betw een the first day o f  
em bryogenesis and the first day post-hatching. The values used to calcu late the  
recoveries w ere the means o f 4 initial yolks and 4 day-old chicks, and the S .E .M . o f  
the replicates w ere in all cases less than 12% o f the m eans.
A m ount in lipids o f day-old chick as % o f  
________that transferred from yolk________
Experiment 1________ Experiment 2
16:0 20.5 25.0
18:0 26.5 26.2
18:1 19.0 22.4
18:2 25.3 26.2
18:3 17.2 21.6
20:4 74.6 50.0
22:6 60.6 30.8
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Table 3.22: Recoveries of triacylglycerol and phospholipid in the newly 
hatched chick. The amounts of total lipid, TG and PL per day old chick are 
expressed as percentages of the amounts of the respective lipid classes transferred 
from the initial yolk between the first day of embryogenesis and the first day post 
hatching. The values used to calculate the recoveries were the means of 4 initial 
yolks and 4 day-old chicks, and the standard error were in all cases less than 12% 
of the means. The initial yolk levels of triacylglycerol were 4004 ± 70 and 2622 ± 
70 mg/yolk for "normal” (experiment 2) and "small” (experiment 1) eggs 
respectively. The respective initial phospholipid levels were 1166 ± 54 and 836 ± 
32 mg/yolk.
Amount in lipids of day-old chick as % of 
that transferred from yolk
Experiment 1 Experiment 2
Total lipids 30.0 30.4
Triacylglycerol 14.6 22.6
Phospholipid 25.8 18.5
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Figure 3.8: Levels of 18:1 and DHA in TG and PL of the embryo. The 
amount (mg/embryo) of 18:1 (a) and DHA (b) incorporated into TG (• )  and PL 
(O) of the whole embryo are shown during incubation of the "normal" eggs. 
Values are the means of measurements on 4 embryos at each time-point and 
S.E.M.’s were in all cases less than 10 % of the means.
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3.1.4.Plasma lipid composition during development
Plasma samples were collected during experiment 2, and also during an 
additional experiment (experiment 3). The eggs used for experiment 3 were obtained 
from a 40 week old laying flock and initially weighed 64.3 ±1.1 (n=12) g and contained 
5.94 ± 0.09 (n=10) g of total lipid per yolk.
The concentration of total lipids in the embryonic circulation (Experiment 3) 
increased from day 12 to day 18 of incubation and then decreased prior to and after 
hatching (Table 3.23). The main plasma lipid class from day 12 to day 14 was 
triacylglycerol, and this class thereafter decreased continuously, reaching very low levels 
just after hatching. From day 14 onwards, cholesteryl ester was the most abundant class 
in the circulation of the embryonic and neonatal chick (Tables 3.24-3.25) reflecting a 
possible accumulation in the circulation of remnant lipoproteins and/or transfer of 
lipoprotein surface components to high density lipoprotein (Figure 1.5 in 1.3.4).
High proportionate levels of DHA were present in plasma TG, especially 
between days 12 to 18. The level of DHA in plasma TG was maximal (up to 13.5 % 
w/w of fatty acids) at around days 12 to 14, decreasing to lower levels around the 
hatching period (Tables 3.26 and 3.30). In contrast, much lower levels of DHA were 
present in plasma PL (Tables 3.27 and 3.31). Thus it appears that, following lipid 
uptake into the yolk sac membrane, DHA is transferred from yolk PL and incorporated 
into TG for secretion as plasma lipoprotein.
Although significant levels of AA were present in plasma TG, much higher levels 
of the fatty acid (up to nearly 20 % w/w of fatty acids) were found in the PL fraction 
(Tables 3.26, 3.27, 3.30 and 3.31). It therefore appears that, in the yolk sac membrane, 
DHA and AA are differentially distributed between the lipid classes into TG and PL 
respectively, prior to lipoprotein assembly. Although some DHA was present in plasma 
CE, the level was never higher than about 4% (w/w). Although FFA was only a minor 
component of plasma lipid (Tables 3.24 and 3.25), very high proportions of DHA (up to 
17% w/w) were in this fraction (Tables 3.29 and 3.33).
In conclusion, the plasma lipids exhibited a number of specific compositional 
features, particularly in relation to DHA distribution, and presumably reflecting the 
characteristics of a highly specialised mechanism for the delivery of long chain 
polyunsaturates to particular tissues.
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Table 3.23: C oncentration o f total lipid in plasm a o f  the em bryo or chick  
(experim ent 3). Values are the m eans ± S.E .M . o f  4 plasm a sam ples at each stage. 
D ays 22 and 25 are equivalent to 1 and 4 days after hatching, respectively.
Day Lipid concentration (mg/ml)
12 2.2 ±0.1
13 3.4 ± 0.1
14 4.6 ±0.1
15 6.4 ±0.2
18 19.5 ± 1.7
19 12.7 ±0.4
22 9.5 ±0.2
25 5.0 ±0.1
Table 3.24: Plasm a lipid com position (lipid class as % w /w  o f  total lipid) 
during developm ent (experim ent 2). Values are the m eans ± S .E .M . o f  4 plasm a  
sam ples at each stage.
% total 
lipid
Day 12 13 14 15 16 19 22
CE 20 ± 0.2 22.4 ±0.1 29.8 ±0.2 32.8 ±0.3 39.4 ±0.5 42.4 ± 1.5 45.4 ± 1.1
TG 40.2 ± 1.1 35.8 ±0 .6 30.2 ± 0.6 26.7 ±0 .6 23.5 ± 0 .7 18.0 ± 0 .8 8.2 ± 0 .9
FFA 1.4 ±0.1 2.1 ±0.5 1.4 ±0.1 1.5 ±0.1 1.5 ± 0.3 3.6 ± 0 .6 2.0 ±0.3
CHOL 10.3 ±0 .6 12.2 ±0.3 9.2 ±0.3 10.3 ±0 .2 9.2 ± 0 .8 6.1 ± 0 .9 8.2 ±0 .9
PL 28.4 ± 0 .6 27.5 ±0.5 29.4 ± 0.4 28.5 ±0 .8 26.5 ± 0 .8 29.8 ± 1.6 36.2 ± 2 .8
Table 3.25: Plasm a lipid com position (lipid class as %  w /w  o f  total lipid) 
during developm ent (experim ent 3). Details as for Table 3.23.
% total 
lipid
Day 12 13 14 15 18 19 22 25
CE 18.7 ± 1.0 21.0 ±0 .4 24.5 ± 0.3 33.2 ±0.5 36.5 ± 1.4 41.4 ±0 .6 45.5 ± 1.4 38.9 ±0 .6
TG 42.8 ±0 .5 38.7 ±0.5 33.8 ±0.9 26.8 ± 0.4 31.4 ±2.1 17.4 ±0 .4 2.3 ± 0 .8 9.1 ± 1.2
FFA 2.3 ±0.3 1.6 ±0.1 1.8 ±0 .2 2.4 ±0 .4 2.7 ± 1.0 2.3 ± 0 .6 5.3 ± 1.9 6.9 ±1 .6
CHOL 12.5 ± 1.1 12.7 ±0.2 12.2 ± 1.5 10.9 ±0.4 6.3 ± 1.1 11.3 ±0 .6 13.4 ± 0 .5 11.2 ±0.3
PL 25.6 ± 1.1 27.5 ± 0.6 27.8 ± 1.7 26.7 ±0.5 23.2 ±1.1 27.7 ± 0 .7 33.6 ± 0 .6 34.0 ±0.5
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Table 3.26: Fatty acid composition (% w/w of total fatty acid) of plasma 
triacylglycerol during development (experiment 2). Values are means ± S.E.M., 
n=4.
Fatty acids 
(%)
Day 12 13 14 15 16 19 22
16:0 26.7 ± 0.4 25.8 ±0.3 25.4 ± 0.4 25.9 ±0 .9 27.5 ± 0. 24.7 ±1 .2 21. ± 0 .7
16:1 2.6 ±0.04 ND ND 2.2 ±0 .8 3.2 ± 0.06 3.5 ± 0.4 ND
18:0 8.0 ±0.1 7.5 ±0.1 7.3 ±0.04 7.7 ±0.1 6.7 ± 0 .2 7.0 ± 0.2 10.8 ±0.3
18:1 32.3 ± 0.4 34.9 ±0 .6 36.3 ± 0.7 38.3 ± 1.0 37.5 ± 0 .8 44.0 ± 0.7 43.7 ± 1.0
18:2 13.3 ±0 .2 13.9 ±0 .2 15.5 ±0.3 15.8 ±0.3 16.6 ±0.1 16.6 ± 0 .7 15.1 ±0.1
18:3 0.7 ±0.05 0.8 ± 0.02 0.9 ± 0.02 0.9 ± 0.07 0.9 ± 0.03 0.8 ± 0.2 0.5 ±0.1
20:4 3.7 ±0.06 4.0 ±0.2 2.9 ±0.1 2.6 ±0.1 2.0 ±0.05 0.7 ± 0.2 2.8 ±0.1
20:5 0.7 ± 0.02 0.6 ± 0.04 0.4 ±0.01 0.3 ± 0.02 0.3 ±0.07 ND ND
22:5 0.5 ± 0.02 0.5 ±0.03 0.7 ±0.03 0.5 ±0.05 0.3 ± 0.05 0.2 ± 0.02 0.8 ±0.05
22:6 11.8 ± 0.1 11.1 ±0.5 9.2 ± 0.4 6.3 ± 1.0 5.7 ±0 .3 1.6 ±0 .4 4.8 ± 1.0
Table 3.27: Fatty acid composition (% w/w of total fatty acids) of plasma 
phospholipid during development (experiment 2). Values are means ± S.E.M., 
n=4.
Fatty acids 
(%)
Day 12 13 14 15 16 19 22
16:0 31.6 ± 0.1 30.9 ±0 .8 30.6 ±0.5 31.9 ± 0.9 31.7 ± 0 .4 25.2 ± 1.2 23.0 ± 0 .7
16:1 ND ND ND ND ND ND ND
18:0 15.8 ±0 .2 16.0 ±0.3 15.8 ±0.3 15.8 ±0 .2 14.6 ±0 .3 17.1 ±0 .3 19.2 ±0.5
18:1 12.7 ±0.1 12.6 ± 1.0 13.0 ±0.1 14.4 ± 0.2 13.8 ± 0 .4 16.6 ±0.3 16.2 ±0 .2
18:2 16.6 ±0.1 19.5 ± 0 .7 25.1 ±0.5 26.0 ±0.5 28.2 ± 1.2 24.4 ±0.1 21.8 ±0.1
18:3 ND ND ND ND ND ND 0.2 ± 0.02
20:4 19.5 ± 0.1 18.4 ±0 .9 13.0 ±0.2 9.9 ±0.3 9.9 ±0 .5 13.5 ± 0 .4 15.2 ±0.5
20.5 0.3 ±0.03 0.3 ± 0.04 ND 0.2 ± 0.02 ND 0.2 ± 0.02 0.4 ± 0.03
22:5 0.2 ± 0.05 0.07 ±0.01 ND ND ND 0.2 ± 0.02 0.3 ± 0.02
22:6 2.4 ±0.1 2.2 ±0.1 1.7 ± 0.1 1.4 ±0.1 1.4 ±0.1 2.3 ± 0.07 3.3 ±0.5
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Table 3.28: Fatty acid composition (% w/w of total fatty acids) of plasma
cholesteryl ester during development (experiment 2). Values are means ± S.E.M .,
n=4.
Fatty acids 
(%)
Day 12 13 14 15 16 19 22
16:0 15.6 ±  0.1 15.1 ±0 .2 9.5 ±0.1 7.7 ±0.1 6.8 ±0.1 7.7 ±0 .3 8.8 ±0 .2
. <:1 0.7 ±0 .2 0.8 ±0 .05 1.0 ±0.1 0.8 ± 0.1 1.0 ±0 .06 0.8 ±0 .2 0.7 ± 0.1
18:0 3.5 ±0.1 3.1 ±0 .06 3.2 ±0 .02 3.2 ±0 .04 3.1 ±0 .04 4.0 ±0 .4 3.4 ±0 .05
18:1 42.6 ±0 .3 43.1 ±0 .2 52.4 ±0 .2 58.1 ±0 .3 60.2 ±0 .06 50.9 ±0 .8 46.5 ±0.1
18:2 27.7 ±0.1 29.1 ±0.1 28.2 ±0 .1 26.2 ±0.04 24.2 ±0.1 28.2 ±0 .4 32.1 ±0 .2
18:3 0.6 ±0.01 0.6 ± 0.02 0.9 ±0.01 0.9 ± 0.1 1.0 ±0.01 0.9 ±0 .05 0.9 ±0.01
20:4 4.8 ±0 .05 4.8 ±0 .4 2.5 ±0.01 1.9 ±0.1 1.7 ±0.05 3.5 ±0.1 4.2 ±0.1
20:5 0.9 ±0 .02 0.7 ±0 .06 0.6 ± 0.02 0.5 ±0.01 0.6 ±0 .05 0.7 ±0 .2 1.1 ±0 .03
22:6 3.5 ±0.1 2.5 ±0 .2 1.6 ±0.01 1.0 ±0 .06 1.3 ±0.08 2.3 ±0 .2 1.9 ±0 .05
Table 3.29: Fatty acid composition (% w/w of total fatty acids) of plasma 
free fatty acids during development (experiment 2). Values are means ± S.E.M., 
n=4.
Fatty acids 
( % )
Day 12 13 14 15 16 19 22
16:0 24.2 ±0 .9 31.2 ± 1.0 24.4 ± 0 .7 24.0 ± 0 . 8 25.8 ±2 .9 24.7 ± 3.0 22.8 ± 0 .7
16:1 1.8 ± 0.1 ND 1.3 ± 0 .4 ND ND ND ND
18:0 18.2 ±0.5 17.8 ± 1.6 16.3 ±0 .5 16.0 ±0 .8 19.2 ±0 .4 27.6 ± 1.0 21.7 ±0 .9
18:1 21.7 ±0 .6 28.4 ± 0.6 27.8 ±0 .8 30.5 ±0 .8 27.3 ±0 .5 34.2 ± 1.8 34.4 ± 1.2
18:2 8.3 ±0.02 9.2 ± 0.5 11.6 ± 0.2 11.5 ± 0 . 7 11.6 ±0 .3 8.0 ±0 .4 11.6 ±0 .5
18:3 0.4 ±0 .02 0.7 ±0.01 0.8 ±0 .06 ND ND ND 1.0 ±0 .04
20:3 ND 1.1 ±0 .2 0.6 ±0.1 ND ND 2.6 ±0 .8 ND
20:4 5.1 ±0 .2 3.8 ±0 .2 4.3 ± 0 .4 4.6 ±0 . 2 3.6 ±0 .6 2.8 ±0 .5 2.9 ±0 .3
20:5 0.7 ±0.3 ND 0.8 ±0.1 ND ND ND ND
22:6 14.0 ±0 .8 5.8 ±2 .0 10.2 ± 1.0 9.4 ± 0 .4 9.6 ± 0.4 ND 4.2 ±0 .3
Table 3.30: Fatty acid composition (% w/w of total fatty acids) of plasma
triacylglycerol during development (experiment 3). Values are means ± S.E.M .,
n=4.
Fatty acids
(%)
Day 12 13 14 15 18 19 22 25
16:0 25.6 ±0 .6 26.2 ±0 .3 25.7 ±0 .2 25.4 ±0.3 27.8 ±0 . 8 29.1 ± 0 .2 29.5 ± 1.6 25.5 ±0 .5
16:1 2.2 ±0 .02 2.2 ±0 .02 2.5 ±0 .06 2.4 ±0 .07 2.4 ±0 .2 2.8 ± 0.1 ND 4.8 ±0 .2
18:0 8.0 ±0 .3 8.2 ±0.01 8.1 ±0 .06 8.2 ±0.1 7.9 ±0.1 7.7 ± 0.1 11.2 ± 1.6 6.5 ± 0.2
18:1 34.4 ± 0.8 34.4 ±0 .3 36.4 ±0.1 39.1 ±0.3 40.7 ± 0 . 7 42.0 ± 0.2 39.8 ± 0 .3 39.1 ±0 .5
18:2 10.9 ±0 .6 10.2 ± 0.1 10.6 ±0 .4 10.6 ±0.1 11.3 ± 0 . 2 11.7 ± 0.2 11.1 ± 0 . 7 14.9 ± 0 . 7
18:3 0.5 ±0.01 0.4 ±0 .07 0.7 ±0.01 0.6 ±0.01 0.7 ±0 .02 0.7 ±0 .02 ND 2.3 ±0.1
20:4 3.5 ±0 .5 3.4 ±0.1 3.0 ±0.03 2.6 ±0 .07 1.6 ±  0.1 1.1 ±0.05 1.6 ±0 .3 0.7 ±0.1
22:6 11.5 ±0 .9 13.5 ±0 .3 10.6 ±0 .5 10 1 ±0 .2 6.4 ±0 .3 3.5 ±0.1 1.4 ±0 . 2 2.0 ±0.1
Table 3.31: Fatty acid composition (% w/w of total fatty acids) of plasma 
phospholipid during development (experiment 3). Values are means ± S.E.M., 
n=4.
rattv acids 
(%)
Day 12 13 14 15 18 19 22 25
16:0 32.7 ±0 .3 32.6 ±0.1 24.1 ±0 .2 31.4 ± 0 .7 27.8 ± 1.3 27.7 ±0 .2 23.9 ± 0 . 4 24.9 ±0.1
16:1 0.2 ±0.01 0.6 ±0 .02 1.3 ± 0.1 0.4 ±0 .3 0.5 ±0.1 0.7 ±0 .02 0.8 ±0 .04 1.9 ± 0.1
18:0 15.8 ±0 .3 15.9 ±0.05 9.9 ± 0.2 15.7 ±0 .3 17.0 ±0 .5 16.8 ± 0.1 21.2 ±0.1 19.9 ±0 .2
18:1 15.3 ±0 .3 14.1 ±0.03 32.4 ±0 .3 16.5 ± 0 .2 17.5 ± 0 .2 15.2 ±0 .2 14.2 ±0 .02 17.2 ±0.06
18:2 13.9 ±0.1 17.4 ±0.1 16.1 ±0 .2 22.4 ±0.1 24.2 ±0 .5 22.9 ±0 .4 18.3 ±0.06 19.7 ±0.04
18:3 ND 0.1 ±0.01 0.5 ±0.01 0.1 ±0.01 ND 0.2 ± 0.02 0.3 ± 0.04 0.6 ±0.01
20:4 17.8 ±0.1 15.4 ± 0.1 7.1 ±0 .2 10.7 ±0 .3 10.9 ± 1.1 12.9 ±0 .7 14.4 ±0 .4 5.0 ±0.03
22:6 3.1 ±0.1 2.3 ±0.03 7.0 ±0 .3 1.8 ±0.1 1.3 ± 0 . 2 2.3 ±0.1 5.1 ±0.1 5.1 ±0 .07
89
Table 3.32: Fatty acid composition (% w/w of total fatty acids) o f plasma
cholesteryl ester during development (experiment 3). Values are means ± S.E.M .,
n=4.
Fatty acids 
(%)
Day 12 13 14 15 18 19 22 25
16:0 17.6 ± 0.1 14.2 ±0 .2 11.8 ±0.1 9.2 ±0 .4 7.6 ±0 .3 8.1 ±0 .05 10.2 ±0.1 13.0 ±0 .2
16:1 0.9 ±0 . 07 1.2 ± 0.1 1.3 ± 0.01 1.3 ±0.06 1.3 ± 0 .0 7 1.5 ±0.01 1.5 ±0.04 4.0 ± 0.1
18:0 3.1 ±0.1 3.0 ±0.1 3.0 ±0 .06 3.3 ±0.1 4.1 ±0 .3 3.4 ± 0.02 2.9 ±0 .05 2.5 ±0.3
18:1 44.5 ±0 . 4 48.3 ±0 .6 53.6 ±0 .2 59.6 ±0 .4 65.4 ±0.1 56.7 ±0 .2 43.1 ±0.1 35.4 ±0 .6
18:2 22.0 ±0 .2 23.9 ±0 .2 23.4 ±0 .06 21.0 ± 0.3 16.8 ±0 .4 22.4 ±0 .05 31.9 ±0 .06 34.3 ±0 .6
18:3 0.3 ±0 .02 0.4 ±0.01 0.5 ±0.01 0.5 ±0.01 0.6 ±0.01 0.7 ±0.01 0.7 ±0.01 2.1 ±0 .3
20:4 4.7 ±0 .2 4.2 ±0 .3 2.8 ± 0.1 2.1 ±0.03 1.7 ±0 .02 3.1 ±0.1 4.0 ±0 .04 1.6 ± 0.1
20:5 1.1 ±0 .02 1.0 ± 0.1 0.9 ±0.03 0.7 ± 0.02 0.8 ±0 .05 1.3 ±0 .03 2.1 ±0 .05 2.2 ±0.1
22:6 4.0 ±0 .6 2.6 ±0 .4 2.5 ±0 .04 2.3 ±0.08 1.7 ±0 .0 7 2.6 ±0 .04 3.1 ±0 .07 2.5 ±0 .2
Table 3.33: Fatty acid composition (% w/w of total fatty acids) of plasma 
free fatty acids during development (experiment 3). Values are means ± S.E.M., 
n=4.
ratty acids 
( % )
Day 12 13 14 15 18 19 22 25
16:0 30.7 ± 1.1 26.3 ±0 .8 27.5 ± 1.0 22.1 ± 1.3 31.3 ±4 .5 32.4 ± 1.4 24.6 ± 1.8 24.0 ± 0.4
16:1 ND ND ND 1.1 ±0 .2 ND ND 1.9 ±0 .2 3.3 ±0 .6
18:0 16.4 ± 1.1 15.6 ±0 .7 20.1 ±0.5 18.5 ± 1.8 29.4 ±2 .3 24.8 ± 1.9 14.0 ± 1.0 9.5 ± 1.4
18:1 23.4 ± 1.7 24.2 ± 1.1 28.7 ±0 .7 27.7 ± 1.6 26.3 ± 1.5 26.9 ± 1.7 38.4 ± 0.5 32.4 ± 1.0
18:2 4.7 ±0.1 6.3 ±0.1 6.9 ±0 .2 7.1 ±0 .6 5.6 ±0 .3 8.8 ± 1.4 11.1 ±0 .5 18.5 ±0 .5
18:3 ND 0.4 ± 0.04 ND ND ND ND 0.9 ± 0.08 3.3 ±0 .2
20:3 5.4 ±0 .8 3.1 ±0.1 3.1 ±0.2 2.5 ±0 .5 7.7 ± 2.1 4.0 ±0 .3 0.7 ±0.1 ND
20:4 3.0 ±0 .5 4.8 ±0 .5 3.0 ±0.1 4.0 ± 0.6 ND ND 1.7 ±0 .4 0.9 ±0.07
20:5 ND 1.1 ± 0.2 ND ND ND ND ND 2.0 ±0 .2
22:6 12.9 ±0 .2 17.1 ±1. 1 10.1 ±0 .6 15.7 ±  1.7 ND ND 5.2 ± 1.1 4.2 ±0 .6
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3.1.5. Fatty acid composition o f adipose tissue TG during development
The development of adipose tissue in the chick embryo was studied in 2 
experiments; experiment 2, as described previously (section 3.1.1) using "normal" size 
eggs from 33 week old laying birds, and an additional experiment using "small" eggs 
from a 24 week old laying flock. Compositional parameters for these "small" eggs are 
given in Table 3.34. The same parameters for the "normal" size eggs have been 
previously described (Table 3.1) but are included in Table 3.34 to facilitate comparison. 
The data in Table 3.34 indicate that the amount of total lipid available to the embryo was 
approximately 1.7-fold greater in the "normal" size compared to the "small" eggs.
Figure 3.9 indicates that the embryo fresh weights were greater during 
development in the "normal" size eggs at all stages of development. Prior to hatching, 
at day 19, there was a 1.3-fold difference in embryo weight between the 2 experiments.
The development of adipose tissue in the embryo is illustrated in Figure 3.10. 
Adipose tissue was undetectable to the unaided eye prior to day 12. After this time, the 
amount of adipose TG increased rapidly, reaching a maximal level just prior to hatching 
at day 19. Over the hatching period, between days 19 and 22, there was no further 
growth of the tissue and in fact a significant decrease in the adipose TG content was 
observed in both experiments. The amount of TG deposited in the adipose tissue was 
proportional to the initial yolk lipid content (Table 3.34 and Figure 3.10); thus at day 19 
the amount of adipose TG was 1.5-fold greater in the "normal" compared to the "small" 
egg experiment. The results in Table 3.35 indicate that the reduced amount of adipose 
tissue in the "small" egg experiment was not simply due to the reduction in embryo size, 
since the adipose TG content as a percentage of whole embryo weight was also 
generally lower. Thus the initial egg size and lipid content affect the subsequent weight 
of the embryo plus a further specific effect on the amount of adipose tissue. The amount 
of lipid transferred from the yolk on the examined days of incubation ("normal" size egg 
experiment) are compared to the amount of TG deposited in the adipose tissue. The 
results in Figure 3.11 indicate that, during embryogenesis, the accumulation of TG in 
adipose tissue is closely related to the transfer of lipid from the yolk. However, during 
the peri-hatching period (day 19 of embryo development to 1 day after hatching), this 
relationship breaks down as accumulation of adipose TG ceases (in fact there is some 
loss of lipid from the tissue over this period i.e. mobilisation) in spite of the continued 
transfer of lipid from the retracted yolk.
The fatty acid compositions (%, w/w) of adipose TG are given in Tables 3.36 
and 3.37. High proportions (up to 7.2 %) of DHA were present in the TG at days 12 
and 14 decreasing to lower levels by hatching. Significant levels of 20:4 (up to 4%) 
were also present at days 12 and 14, again decreasing at the later stages. The major 
fatty acid in adipose TG was 18:1 at all stages. The absolute amounts of 18:1, in terms
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of mg of the fatty acid in TG per adipose depot, are shown in Figure 3.12. The amount 
of 18:1 increased continuously to reach a maximum value just prior to hatching and the 
levels were dependent on the initial yolk lipid content. Between days 19 and 22, the 
amount of 18:1 remained the same ("normal" size eggs) or decreased ("small" eggs). 
Thus the pattern of change in the amount of adipose TG was closely reflected in the 
amounts of constituent 18:1. Furthermore, the changes in the absolute amounts (mg in 
TG/depot) of 16:0, 18:0, 18:2, 18:3 and 20:4 (data not shown) followed a pattern which 
was essentially identical to that shown for 18:1 in Figure 3.12.
In marked contrast, the changes in the absolute amount (mg in TG/depot) of 
DHA in adipose TG followed a different pattern from the other fatty acids (Figure 3.13). 
Firstly, the amount of DHA did not increase continuously up to hatching but instead 
reached a plateau level by day 16. Secondly, there was a dramatic decrease in the DHA 
content of the tissue over the hatching period, suggesting a preferential mobilisation of 
this fatty acid.
Thus whereas the amounts of oleic acid mobilised perinatally from the tissue in 
the 2 experiments amounted to 1 and 20% of the day 19 values (Figure 3.12), the 
respective mobilisations of DHA over this period amounted to 70 and 85% of the pre­
hatch adipose DHA stores (Figure 3.13).
In an additional experiment (experiment 3 as described in section 3.7.4.), 
measurements on adipose tissue composition were performed on birds which were 
maintained to day 4 after hatching with free access to food. The percentage fatty acid 
compositions are shown in Table 3.38. The TG contained a high proportion of DHA at 
day 15, and this value decreased dramatically at the later developmental stages. The 
absolute amounts (mg in TG per depot) of the individual fatty acids are shown in 
Figures 3.14 a and b. The amounts of 16:0, 18:0, 18:1, 18:2 and 20:4 increased 
continuously until hatching, with little further change during the first 4 post-hatch days. 
However, in agreement with the previous study (Figure 3.13), the amount of DHA 
decreased over the hatching period, with a further decrease by 4 days post hatch (Figure 
3.14 b). In this experiment, the amount of DHA in adipose TG was considerably higher 
than in the previous experiments (Figure 3.13 and 3.14 b) reflecting the differences in 
the initial yolk DHA contents (Tables 3.1 and 3.34). Also, over the hatching period (day 
18 to 22 in experiment 3), the proportion of adipose DHA mobilised was less than in the 
previous studies.
However, the absolute amounts of DHA released from the tissue were very 
similar (approximately 4 mg) in the 3 experiments.
In conclusion, the results in this section suggest that DHA is preferentially 
mobilised from adipose TG during the peri-hatching and neonatal periods.
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Table 3.34: Characteristics of eggs prior to incubation for the adipose 
tissue study. Results are the means ± S.E.M. of measurements on 4 eggs with the 
exception of egg weights where n=10. For convenience, the eggs from the 33 and 
24 week old flocks are colloquially referred to in the text as "normal'’ size and 
"small" respectively. Significant differences for values on the same line (between 
experiments) are illustrated with superscript character aP<0.05, bP<0.01, 
CP<0.001, nP>0.05 not significant.
Age of parental flock (weeks) 
24 33
Egg weight (g) 48.4 ±0.7 62.2 ± 0.7 c
Total lipid (g/yolk) 3.4 ±0.1 5.7 ±0.1 c
Lipid ciass % (w/w) 
of total lipid
TG 75.0 ± 0.8 70.5 ± 0 .4b
PL 18.5 ±0.6 20.5 ± 0 .8n
CHOL 3.3 ±0.5 6.6 ± 0 .6 b
CE 2.1 ± 0.2 1.7 ± 0.1 n
FFA 1.2 ±0.1 0.86 ± 0.07 a
mg fatty acid/yolk
16:0 668.5 ±30.0 1086.5 ± 27.3 c
18:0 242.7 ±9.7 413.8 ± 12.0c
18:1 966.2 ± 42.4 1757.7 ± 61.6c
18:2 545.3 ±20.4 689.6 ±71.1 a
18:3 44.2 ±2.1 5 4 .1 ± 6 .2 n
20:4 51.2 ± 1.1 73.1 ± 3 .8b
22:6 67.0 ±2.7 93.8 ± 4 .7 a
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Figure 3.9: Embryo growth during the "normal" (O) and "small" (•) size 
egg experiments are shown. Mean ± S.E.M. of 4 sample replicates.
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Figure 3.10 : Adipose tissue development in the embryo. The adipose 
depots defined in the method section, were quantitatively dissected from the 
embryos. The TG content (mg/depot) of the adipose tissue are depicted for the 
"norm al” size (O) and "small" (•) egg experiments. Means ± S.E.M. of 4
replicates. Comparison between days 22 and 19 CP<0.01, dp<0.02.
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Table 3.35: Triacylglycerol content as a percentage of whole embryo 
weight. Significant differences for value on the same line (between experiments) 
are illustrated with superscript character aP<0.05, bp<0.01, CP<0.001, nP>0.05 not 
significant.
Days of 
incubation
Age of parental flock 
24 33
14 0.20 0.27c
16 0.53 0.80c
19 0.94 0.99n
22 0.56 0.75c
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Figure 3.11: Dynamics of lipid deposition in adipose depot against lipid 
transfer from yolk during embryo development ("normal" size egg experiment). 
Linear regression (omitting the day 22 value), r2= 0.997, y=0.13*x - 62.8.
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Table 3.36: Fatty acid composition o f adipose tissue triacylglycerol during
development ("normal” eggs).
Fatty acids 
(%)
Day 12 14 16 19 PHI
16:0 30.6 ±0.5 28.8 ± 1.1 28.4 ±0.2 28.6 ±0.2 28.0 ±0.3
16:1 2.5 ±0.1 2.8 ±0.1 2.9 ±0.03 2.8 ±0.03 2.8 ± 0.1
18:0 7.5 ±0.3 7.8 ±0.3 8.0 ±0.7 8.0 ±0.03 7.9 ±0.1
18:1 33.0 ±  1.7 32.5 ± 1.1 35.5 ±0.1 37.5 ±0.1 40.6 ±0.2
18:2 16.8 ± 1.3 16.2 ±0.6 17.0 ±0.02 17.9 ±0.1 16.8 ±0.02
18:3 0.9 ±0.2 1.0 ±0.2 1.3 ±0.02 1.4 ±0.04 1.3 ±0.03
20:4 2.0 ±0.1 4.2 ± 1.5 1.6 ±0.01 1.2 ±0.03 1.0 ±0.2
20:5 0.3 ±0.1 0.29 ±0.02 0.2 ±0.0 0.1 ±0.01 0.07 ±0.00
22:6 5.4 ±0.2 4.84 ±0.7 3.8 ±0.02 1.6 ±0.03 0.7 ±0.04
Table 3.37: Fatty acid composition of adipose tissue triacylglycerol during 
development ("small" eggs).
Fatty acids 
(%)
Day 12 14 16 19 22
16:0 28.0 ±0.2 27.0 ±0.1 28.1 ±0.2 28.4 ±0.2 28.4 ± 1.3
16:1 2.5 ±0.1 2.5 ±0.02 2.8 ± 0.1 2.6 ±0.0 1.8 ±0.6
18:0 7.8 ±01 7.7 ±0.06 7.2 ± 0.1 7.2 ±0.3 7.1 ±0.7
18:1 28.3 ±0.1 31.0 ± 0.5 32.6 ± 0.1 33.5 ±0.2 34.9 ±0.8
18:2 20.2 ±0.3 20.2 ±0.4 20.8 ±0.1 22.7 ±0.5 23.8 ±0.6
18:3 1.5 ±0.4 1.5 ±0.04 1.6 ±0.05 1.6 ± 0.1 1.6 ± 0.1
20:4 2.4 ±0.1 2.2 ±0.2 1.5 ± 0.0 1.2 ±0.03 0.7 ± 0.1
20:5 0.4 ±0.0 0.4 ±0.0 0.2 ±0.0 0.1 ±0.0 0.04 ±0.01
22:5 0.8 ±0.0 0.7 ±0.0 0.6 ± 0.1 0.4 ±0.0 0.3 ±0.0
22:6 7.4 ± 0.1 6.3 ±0.1 4.0 ± 0.1 1.6 ± 0.0 0.6 ±0.1
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Figure 3.12: Oleic acid content of adipose triacylglycerol. The amounts 
(mg/depot) of oleic acid in adipose triacylglycerol are depicted for the "small” 
(O) and "normal" (•) size experiments. Means of 4 replicate tissue samples ±
S.E.M.. Comparison between days 22 and 19 : CP<0.01.
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Figure 3.13: DHA content of adipose triacylglycerol. The amounts 
(mg/depot) of DHA in adipose triacylglycerol are depicted for the "small" (O) 
and "normal" (•) size egg experiments. Means of 4 replicate tissue samples ±
S.E.M.. Comparison between days 22 and 19 : aP<0.01.
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Table 3.38: Fatty acid composition (% w/w of total fatty acids) of adipose 
TG during development (experiment 3). Values are means ± S.E.M.. Each 
replicate refers to tissue from an individual embryo or chick. Days 22 and 25 are 
equivalent to 1 and 4 days respectively after hatching.
Fatty acids 
(%)
Day 15 
(n=8)
18
(n=8)
22
(n=4)
25
(n=3)
mg TG/depot 
Fatty acid (% 
w/w of total 
fatty acid)
66.0 ±6.5 285.6 ±23.5 402.3 ±42.9 401.7 ±48.0
16:0 28.3 ±0.3 29.5 ±0.4 29.9 ±0.5 27.8 ±0.3
16:1 2.8 ± 0.1 3.5 ±0.2 3.6 ± 0.3 3.9 ±0.2
18:0 7.6 ±0.3 7.4 ±0.2 7.7 ±0.3 7.1 ± 0.03
18:1 38.0 ± 0.4 39.7 ± 0.7 40.4 ±0.7 41.3 ±0.8
18:2 11.6 ± 0.4 13.1 ±0.4 14.2 ±0.5 16.6 ±0.3
18:3 0.7 ±0.04 0.7 ±0.07 0.8 ±0.0 1.5 ±0.1
20:4 2.0 ±0.2 1.5 ± 0.1 1.0 ±0.04 0.5 ±0.04
22:6 7.2 ±0.2 3.4 ± 0.2 1.4 ±0.2 0.3 ±0.03
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Figure 3.14: Major fatty acid content of adipose triacylglycerol. The 
amounts (mg/depot) of fatty acids in adipose triacylglycerol are depicted for 
experiment 3. Means of 4 replicate tissue samples and in all cases S.E.M. were 
less than 5% of the means.
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3.1.6. Fatty acid composition o f the lipids o f the liver during development
The fatty acid compositions o f  the liver were determined on the tissue samples 
from experiment 2 (defined as in Section 3.1.1). In agreement with previous studies 
(Noble and Cocchi, 1990), the proportion o f  CE increased dramatically during 
development, comprising nearly 70% (w /w ) o f  the total lipid by the time o f  hatching 
(Table 3.39). The changes in the amount o f  the lipid classes in the liver are illustrated in 
Figure 3.15. The proportion o f  D H A (% w /w  o f  total fatty acids) in the TG fraction 
was very high (17.6% ) at day 13, decreasing to about half this value just prior to  
hatching (Table 3.40). High levels (up to 24%) o f  A A  were present in the PL fraction, 
which also contained significant levels o f  D H A  (Table 3.41). The proportion o f  D H A  in 
liver PL increased 1.5-fold over the hatching period. Cholesteryl oleate was the major 
component o f  the cholesteryl ester fraction throughout development (Table 3.42). 
These results are consistent with those o f  previous studies (Noble and Cocchi, 1990; 
section 1.3.5). The FFA fraction also contained high levels o f  both AA and D H A (Table 
3.43).
The absolute amounts (mg/liver) o f  the various fatty acids in the total lipids o f  
the liver are shown in Figure 3.16 (a and b). 18:1 was the major component from day 
14 onwards. The amounts o f  20:4 and D H A in total liver lipid increased continuously 
until hatching and then decreased slightly by day 22.
Figure 3.17 illustrates the developmental changes in the absolute amounts (mg in 
lipid class per liver) o f  the main fatty acids in the different liver lipid classes. The major 
fatty acid, 18:1, mainly distributed into CE with lower amounts present in TG and PL 
(Figure 3.17 b), reflecting the massive deposition o f  cholesteryl oleate in the liver. A  
similar general pattern was observed for 18:2 (Figure 3.16), although the amount o f  this 
fatty acid present in CE was low  compared to 18:1. In contrast, the saturated fatty 
acids, 16:0 and 18:0, were mainly distributed into PL, with lower amounts present in TG  
and CE (Figure 3.17 a). Almost all the 20:4 content o f  the liver was present as a 
component o f  PL (Figure 3.17 c). The amount o f  D H A as a component o f  PL increased 
continuously during embryonic development and continued to increase over the peri- 
hatching period. Whereas the amount o f  D H A  in TG also increased up to  day 19, the 
level then decreased by day 22 (Figure 3.17 d). Thus, during the hatching period, there 
was an increase in the DH A content o f  PL with a corresponding decrease in the amount 
o f  this fatty acid in TG. D H A was the only major fatty acid to exhibit an increase in the 
PL fraction at this time : the amounts o f  all the other major fatty acids in PL either 
decreased or remained constant between days 19 and 22 (Figure 3.17 a, b and c).
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Table 3.39: Lipid compositions of the liver during development from
experiment 2. Values are means ± S.E.M., n=4.
Dav 12 13 14 15 16 19 22
Liver fresh 
\vt (mg) 
Amount of
79.0 134.7 238.0 330.4 459.7 654.7 510.0
total lipid 
(mg)
% total 
lipid
3.12 5.2 ±0 .2 13.3 ±1 .0 17.9 ±0 .4 25.8 ±0.1 91.4 ± 0.6 75.1 ±0.5
PL 63.5 ± 1.0 57.7 ±2 .4 43.8 ± 1.8 40.2 ± 3.0 32.5 ±3.1 13.2 ± 1.9 15.2 ± 1.2
CE 4.2 ±0 .4 11.2 ± 1.1 18.3 ± 1.7 28.7 ± 5.0 43.5 ± 3.2 69.0 ±4.1 68.2 ±4 .8
TG 10.8 ±0 .5 8.8 ±0 .9 12.4 ±0 .8 11.0 ± 0.6 7 ±0 .8 5.0 ±0 .8 3.3 ±0 .7
CHOL 0.2 ± 0.02 7.3 ± 0 .7 8.0 ±0 .9 8.3 ± 0.8 7.4 ± 0.3 5.5 ±0 .8 5.8 ±0.1
FFA 13.8 ±0 .2 15 ± 1 15.5 ± 2.8 11.8 ± 0.8 9.6 ±0 .3 7.3 ± 0 .7 7.5 ± 2 . 7
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Figure 3.15: C ontent o f lipids in the liver during developm ent. CE (A ) ,  
FFA (O ), PL (□), TG  (<a) and CH O L (A). Results are means o f 4 replicates, 
S.E .M . were alw ays less than 10 % o f the means.
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Table 3.40: Fatty acid composition of liver triacylglycerol (% w/w total
fatty acid). Means ± S.E.M., n=4.
% total 
fattv acid
Day 12 13 14 15 16 19 22
16:0 23.9 ± 1.5 26.4 ±2 .2 23.3 ±2.1 26.6 ± 1.0 24.2 ± 1.7 20.8 ± 0.8 23.7 ±7 .9
18:0 9.6 ±0 .6 11.5 ±  1.5 8.9 ± 0 . 7 10.8 ±0 .5 11.0 ±  1.2 9.9 ± 1 .0 13.4 ± 1.2
18:1 36.4 ±2.1 28.6 ±4 .4 38.4 ±4.1 32.3 ± 1.0 34.6 ± 5 . 8 44.7 ± 1.9 43.5 ±4 .0
18:2 10.7 ±0 .6 10.1 ± 1.5 13.7 ±  1.4 11.8 ±  0.5 12.7 ± 1 . 7 12.24±0.02 11.9 ± 4.0
18:3 0.60 ±0 .03 0.68 ± 0.11 1.0 ±  0.1 0.7 ±0 .1 0.8 ± 0.1 0.85 ±0 .02 0.4 ± 0.4
20:4 3.9 ±0 .6 5.1 ±0 .9 3.1 ±0 .2 3.9 ±0 .2 4.0 ± 0 . 6 3.3 ±0 .2 2.4 ±0 .4
22:6 14.9 ±0 .3 17.6 ±2 .2 11.7 ± 0.7 13.8 ±0 .5 12.7 ±  1.2 8.2 ± 0.1 4.7 ± 1.2
Table 3.41: Fatty acid composition of liver phospholipid (% w/w total fatty 
acid). Means ± S.E.M., n=4.
% total 
fattv acid
Day 12 13 14 15 16 19 22
16:0 22 .6 ± 1.1 22.1 ± 0.8 20.7 ± 1.8 20.6 ±0 . 9 19.5 ±2.1 18.5 ±2 .3 18.9 ± 1.8
18:0 22.8 ± 0.1 23.4 ± 1.3 24.3 ±  1.5 24.3 ± 1.2 24.7 ± 2 . 4 26.9 ±3 .2 26.1 ± 2.1
18:1 7.6 ±0 .0 7.1 ±0 .2 8.1 ± 0 .7 8.0 ±0 .3 7.9 ±0 .8 8.4 ± 1.4 8.0 ±0.5
18:2 8.9 ±0.1 9.87 ±0 .42 13.0-± 1.0 14.4 ±0 .7 15.9 ± 1.6 14.0 ± 2 . 4 13.0 ± 0.1
18:3 0.1 ± 0.0 0.10 ± 0.01 0.10 ±0.03 0.08 ± 0.03 0.07 ±0 .04 0.09 ±0 .05 0.1 ± 0.1
20:4 23.2 ±0 .6 24.4 ± 1.2 23.6 ± 1.6 22.3 ± 0 .9 22.2 ± 2.2 21.9 ± 3.6 18.5 ± 1.0
22:6 14.7 ± 0.1 13.0 ± 0.8 10.3 ± 0 . 7 10.3 ±0 .5 9.7 ± 0 .9 10.3 ± 1.8 15.4 ±3 .2
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Table 3.42: Fatty acid composition of liver cholesterol ester (% total fatty
acid). M eans ± S.E.M ., n=4.
% total 
fattv acid
Day 12 13 14. 15 16 19 22
16:0 10.3 ±0 .4 5.7 ± 0 .7 4.3 ± 0 .2 4.1 ± 1.0 2.9 ± 0 . 2 2.8 ± 0.2 2.7 ±0 .3
18:0 5.5 ± 0 .0 3.1 ±0 .3 3.3 ±0 .2 3.2 ± 0 . 6 3.0 ±0 .2 3.3 ±0 .3 3.3 ±0 .4
18:1 74.2 ± 8 . 7 . 66.4 ±6 .9 77.5 ±7.1 73.6 ± 13.3 76.9 ±5 .3 74.3 ± 5 .4 77.3 ± 7.0
18:2 7.5 ± 1.2 11.9 ±  1.2 11.3 ± 1.4 12.6 ±2 .5 12.4 ±  1.0 13.8 ± 1.0 12.5 ±0.3
18:3 0.4 ±0 .4 0.52 ± 0.09 0.47 ±0 .09 0.67 ±0 .10 0.78 ± 0.05 0.81 ±0 .06 0.7 ± 0.0
20:4 0.1 ± 0.1 2.7 ±0 .3 0.7 ±0 .6 1.2 ± 0.2 1.0 ±  0.1 1.8 ± 0.1 1.2 ± 0.1
22:6 2.0 ± 1.6 9.7 ±0 .9 2.4 ±2.1 4.6 ± 1.1 3.0 ±0 .5 3.1 ±0 .4 2.2 ± 0.0
Table 3.43: Fatty acid composition of liver free fatty acids (% total fatty 
acid). Means ± S.E.M., n=4.
% total 
fattv acid
Day 12 13 14 ] 5 16 19 22
16:0 55.8 ± 19.5 19.0 ±0 .7 17.9 ±1 .7 20.6 ± 1.6 17.6 ±0 .6 14.7 ±2.3 14.8 ±4 .4
18:0 3.9 ±  10.4 12.1 ±0.9 11.7 ± 1.7 11.2 ±  1.2 11.7 ± 0.5 13.8 ± 1.3 12.0 ±4.2
18:1 0.7 ±2 .8 18.2 ± 1.0 21.0 ±2 .7 21.1 ± 1.9 24.3 ± 0.6 23.3 ±2 .5 28.1 ±8 .9
18:2 3.5 ±0 .5 11,7± 0.6 13.6 ± 1.9 14.6 ± 1.2 15.9 ±0 . 4 13.7 ± 1.4 14.8 ±5 .9
18:3 1.5 ±0.1 0.36 ±0.01 0.48 ±0 .05 0.37 ± 0.09 0.59 ± 0.02 0.43 ± 0.06 0.7 ±0 .4
20:4 27.6 ± 5.1 22.3 ± 1.5 18.5 ± 3.2 16.5 ± 1.5 14.4 ±0 .3 17.4 ± 1.6 11.6 ±3 .9
22:6 7.0 ±3.2 16.3 ± 0 .7 16.8 ±3 .0 15.5 ± 1.6 15.5 ±0.5 16.6 ± 1.5 17.9 ± 8 .1
114
Figure 3.16: Amount (mg/liver) of individual major fatty acids, (a) 16:0 
and 18:0 (O), 18:1 (□ ), 18:2 (■),(b) AA (•)  and DHA (A). Results are means of 
4 replicates, S.E.M. were always less than 10 % of the means.
CM
CM
CM
CM
o>
CO
10
CO
CM
-Q
CM
CM
CM
o>
CO
CO
It)
CO
CM
oCMCN| O COCO
C
0
E
Q.
O
0>
0
■u
(/)
>»0
Q
J 9 A | |  /  6 i u
116
Figure 3.17: Distribution of major fatty acids between lipid classes in the 
liver. The amounts (mg of fatty acid in lipid class per liver) of (a) 16:0, (b) 18:1, 
(c) AA and (d) DHA , determined in the PL (O), TG (• )  and CE (□). Results 
are means of 4 replicates, S.E.M. were always less than 10 % of the means.
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3.1.7. Fatty acid composition o f the lipids o f the heart during development
The fatty acid compositions of the lipid classes were determined in hearts 
obtained from experiment 2 (defined in section 3.1.1). Unlike liver and adipose tissue, 
the heart contained relatively low levels of lipid, in which the structural lipid, PL, 
predominated. However, the amount of TG in the heart increased considerably by the 
peri-hatching period (Table 3.44). The TG fraction of heart exhibited certain similarities 
to that of adipose tissue, containing high levels of DHA and significant levels of AA at 
day 14, with decreased proportions of both these fatty acids at the later stages (Table 
3.45). Although cholesteryl oleate was the major species of CE present in heart, the 
proportion of this species was considerably lower than in liver (Table 3.46). AA was a 
major component of the PL fraction (Table 3.47). The absolute amount (ng in lipid 
class/heart) of 18:1, AA and DHA in the PL and TG fractions are shown in Figure 3.18. 
The amount of 18:1 in both lipid classes increased throughout the period studied (Figure 
3.18 a). The amount of AA in PL also increased continuously, but the level of this fatty 
acid in TG remained at a very low level throughout development (Figure 3.18 b). The 
results in Figure 3.18 c suggest that the maximum amount of DHA in both PL and TG 
had already been attained by day 14, with little change thereafter. It is clear from these 
results that the heart is not a major site of DHA accumulation.
3.1.8. Fatty acid composition o f  brain PL during development.
In order to investigate the effects of variations in the initial yolk lipid and DHA 
content on the subsequent composition of brain phospholipid, 3 experiments were 
performed using eggs of different sizes. These experiments correspond to experiments 1 
and 2 described in section 3.1.1 (Table 3.1) and to another "small" egg experiment 
(experiment 4) performed for brain collection (Table 3.48). The relevant parameters of 
the eggs used for these experiments are given in Table 3.48. The major lipid classes 
present were PL and CHOL. Only trace levels of TG, CE and FFA were detected and 
these are not included in Tables 3.49, 3.50 and 3.51. The relative proportions of PL and 
CHOL did not change dramatically during development, although some increases in the 
proportion of CHOL were observed at the later stages, possibly reflecting myelination. 
The percentage composition of the PL fatty acids was also relatively constant during 
development. Within each experiment the proportion of DHA (% w/w of PL fatty 
acids) did not change to any extent from about day 12 to hatching, and composed up to 
21% (w/w) of the total fatty acids.
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The absolute amounts (mg/brain) of 16:0, AA and DHA in the brain PL are 
presented in Figure 3.19. The amounts (mg/brain) of DHA increased continuously 
throughout the developmental period studied approximately in parallel with the amounts 
of the other major fatty acids, and largely reflecting the increase in the amount of PL and 
the growth of the brain. Only a small proportion (less than 10%; Table 3.48) of the 
DHA initially present in the yolk was recovered in the brain phospholipids of the newly 
hatched chick. In spite of the much lower initial DHA content of the yolk lipid in 
experiment 4 compared to experiment 2, there was only a minor difference in the 
neonatal brain DHA content between the 2 experiments. However, the extremely low 
initial yolk DHA level in experiment 1 was reflected in a greater reduction in the amount 
of this fatty acid in the neonatal brain (Table 3.48).
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Table 3.44: Lipid composition of heart during developm ent Means ±
S.E.M ., n=4.
Day 14 15 16 19 22
Heart fresh
weights (g) 0.11 0.14 0.16 0.23 0.29
mg total 3.0 ± 0.1 3.9 4.7 ±0.06 6.6 ±0.07 8.7 ±0.3
lipid/heart
% total
lipid
TG 7.2 ±0.4 7.7 6.5 ±0.3 15.4 ±3.3 20.7 ± 1.8
PL 67.4 ±0.6 63.0 63.8 ±1.1 57.5 ±2.3 60.5 ± 1.3
CE 4.3 ±0.1 6.2 6.8 ±0.3 6.8 ±0.3 6.2 ±0.7
FFA 8.5 ±0.4 10.2 10.3 ± 1.1 8.0 ± 1.0 6.6 ±0.2
CHOL 12.6 ±0.4 12.9 12.4 ±0.2 11.7 ± 0.5 6.3 ±0.7
Table 3.45: Fatty acid composition (% w/w total fatty acids) of heart 
triacylglycerol. Means ± S.E.M., n=4.
acid Day 14 15 16 19 22
16:0 30.3 ±0.6 29.2 ±2.5 33.5 ±0.3 30.3 ± 1.1 31.3 ±0.9
18:0 9.7 ± 0.1 7.8 ± 1.1 8.7 ±0.2 6.8 ±0.6 6.4 ±0.3
18:1 28.7 ± 0.8 34.8 ±2.9 30.1 ±0.3 35.4 ±2.0 41.5 ± 0.5
18:2 13.3 ±0.2 17.5 ±2.6 14.3 ±0.2 17.4 ±0.8 17.2 ±0.5
18:3 1.2 ±0.02 1.1 ±0.2 1.2 ±0.05 0.9 ± 0.1 0.7 ±0.05
20:4 5.1 ±0.4 3.4 ± 1.2 5.0 ±0.2 2.6 ± 0.6 1.1 ±0.09
22:6 9.2 ± 1.0 3.3 ± 1.7 5.3 ±0.2 1.7 ± 0.2 0.7 ±0.07
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Table 3.46: Fatty acid composition (% w/w total fatty acids) o f heart
cholesteryl ester. Means ± S.E.M., n=4.
acid Day 14 16 19 22
16:0 12.2 ±0.2 10.3 ±0.2 8.8 ±0.7 10.5 ±0.2
18:0 4.7 ±0.2 4.6 ±0.2 4.4 ±0.2 3.9 ± 0.1
18:1 47.2 ±0.2 51.6 ± 0.7 52.9 ± 1.2 50.6 ±2.3
18:2 21.7 ± 0.3 21.7 ± 0.4 21.6 ± 0.5 22.4 ± 1.3
18:3 1.0 ±0.02 1.0 ±0.04 1.1 ±0.07 0.7 ±0.07
20:4 5.2 ±0.1 4.3 ±0.3 5.0 ±0.3 5.8 ±0.8
22:6 4.7 ±0.3 3.6 ±0.05 4.1 ±0.1 2.8 ±0.2
Table 3.47: Fatty acid composition (% w/w total fatty acids) of heart 
phospholipid. Means ± S.E.M., n=4.
acid Day 14 16 19 22
16:0 27.2±0.2 28.0±0.6 26.4±0.6 24.2±0.5
18:0 20.2±0.6 18.9±0.4 19.9±0.1 20.7±0.2
18:1 17.1±0.4 17.6±0.5 16.7±0.5 16.1±0.3
18:2 8.8±0.2 10.6±0.2 10.1±0.3 11. 0±0.3
18:3 ND ND ND ND
20:4 17.8±0.3 18.9±0.9 23.2±0.3 24.5±0.5
22:6 7.3±0.7 4.3±0.3 3.7±0.6 2.5±0.3
Table 3.48: Relevant lipid parameters for experiments 1, 2 and 4.
Experiments
1___________ 2___________ 4_
Initial yolk lipid content (g) 3.8 5.6 3.4
Initial yolk lipid DHA content (mg) 33 94 67
One day post hatch brain DHA (mg) 2.8 3.6 3.4
% DHA recovered in the brain 8.5 3.8 5.1
(compared to yolk)________________________________________________
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Figure 3.18: Absolute amounts of 18:1 (a), AA (b) and DHA (c) in the 
chick embryo heart. Amounts (pg in lipid class / heart) of these fatty acids 
in TG (•)  and PL (O).
10
00
 
-
I
 
1 
 
 
—
 
1 
10
00
j jeaq jad  p : o z  6 ^
*jeai| jad  9 : 3 3  6 ^jjeaq jad  1 : 2 1  6 ^
124
Da
ys
 
of 
de
ve
lo
pm
en
t
Table 3.49: Brain lipid composition (experiment 1). Statistical 
comparisons were made against the D ll value, differences at aP<0.05, bp<0.01, 
CP<0.001, nP>0.05 not significant.
Day 11 13 15 18 22 25
Fresh brain 0.175 ± 0.296 ± 0 42 ± 0.72 ± 0.90 ± 1.07 ±
weight (g) 0.004 0.005 0.03 0.02 0.04 0.09
Total lipid
content 4.0 ±0.1 6.4 ±0.2 10.6 ±0.3 17.6 ± 1.5 32.1 ± 1.8 47.7 ±4.5
(mg/brain)
Lipid classes (% w/w of
total lipid)
PL 76.4± 1.6 73.3± 0.5 74.5± 2.1 73.3± 0.8n 64.5± l . l c 64.1± 4.7a
CHOL 22.3± 2.2 26.7± 0.5 25.5± 2.1 26.7± 0.8n 35.5± l . l c 35.9± 4.7a
Fatty acid composition
(% w/w of total fatty
acids) of brain PL
16:0 37.0 ±0.6 36.7 ±0.9 34.8 ± 1.6 34.8 ±2.5 29.3 ± 1.3 27.3±2.4n
18:0 14.5 ±0.2 29.8 ±0.6 17.8 ± 1.0 17.5 ± 1.1 18.9 ± 1.3 19.8±1.9n
18:1 18.1 ±0.2 17.6 ±0.3 17.4 ±0.9 17.4 ± 1.2 19.5 ± 1.3 20.7±2.4n
18:2 2.1 ±0.1 2.1 ±0.09 2.4 ± 0.13 2.0 ±0.05 2.3 ±0.07 2. l±0.3n
18:3 0.3 ±0.05 0.3 ±0.01 0.3 ±0.02 0.4 ±0.04 0.7 ±0.07 0.8±0. l n
20:4 10.1 ±0.2 10.1 ±0.02 9.8 ±0.5 8.7 ±2.5 11.2 ± 0.4 10.8±1.4n
22:6 17.9 ±0.3 17.9 ±0.3 19.4 ± 0.9 19.2 ± 1.1 18.2 ± 1.3 18.4±2.4n
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Table 3.50: Lipid composition of the brain during development
(experiment 2).
Day 12 13 14 15 16 19 22
Fresh brain 0.142 0.321 0.559 0.559 0.691 1.033 1.022
weight (g) 
Total lipid 
content 3.79 ±0 .02 8.0 ±1 .0 13.1 ± 1.0 14.8 ±0 .5 19.1 ±0 .7 34.5 ± 1 8 43.0 ±2 .0
(mg/brain) 
Fatty acid
composition (% 
w/w of  total
fatty acids) of  
brain PL
16:0 36.7 ±  1.6 36.4 ±3 .6 33.8 ±1.1 34.7 ±  1.2 34.3 ± 0 .6 31.7 ± 1.5 29.7 ± 1.7
18:0 15.7 ± 0.5 14.6 ± 1.4 16.1 ±0 .5 15.3 ± 0 .6 16.2 ±0 .3 17.8 ± 0 . 7 18.5 ± 1.1
18:1 15.7 ±0 .5 18.2 ± 1.8 17.7 ±0 .6 18.1 ± 0 . 8 17.4 ±0.1 17.2 ±0 .66 18.5 ± 1.1
18:2 2.1 ±0 .05 2.2 ±0 .4 0.2 ±0 .08 2.2 ±0.1 2.3 ± 0 .0 1.8 ±0 .3 2.2 ±0.3
18:3 0.3 ±0.01 0.3 ±0 .02 0.3 ±0.01 0.3 ±0.003 0.3 ±0.01 0.5± 0.02 0.7 ±0.005
20:4 8.4 ±0 .3 6.6 ±2 .2 8.8 ±0 .3 8.6 ±0 .3 8.7 ±0 .2 9.2 ±0 .3 9.5 ±0 .6
22:6 21.0 ±  1.0 21.8 ±  2.2 20.9 ±0 .6 20.8 ±0 . 7 20.8 ± 0.6 21.8 ± 0.7 20.8 ± 1.7
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Table 3.51: Lipid composition of the brain during development
(experiment 4).
Day 12 14 16 19 22
Fresh brain 
weight (g) 
Total lipid
0.27 0.38 0.48 0.69 0.76
content 6.6 ± 0.2 
(mg/brain)
Lipid classes (% w/w 
of total lipid)
10.1 ±0.2 13.3 ±0.4 25.2±0.6 35.9 ±0.5
PL 78.2 ±0.2 77.7 ±0.6 77.8 ±0.3 76.7 ±0.7 75.2 ±0.2
CHOL 21.9 ±0.2 
Fatty acid composition 
(% w/w of total fatty 
acids) of brain PL
22.3 ±0.6 22.2 ±0.3 23.3 ±0.7 24.8 ±0.2
16:0 37.0 ±0.2 36.3 ±0.4 36.5 ±0.2 34.4 ±0.2 32.1 ±0.2
16:1 3.3 ±0.03 3.5 ± 0.04 3.1 ±0.1 2.4 ±0.03 1.6 ±0.07
18:0 12.6 ± 0.1 12.9 ± 0.1 13.1 ±0.1 15.9 ±0.1 17.4 ±0.1
18:1 16.4 ±0.2 16.7 ±0.3 15.8 ± 0.1 16.2 ±0.3 16.4 ±0.2
18:2 2.3 ±0.1 2.3 ±0.07 2.2 ±0.07 2.0 ±0.06 2.1 ±0.1
18:3 0.2 ±0.05 0.2 ± 0.0 0.1 ±0.0 0.4 ±0.0 0.5 ±0.0
20:4 7.8 ± 0.1 8.1 ±0.3 7.8 ± 0.1 8.1 ±0.3 9.2 ±0.2
20:5 2.0 ±0.0 1.9 ± 0.1 1.8 ±0.1 1.8 ± 0.1 2.3 ±0.1
22:6 16.7 ±0.4 17.0 ±0.2 17.5 ±0.2 17.8 ±0.2 17.2 ±0.2
127
Figure 3.19: Absolute amounts of 16:0, AA, DHA in the brain PL. 
Amounts (mg/brain) of 16:0 (O), AA (□ ) and DHA (•)  are represented for
experiments 1 (a) and 2 (b).
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3.2-BRAIN PHOSPHOLIPID CLASSES AND THEIR FATTY ACID
COMPOSITION
3.2.1. Isolation o f  PL classes by HPLC
A typical chromatogram illustrating the separation of the major PL classes 
isolated from the brain of the day-old chick, using the HPLC system described in 
Section 2.2.2, is shown in Figure 3.20. It can be seen that the method allows PE, PI, PS 
and PC to be clearly resolved. Three criteria were used to identify the peaks: (i) The 
sequence of elution and retention times were compared with the published values in the 
original paper by Christie (1985) in which this method was first described, (ii) 
Comparison with the retention times of purchased standards of PE, PI, PS and PC on 
this HPLC system, (iii) Collection of the peaks and analysis by HPTLC as described in 
section 2.2.4.. Identification of the spots on the plate was by comparison with the 
original paper by Olsen and Henderson (1989) and by co-chromatography of standards.
3.2.2. Fatty acid composition o f PL classes during brain development in the chicken
Brain samples collected during experiment 4 were analysed. PC was the major 
PL fraction present, followed by PE, PS and PI. The proportions of the PL classes in 
the brain did not change significantly during embryonic development, although the 
proportion of PE decreased by one day after hatching (Table 3.52).
Each PL class exhibited a highly characteristic fatty acid composition: PC 
consisted largely of saturated and mono-unsaturated acids, mainly 16:0 and 18:1 with 
only very low levels of polyunsaturates including AA and DHA (Table 3.53). This 
profile was fairly constant during development apart from an increase in the proportion 
of 18:0 and a decrease in that of DHA. The composition of PE was very different from 
that of PC. DHA was the major component of PE (up to 40% w/w of total fatty acid) 
throughout embryonic development and high levels of AA (approximately 13%) were 
also present (Table 3.54). 18:0 was the major saturated fatty acid in PE. The fatty acid 
profile of PE was relatively constant throughout embryogenesis, but the proportion of 
DHA decreased significantly by the first day after hatching, with a corresponding 
increase in the 18:0 and 18:1 levels. The composition of PS (Table 3.55) exhibited 
many similarities to that of PE. Again, DHA was the major fatty acid at days 12 and 14 
(up to 40% w/w), and the major saturated component was 18:0. The level of AA was 
lower in PS than in PE. The fatty acid profile of PS did however change somewhat
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during development; the proportion of DHA decreased by approximately 50% by 
hatching, while the proportions of 18:0 and 18:1 increased significantly.
The composition of PI (Table 3.56) was characterised by very high levels (up to 
45 % w/w) of AA, but only low levels of DHA. 18:0 was the major saturated 
component, and relatively high levels of 18:1 were also present. The highest levels of 
AA were found at the.earlier stages (days 12 and 14), decreasing significantly by the 
time of hatching, with corresponding increases in the level of 18:1 and also 18:2.
In conclusion, these results indicate that the DHA content of the chick embryo 
brain is present mainly in PE, with significant levels also present in PS. AA is present 
largely in PE and PI, whereas only relatively low amounts of the long chain 
polyunsaturates are present in PC.
3.2.3. Fatty acid composition o f  PL classes in the brain o f  the duck embryo
Lipid analysis of the initial egg yolk (i.e. prior to incubation) were carried out 
and results are given in Table 3.57. The general characteristics were similar between the 
two species. DHA was present in lower amounts in the duck yolk compared to the 
chicken's (nearly 6-fold).
Samples were collected from duck embryos at days 18 and 21 of the 28 day 
embryonic period. As in the chick, the major PL class in duck brain was PC, followed 
by PE, PS and PI at day 18. However, an increased proportion of PI was evident at day 
21 (Table 3.58).
There was a general similarity in the fatty acid composition of the PL classes 
between the two species. PC from duck brain consisted mainly of saturated and 
monounsaturated fatty acids, particularly 16:0 and 18:1 with only low level of DHA and 
AA (Table 3.59). PE was rich in both DHA and AA (Table 3.59); however the ratio of 
DHA / AA was much lower in the duck than in the chicken, reflecting the low levels of 
DHA and high level of AA in the lipids of the initial yolk of the duck eggs (Table 3.57). 
PS ,in the duck, was also rich in DHA (Table 3.60), but again the levels of this fatty acid 
were lower than in the chicken. PI was rich in AA, but the proportion of DHA 
increased considerably between days 18 and 20 (Table 3.60).
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Figure 3.20: Brain PL separation. Chromatogram obtained by HPLC. 
RT: retention time, FC: free cholesterol, PE:phosphatidylethanolamine, PI: 
phosphatidylinositol, PS: phosphatidylserine, PC: phosphatidylcholine and 
SPH: sphingomyelin.
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Table 3.52: Proportions of the major phospholipid classes of the brain 
during chick embryo development. Results are the % (w/w) of total PL, and refer 
to means ± S.E., n=4. Statistical comparisons against the D12 value are indicated, 
differences at aP<0.05, bp<0 .0 1 , cp<0.001, nP>0.05 not significant.
Day 12 14 16 19 22
PC 43.8 ± 1.7 40.8 ± 0.6n 45.3 ±2.1" 42.6 ± 1.2" 48.5 ±5.5"
PE 28.5 ± 1.2 34.6 ±4.5" 30.3 ±1.1" 27.5 ±0.6" 19.5 ± 1.0b
PS 18.3 ±0.8 19.5 ±3.6" 17.5 ±2.5" 18.5 ±2.0" 19.2±4.6a
PI 9.4 ± 0.9 15.4 ±2.7" 6.9 ± 1.3" 11.4 ± 1.1" 12.8 ±0.1"
Table 3.53: Fatty acid composition of phosphatidylcholine (% w/w of total 
fatty acids). Values are means ± S.E., n=4. Statistical comparisons against the 
D12 value are indicated, differences at aP<0.05, bp<0.01, CP<0.001, nP>0.05 not 
significant.
Day 12 14 16 19 22
C16:0 59.1 ±2.1 61.4 ±1.1 59.3 ±1.0 57.2 ± 2.4n 56.2 ± 1.6"
C16:1 2.2 ± 1.3 ND 2.0 ± 1.2 ND ND
C18:0 4.8 ±0.1 3.8 ±0.8 4.8 ±0.3 7 .9±0 .8b 10.7 ± 0.9b
Cl 8:1 22.7 ±0.2 23.8 ±0.2 22.9 ±0.5 24.7 ± 1.5" 25.2 ± 0.1c
C18:2 2.6 ±0.1 2.6 ±0.1 2.8 ±0.1 2.2 ± 0.1c 2.58 ±0.01"
C18:3 0.25 ± 0.02 0.18 ±0.03 0.20 ±0.01 0.3 ±0.1" 0.6 ± 0.1a
C20:4 2.9 ±0.2 3.0 ±0.1 2.6 ±0.3 3.3 ±0.3" 2.1 ±0.2"
C22:6 3.5 ±0.4 4.1 ±0.2 4.2 ± 0.2 4.0 ± 0.2" 1.7 ± 0.5a
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Table 3.54: Fatty acid composition of phosphatidylethanolamine (% w/w of 
total fatty acids). Values are means ± S.E., n=4. Statistical comparisons against 
the D12 value are indicated, differences at aP<0.05, bP<0.01, CP<0.001, nP>0.05 
not significant.
D12 14 16 19 22
C16:0 14.5 ±0.7 13.5 ± 1.2 15.4 ±1.6 12.6 ±0.8 10.0±0.2b
Cl 8:0 20.0 ± 1.0 21.4 ±0.5 22.3 ± 0.5 25.3 ± 1.5 31.1 ± 1.7C
C18:l 10.2 ±0.6 9.0 ±0.4 9.2 ±0.1 11.7 ± 2.1 18.9 ± 0.6a
C18:2 0.89 ±0.02 0.87 ± 0.04 1.20 ±0.04 0.7 ±0.2 1.5±0.1b
C18:3 0.31 ±0.01 0.23 ±0.01 0.26 ±0.01 0.3 ±0.1 1.3 ± 0.1c
C20:4 12.7 ±0.1 13.0 ±0.4 12.5 ±0.4 13.7 ±0.8 14.2 ± 0.8n
C22:6 39.0 ± 1.4 40.5 ± 0.9 37.5 ± 1.5 35.4 ±2.0 22.7 ± 0.4C
Table 3.55: Fatty acid composition of phosphatidylserine (% w/w of total
fatty acids). Values are means ± S.E., n=4. Statistical comparisons against the 
D12 value are indicated, differences at aP<0.05, bP<0.01, CP<0.001, nP>0.05 not 
significant.
Day 12 14 16 19 22
C16:0 8.9 ±0.5 10.1 ±0.5 13.9 ± 1.5 24.2 ±5.5 9.2 ± 0.2n
C16:1 0.3 ±0.3 0.7 ±0.7 0.2 ±0.2 10.4 ±0.9 ND
C18:0 35.8 ± 1.0 37.4 ± 1.0 37.3 ±0.6 25.9 ±0.4 47.9 ± 1.6C
C18:1 8.7 ±0.8 7.0 ±0.3 7.9 ±0.6 13.7 ± 1.7 17.45 ±0.03c
C18:2 1.9 ±0.3 1.4 ±0.3 1.5 ±0.3 2.0 ±0.5 2.28 ± 0.03n
C18:3 0.29 ± 0.03 0.17 ±0.01 0.17 ±0.06 0.43 ± 0.01 1.15 ± 0.02c
C20:4 3.1 ±0.2 3.2 ±0.2 4.1 ±0.4 2.1 ±0.8 2.73 ± 0.03n
C22:6 39.4 ±0.9 39.7 ±0.6 33.9± 1.0 18.1 ±4.6 18.7 ± 1.7a
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Table 3.56: Fatty acid composition of phosphatidylinositol (% w/w of total 
fatty acids). Values are means ± S.E., n=4. Statistical comparisons against the 
D12 value are indicated, differences at aP<0.05, bp<0 .0 1 , cp<0.001, nP>0.05 not 
significant.
Day 12 14 16 19 22
C16:0 6.2 ±0.7 3.5 ±0.5 10.2 ± 1.8 9.4 ± 1.8 7.8 ± 0.1n
Cl 8:0 36.3 ±0.3 37.6 ±0.9 35.3 ±6.7 37.9 ± 1.4 38.4 ± 1.3n
C18:l 12.0 ±0.6 9.0 ±0.9 19.8 ±3.3 11.7 ± 0.9 19.0 ± 0.4C
Cl 8:2 0.8 ±0.1 0.6 ±0.2 1.7 ±0.7 1.0 ±0.2 5.6 ± 0.4C
C18:3 ND ND 0.1 ±0.1 ND 0.9 ±0.3
C20:4 40.5 ±0.3 45.0 ±0.6 26.1 ±9.0 35.2 ±2.4 23.3 ±0.6C
C22:6 3.10 ± 0.6 3.8 ±0.6 6.4 ± 0.9 4.0 ± 1.1 3.0 ± 0.7n
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Table 3.57: Characteristics of duck and chicken eggs prior to incubation. 
Values are the means ± S.E.M. of measurements on 4 eggs with the exception of 
egg weights where n=10.
Duck Chicken
Egg weight (g) 78.9 ± 1.0 62.2 ±0.7
Total lipid (g/yolk) 6.8 ± 0.1 5.7 ±0.1
Lipid class % (w/w)
of total lipid
TG 70.8 ±0.5 70.5 ±0.4
PL 21.7 ± 0.3 20.5 ±0.8
CHOL 4.9 ±0.2 6.6 ± 0.6
CE 0.8 ±0.2 1.7 ± 0.1
FFA 0.8 ±01 0.86 ±0.07
mg fatty acid/yolk
16:0 2122 ±34.0 1086.5 ±27.3
18:0 234.0 ± 10.9 413.8 ± 12.0
18:1 3534.0 ±77.6 1757.7 ± 61.6
18:2 395 ± 21.0 689.6 ±71.1
18:3 121 ±4.9 54.1 ±6.2
20:4 105 ±7.0 73.1 ±3.8
22:6 16.0 ± 1.0 93.8 ±4.7
Table 3.58: Proportion of the major phospholipid classes of the brain
during duck embryo development (% w/w of total phospholipid). Means :
n=4.
PC PE PS PI
Day 18 59.1 ± 1.4 19.1 ± 1.8 12.1 = 0.5 9.7 ±0.5
Day 21 48.8 ± 1.6 29.8 ± 1.3 6.3 ± 1.5 15.1 ± 1.4
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Table 3.59: Fatty acid composition of phosphatidylcholine (PC) and 
phosphatidylethanolamine for duck brain (PE; % w/w of total fatty acids). Means 
± S.E., n=4, when statistical differences between days 18 and 21: values differing 
at aP<0.05, bP<0.01, CP<0.001.
PC 18 21 PE Day 18 21
16:0 57.4 ±0.4 60.90 ± 1.2a 16:0 24.0 ±3.3 13.9 ±  1.5a
18:0 4.69 ±0.04 4.8 ±0.4 18:0 21.5 ±2.6 20.5 ±2.3
18:1 30.5 ±0.4 27.3 ±0.8b 18:1 18.4 ± 0.8 15.2 ± 0.7a
18:2 1.2 ± 0.1 0.8 ± 0. l a 18:2 0.5 ±0.5 0.3 ±0.2
18:3 0.33 ±0.02 0.40 ± 0.02a 18:3 0.5 ± 0.1 0.49 ±0.03
20:4 3.4 ±0.2 3.2 ±0.3 20:4 18.8±  1.1 20.7 ± 1.6
22:5 ND ND 22:5 1.62 ±0.02 1.9 ± 0. l a
22:6 1.9 ±0.2 1.9 ±0.2 22:6 16.1 ±3.4 25.5 ± 0.5a
Table 3.60: Fatty acid composition of phosphatidylserine (PS) and
phosphatidylinositol for duck brain (PI; % w/w of total fatty acids). Means ± 
S.E., n=4, when statistical differences between days 18 and 21: values differing at 
aP<0.05, bP<0.01, CP<0.001.
PS Day 18 21 PI Day 18 21
16:0 3.5 ±0.3 13.9 ± 3.3a 16:0 3.9 ±0.4 4.9 ± l . l c
18:0 45.9±  1.5 42.3 ± 1.8 18:0 30.2 ± 1.2 40.8 ± 0.4C
18:1 12.9 ± 1.3 13.1 ± 1.2 18:1 17.8 ±2.4 13.3 ±0.9
18:2 1.2 ± 0.5 0.56 ±0.03 18:2 1.5 ±0.3 NDb
18:3 0.41 ±0.02 0.4 ± 0.1 18:3 0.33 ±0.04 0.40 ±0.04
20:4 7.4 ±0.9 5.6 ±0.2 20:4 36.7 ±2.0 23.6 ±  l . l b
22:5 1.2 ±0.3 0.9 ±0.2 22:5 ND 0.74 ± 0.07c
22:6 26.9 ± 1.8 22.3 ± 1.6 22:6 3.0 ± 1.0 15.7 ± 0.3C
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3.3 RELEASE OF FATTY ACIDS FROM ADIPOSE TISSUE IN VITRO.
The results in section S. 1.5 indicate firstly that the adipose tissue triacylglycerol 
(TG) represents a major store of DHA in the embryo and secondly that DHA appears to 
be selectively mobilised from the tissue in vivo. The studies described in the present 
section were designed to test the theory of preferential mobilisation of DHA by using in 
vitro methods. The basis of this approach was to maintain pieces of adipose tissue in 
culture medium for various periods of time and to compare the pattern of the free fatty 
acids (FFA) released into the culture medium with the fatty acid composition of the 
tissue TG. Three experiments (A, B and C), using different batches of chicken eggs, 
were designed to study different aspects of the release of fatty acids from the adipose 
tissue, including the effect of the incubation period and the effect of hormonal 
stimulation on the lipid release. An additional experiment was also carried out using 
adipose tissue from pheasant embryos.
Eggs were incubated as described in 2.1.1. Adipose depots were collected and 
incubated as described in sections 2.1.2 and 2.3.1 respectively.
3.3.1. Preliminary experiment
A preliminary experiment (Experiment A) was carried out using adipose tissue 
from day 16 of the chicken's embryonic development. Adipose tissue pieces were 
incubated for 1 hour. The results (Table 3.61) showed that the free fatty acid profile of 
the incubation medium was significantly different from that of the initial adipose 
triacylglycerol (i.e. before incubation). The proportions of long chain PUFA (18:3, 
20:4, 20:5 and 22:6) were significantly increased in the medium. The proportions of 
DHA and AA increased in the medium by 5- and 2.5-fold respectively.
3.3.2. Effect o f  different incubation period on the lipid and fatty acid release
In Experiment B, pieces of adipose tissue from chicken embryo were incubated 
for 1 or 24 hours. The amounts of total fatty acid released, expressed as a percentage of 
that initially present in the tissue TG, were compared for the two time periods. For both 
incubation times, a similar trend of fatty acid release was observed, the highest 
percentage rate of release being for day 14 of development followed by a decrease by 
day 18 and stabilisation over the hatching period (Figure 3.21). The lipid release was 
not linear with time with the percentage release by 24h being only 3-, 8- and 5-fold 
greater than after lh for the samples at days 14, 18 and 22 respectively.
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Tables 3.62, 3.63, 3.64 and 3.65 show the various fatty acid profiles for days 14, 
16, 18 and 22 of development respectively. In each case the fatty acid profiles of the 
tissues did not significantly change before and after 1 hour of incubation (data not 
shown). Also no significant differences were found either at days 14 and 22 between 
fatty acid profiles of the tissue before and after 24 hours of incubation (data not shown). 
However at day 18, the proportion of DHA in the tissue TG did decrease significantly 
after 24h incubation. The ratio of the proportion of a particular fatty acid in the medium 
to its proportion in tissue TG is given in each case. A ratio superior to 1 indicates a 
preferential release of the fatty acid into the medium while a ratio inferior to 1 indicates 
a preferential retention of the fatty acid in the adipose tissue TG. As noticed in 
experiment A (section 3.3.1) long chain PUFA (18:3, 20:4, 20:5, 22:5 and 22:6) were 
preferentially released in the medium for both the 1 and the 24 hour incubations. All 
monounsaturated and saturated fatty acids with the exception of 18:0 were preferentially 
retained in the tissue TG. For days 16 and 18 of development, the percentages of 20:4, 
22:5 and 22:6 in the 24 hour incubation medium were lower than the values in the 1 
hour medium. Figure 3.22 shows the logarithmic values of the ratios from Tables 3.62, 
3.63, 3.64 and 3.65. Logs were used in order to express the ratios superior and inferior 
to 1 on the same scale. A log10 value equal to zero would indicate that the percentage 
of that fatty acid released into the medium was identical to that in the tissue whereas a 
positive value indicates preferential release and a negative value indicates preferential 
retention.
3.3.3. Effect o f  glucagon on the extent o f  lipolysis and on the profile o f  fatty acid 
released
Two concentrations of glucagon were used in experiment C: 100 ng/ml and 1 
pg/ml of medium. Adipose tissues pieces from chicken embryo were incubated for 1 
hour. An analysis of variance was carried out on the data using Minitab version 8.2. 
The variables analysed were the percentage of tissue lipid mobilised and the ratios of % 
fatty acid in medium FFA/% in adipose TG taking into consideration the day of 
development, the treatments and the interaction of both of these factors. Figure 3.23 
shows the percentage of tissue lipid mobilised at each developmental stage and Table 
3.66 gives the analysis of variance of these data. Both the treatments and the day of 
development had a significant effect on the variance of the lipid released. The general 
trend of the percentage of lipid mobilised at each stage of embryonic development was 
similar for the three treatments (Figure 3.23). The lipid release for all three treatments 
was highest at days 14 and 22 of development with a decrease at days 16 or 18 (see 
Figure 3.23 for statistical differences) in accordance with experiment B. Both doses of 
glucagon significantly increased the percentages of lipid mobilised at days 14 and 22.
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However, the tissue was insensitive to both glucagon concentration at Day 16. Only the 
highest concentration of glucagon (1 pg/ml) induced an increase in lipid mobilisation 
compared to the controls' on day 18 which suggests that the sensitivity of adipose tissue 
to glucagon increases from day 16 to the hatching period. Tables 3.67, 3.68, 3.69 and 
3.70 show the fatty acid profiles of the incubation medium FFA for the three different 
treatments and also of the adipose tissue TG before incubation. The fatty acid 
composition of the tissue TG did not change significantly during the lh incubation in all 
cases (data not shown). As in experiments A and B, the proportions of long chain 
PUFA were higher in the medium FFA than in the adipose tissue TG. Medium/tissue 
ratios were calculated for each fatty acid (as described in 3.3.2) and compared by an 
analysis of variance. The day of development was a source of variation for the ratios of 
all the major fatty acids except 16:1, 18:0 and 18:3. This analysis also showed that the 
treatments were a significant source of variation only for the medium/tissue ratios of the 
very long chain PUFA (20:4, 20:5 and 22:6). The day-treatment interactions were not 
significant for any ratio except the one for 20:5 (Table 3.73). The presence of glucagon 
was associated with significant reductions in the medium/tissue ratios of the long-chain 
PUFA (20:4, 20:5, 22:6) compared to the control. However, even in the presence of 
glucagon, the preferential release of 20:4, 20:5, 22:5 and 22:6 from the tissue TG into 
the medium, although attenuated was still consistently observed. The treatments had no 
effect on the ratios of other fatty acids on day 14, day 16 and day 18 (Tables 3.71 and 
3.72), although both doses of glucagon significantly decreased the proportion of 18:0 in 
the medium on day 22. Figure 3.24 shows the log. of the ratios for the control 
incubations at each day of development studied. As in Figure 3.22, the preferential 
release of long chain PUFA (18:3, 20:4, 20:5, 22:5 and 22:6) was observed using tissue 
obtained throughout embryonic development.
3.3.4. Composition o f fatty acids mobilised in vitro fo r  adipose tissue obtained from  
embryos o f the wild pheasant (Phasianus colchicus)
A similar study to that described for experiment A (section 3.3.1) was designed 
using adipose tissue obtained from pheasant embryos. The limited number of eggs 
available only allowed an investigation at one developmental stage. The eggs were 
opened at day 16 of development, the total embryonic period being 24-26 days. Table 
3.74 gives general characteristics of the adipose tissues collected (method as in 2.1.2). 
Adipose tissue from pheasant embryos consisted mainly of triacylglycerol (97.4% of 
total lipids). The adipose tissues were incubated for 1 hour. The results (Table 3.75) 
shows again that the long chain PUFA were preferentially released in the incubation 
medium with proportions of DHA and AA higher in the medium FFA than in the 
adipose tissue TG (1.7 and 2.7-fold respectively, Figure 3.25).
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3.3.5.Summary
The conclusions of this section, in which the mobilisation of fatty acids from 
adipose tissue TG has been studied during the in vitro incubation of adipose tissue 
pieces, are summarised below.
(i) The basal rate (i.e. in the absence of lipolytic agonists) of TG mobilisation 
measured by the release of FFA into the incubation medium and expressed as the 
percentage of tissue TG-fatty acid released, was relatively high using tissue at an earlier 
stage of adipose growth (i.e. day 14) but was lower at days 16 and 18, increasing again 
after hatching.
(ii) The tissue was sensitive to glucagon stimulation of TG mobilisation at day 14 
but this sensitivity appeared to be lost by day 16 and then re-acquired by days 18 and 
22 .
(iii) A major finding was that C20 and C22 polyunsaturates (i.e. 20:4, 20:5, 22:5 
and 22:6) were preferentially mobilised from the tissue. As a result, the proportion of 
these fatty acids measured in the medium FFA was consistently greater than the original 
proportion in the tissue TG; typically 2-3-fold greater in the case of DHA, although in 
some incubations there was a 5-7-fold preferential release of DHA.
This preferential release was found at all developmental stages, during both 1 
and 24h incubations, in the presence and absence of glucagon, and in adipose tissue for 
both chick and pheasant embryos.
(iv) Although this preferential release was still apparent when glucagon was 
present, there was a general tendency, not always statistically significant, for the extent 
of preferential release to be somewhat reduced in the presence of this hormone.
Thus these in vitro studies are consistent with the results in vivo (section 3.1.5) 
which suggest that DHA may be preferentially moilised from the adipose tissue of the 
chick embryo. The fact that such a process, occuring in vivo would result in the 
preferential release of DHA into the bloodstream as the free fatty acid, a form in which 
the fatty acid may be taken up by the embryonic brain, is a topic considered at some 
length in the Discussion section.
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Table 3.61: Fatty add compositions (% of total fatty acid) of adipose tissue 
triacylglycerol (AT-TG) and free fatty acid of incubation medium at day 16 of 
development (experiment A). Means ± S.E., n=4. Statistical comparison between 
tissue and incubation medium: aP<0.05, bP<0.01, cp<o.ooi.
Fatty
acids
% in AT-TG before 
incubation
% in medium FFA
16:0 28.5 ±0.35 27.21 ±0.98
16:1 3.26 ± 0.14 6.25±0.66b
18:0 8.15 ± 0.57 9.05 ±0.46
18:1 39.97 ± 1.55 23.38 ±0.95c
18:2 14.09 ± 1.05 11.82 ±0.99
18:3 0.68 ±0.05 0.95 ± 0.05b
20:4 2.19 ± 0.11 5.59 ± 0.52c
20:5 0.10±0.00 0.85 ± 0.08c
22:5 0.18 ±0.02 0.31 ±0.11
22:6 2.43 ±0.22 12.88 ±0.71c
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Figure 3.21: The amount of fatty acid released into the medium from 
incubated adipose tissues at various stages of embryonic development. The 
percentage release was calculated as : Amount of fatty acid in the medium 
divided by the sum of the amounts of fatty acid in the medium and in adipose 
TG after incubation. Values are means ± S.E. of 4 replicates. Statistical 
differences between lh-24h incubation period: at rtP<0.05, ^P<0.01, CP<0.001. 
Statistical differences between lh incubation day 18 vs day 14, and 1 hour day 
22 vs day 14; 24 hours day 18 vs day 14, 24 hours day 22 vs day 14: values 
differing at *P<0.05, ~*P<0.01.
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Table 3.63: Fatty acid compositions (% of total fatty acid) of adipose tissue 
TG and incubation medium FFA at Day 16 of development from experiment B. 
Means ± S.E., n=4. Statistical differences between tissue and incubation medium: 
at aP<0.05, bP<0.01, CP<0.001.
Fatty
acids
% in AT-TG 
before incubation
% in medium FFA, 
1 hour incubation
Ratio %FA (lh) 
medium / AT
16:0 29.04 ±0.36 15.04 ±0.86c 0.52
16:1 3.48 =±=0.15 2.22 ± 0.12c 0.64
18:0 7.69 ± 0.10 13.51 ±0.51c 1.76
18:1 38.29 ± 1.10 32.25 ±0.49b 0.84
18:2 14.28 ±0.56 16.92 ±0.43a 1.18
18:3 1.05 ±0.04 3.56 ± 0.21c 3.39
20:4 2.15 ±0.03 4.70 ± 0.30c 2.19
20:5 0.13 ±0.01 0.97 ± 0.05c 7.46
22:5 0.39 ±0.02 1.40 ± 0.04c 3.59
22:6 2.79 ±0.02 8.73 ± 0.68c o -tnJ. 1 J
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Figure 3.22: Log10 of ratios (% FA in medium FFA / % FA in adipose 
tissue TG) at various stages of embryonic development. Values for experiment 
B, 1 hour incubation.
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Figure 3.23: Percentage of tissue TG mobilised to form medium FFA from 
incubated adipose tissue pieces obtained at various stages of embryonic 
development from experiment C. Percentage calculated as : Amount of FFA in 
medium divided by the sum of the amounts of FFA in medium and in adipose 
TG after incubation. Values are mean of 4 replicates ± S.E.M.. Statistical 
differences between treatment and control at each time point: rtP<0.05, ^P<0.02, 
CP<0.01. Abbreviation: glue refers to glucagon. Statistical comparison 
treatment at a time point and D14s' value for the same treatment: *P<0.05.
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Table 3.66: Analysis of variance of % tissue lipid mobilised (Amount of 
FFA in medium divided by the sum of amounts of FFA in medium and in 
adipose tissue TG after incubation), DF : degree of freedom.
% lipid released
Source of variation DF F P
Day *■>J 15.34 P<0.001
Treatment 2 8.86 P<0.01
Day*treatment 6 1.715 NS
Table 3.67: Fatty acid compositions (% of total fatty acid) of adipose tissue 
TG and incubation medium FFA (1 hour) at day 14 of development from 
experiment C. Means ± S.E., n=4. Statistical comparison between tissue and 
incubation medium: aP<0.05, bP<0.01, CP<0.001.
Fatty % in AT-TG % in medium, % in medium, % in medium,
acids before control glucagon glucagon
incubation 100 ng/ml 1 gg/ml
16:0 28.27 ±0.51 20.52 ±0.80c 21.04 ±0.50c 21.85 ±0.35c
16:1 3.18 ± 0.10 3.68 ±0.19 3.29 ±0.09 3.45 ±0.23
18:0 7.69 ±0.23 11.19 ± 1.59 13.42 ± 1.21b 13,00 ±0.73c
18:1 37.41 ±0.77 31.82 ± 1.55a 30.09 ± 1.10b 29.79 ± 1.08b
18:2 14.42 ±0.37 17,77 ±0.94a 16.74 ±0.24b 16.92 ±0.27b
18:3 0.89 ±0.28 3.73 ±0.33c 4.50 ± 0.25c 4.48 ± 0.30c
20:4 1.90 ± 0.19 2.59 ± 0.15a 2.50 ± 0.09a 2.43 ±0.15
20:5 0.20 ±0.02 0.95 ±0.10c 1.01 ±0.06c 0.95 ± 0.06c
22:5 0.49 ±0.07 1,05 ± 0.09c 0.98 ± 0.06c 0.96 ± 0.06c
22:6 4.79 ±0.53 5.70 ± 0.20a 5.51 ±0.64 5.20 ±0.38
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Table 3.68: Fatty acid compositions (% of total fatty acid) of adipose tissue 
TG and incubation medium FFA (1 hour) at day 16 of development from 
experiment C. Means ± S.E., n=4. Statistical comparison between tissue and 
incubation medium: aP<0.05, bP<0.01, CP<0.001.
Fatty % in AT-TG % in medium, % in medium, % in medium,
acids before control glucagon glucagon
incubation 100 ng/ml 1 tig/ml
16:0 28.96 ±0.34 20.90 ±0.26c 21.83 ±0.24c 22.16 ±0.23c
16:1 3.28 ±0.23 3.89 ±0.27 3.87 ±0.20 3.88 ±0.30
18:0 8.85 ± 0.51 12.99 ± 1.25a 11.36 ± 0.99 11.33 ± 1.38
18:1 38.94 ± 1.26 30.07 ± 1,72b 32.09 ± 1.30b 29.57 ± 1.23b
18:2 13.39 ± 1.08 16.99 ±0.54a 17.62 ±0.40a 18.01 ±0.64b
18:3 1.15 ± 0.13 3.78 ±0 .19C 3.95 ± 0.26c 4.00 ± 0.38°
20:4 1.50 ±0.02 2.35 ±0.19c 2.11 ±0.11c 2.18 ± 0.13c
20:5 0.14 ±0.00 0.79 ± 0.08c 0.80 ± 0.09c 0.84 ± 0.09c
22:5 0.38 ±0.02 0.97 ± 0.04c 0.83 ±0.09b 0.89 ± 0.06c
22:6 2.71 ±0.12 6.15 ±0.83b 4.49 ± 0.41b 6.07 ± 0.82b
Table 3.69: Fatty acid compositions (% of total fatty acid) of adipose tissue 
TG and incubation medium FFA (1 hour) at day 18 of development from 
experiment C. Means ± S.E., n=4. Statistical comparison between tissue and 
incubation medium: aP<0.05, bP<0.01, CP<0.001.
Fatty % in AT-TG % in medium, % in medium, % in medium,
acids before control glucagon glucagon
incubation 100 ng/ml 1 gg/ml
16:0 29.07 ±0.25 23.36 ±0.26c 23.66 ± 1.36b 23.30 ±0.72c
16:1 3.92 ±0.09 4.22 ±0.38 3.78 ±0.36 3.74 ± 0.14
18:0 8.01 ±0.22 14.56 ±2.41a 14.05 ± 1.47b 13.0 ± 1.33a
18:1 40.52 ±0.55 29.37 ± 2.09c 31.06 ± 0.74c 30.00 ±0.32c
18:2 14.21 ±0.17 15.61 ± 0.21b 16.37 ±0.44b 17.00 ±0.16c
18:3 1.25 ±0.04 4.02 ± 0.39c 4.03 ±0.8C 4.25 ± 0.26c
20:4 1.07 ± 0.14 2.20 ± 0.11c 1.94 ± 0.01c 2.16 ± 0 .12b
20:5 0.08 ±0.01 0.83 ± 0.1 l c 0.78 ± 0.04c 0.89 ± 0.045c
22:5 0.21 ±0.02 0.95 ±0.09c 0.78 ± 0.07c 0.96 ± 0.03c
22:6 0.94 ±0.17 3.67 ± 0.40c 2.43 ±0.05c 3.70 ± 0.52c
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Table 3.70: Fatty acid compositions (% of total fatty acid) of adipose tissue 
TG and incubation medium FFA (1 hour) at day 22 of development from 
experiment C. Means ± S.E., n=4. Statistical comparison between tissue and 
incubation medium: aP<0.05, bP<0.01, CP<0.001.
Fatty % in AT-TG % in medium, % in medium, % in medium,
acids before control glucagon glucagon
incubation 100 ng/ml 1 fig/ml
16:0 28.95 ± 1.17 17.91 ± 0.74c 18.86 ±0.49c 17.89 ±0.08c
16:1 2.51 ±0.84 3.03 ±0.20 3.64 ± 0.14 3.33 ±0.20
18:0 6.84 ±0.57 15.04 ±0.58c 10.35 ±0.51b 11.41 ± 0.43c
18:1 38.93 ± 1.08 34.70 ± 1.02a 38.64 ±0.62 36.44 ±0.56
18:2 19.38 ± 1.9 18.45 ±0.58 21.19 ± 0.84 21.23 ± 1.08
18:3 1.13 ±0.38 3.70 ± 1.17 1.90 ± 1.01 4.28 ± 0.02c
20:4 0.76 ±0.07 2.36 ± 0.27c 2.04 ± 0.04c 1.98 ± 0.07c
20:5 0.04 ±0.01 0.92 ± 0.04c 0.69 ± 0.04c 0.76 ± 0.01c
22:5 0.17 ±0.04 0.94 ±0.06 0.67 ± 0.10 0.70 ±0.01
22:6 0.62 ±0.21 2.14 ± 0.43a 1.49 ± 0 .14a 1.33 ±0.29
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Figure 3.24: Log10 ratio (% FA in medium FFA / % FA in initial adipose 
TG) for the control during various stages of embryonic development.
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Table 3.74: Characteristics of pheasant {Phasianus colchicus) adipose 
tissue at day 16 of incubation. Values are means ± S.E., n=2.
Adipose depot wt (g) Amount of lipid / depot (mg)
0.13 ±0.01 29.5 ±2.2
% of total lipids
TG 97.4 ±0.2
PL 2.7 ±0.2
% 16:0 16:1 18:0 18:1 18:2 18:3 20:4 22:6
FA
TG 29.1 5.0± 6.2± 39.3 15.1 1.2± 0.8± 2.7±
±0.0 0.2 0.0 ±1.0 ±1.2 0.1 0.0 0.6
PL 28.7 ND 14.8 33.9 13.5 0.7± 4.5± 3.5±
±0.9 ±1.0 ±0.8 ±0.8 0.1 0.3 0.3
Table 3.75: Fatty acid profiles of pheasant adipose TG and incubation
medium FFA. Values are means of 2 separate replicates ± S.E. Statistical 
differences between tissue TG before incubation and incubation medium: 
aP<0.05, bP<0.01, CP<0.001.
% FA in AT-TG 
before incubation
% FA in medium 
after lh incubation
Ratio %FA medium 
/% FA AT-TG
16:0 29.1 ±0.03 21.28 ± 1.25° 0.73
16:1 4.95 ±0.17 4.34 ± 0 .17a 0.88
18:0 6.16 ± 0.2 13.19 ± 0.37c 2.14
18:1 39.26 ± 1.02 31.04 ±0.89c 0.79
18:2 15.05 ± 1.19 16.01 ±0.75 1.06
18:3 1.16 ± 0.06 4.36 ± 0.22c 3.76
20:4 0.81 ±0.05 2.22 ± 0.12c 2.74
20:5 0.15 ±0.02 1.43 ±0.09c 9.53
22:6 2.74 ±0.60 4.76 ± 0.5a 1.74
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Figure 3.25: Log (ratio %FA in medium FFA/%FA in adipose tissue TG) 
for pheasant adipose tissue, lh incubation.
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4.1-RECENT VIEWS REGARDING THE IMPORTANCE OF PUFA IN 
NEURAL FUNCTION
The importance of DHA for the functional development of both the brain and the 
retina was described in section 1.4. During the past year an increasing number of 
studies have focused on the importance of n-3 fatty acids for human health in new areas 
such as mental health and illness. Adams et al (1995) showed a significant correlation 
between the erythrocyte PL ratio of AA to EPA and the severity of mental depression. 
This ratio was high in depressed patients and could not be explained by different dietary 
intakes of EPA. Laugharne et al (1995) and Glen et al (1994) reported a depletion of 
both AA and DHA in red cell membrane of schizophrenic patients. In these studies no 
evidence was given to indicate if n-3 fatty acid depletion was a symptom or a cause of 
the illness. Salem et al (1995) reported the effect of alcoholism on blood and tissue 
EFA levels. They reported that alcoholics had losses in blood PUFA due to alcohol 
induced EFA catabolism. Results obtained from various mammals after chronic alcohol 
exposure showed a decrease of DHA level in neural tissues which correlated with the 
functional impairments of these tissues. The level of 22:5n-6 increased in the brain to 
compensate for the loss of DHA. In the three cases cited above, decreases in the 
severity of symptoms could be obtained by nutritional therapy (i.e. by increasing the 
dietary EFA levels).
Makrides et al (1995) have provided more evidence with regards to DHA 
supplementation of infant milk formula. They reported the effect on the visual acuity of 
supplemented infants at 16 and 30 weeks of age as an indicator of neural maturation. 
They showed that this supplementation resulted in an improvement in visual acuity, 
compared to babies with standard formula, to match that of fully breastfed infants. 
However, the long term outcomes still have to be studied. Connor et al (1995) looked 
at the problem at a different angle as they supplemented the diet of women from their 
26th to 35th week of pregnancy. This supplementation significantly increased the 
erythrocyte DHA level of both the mother and the new-born infant. At a recent major 
conference on the role of fatty acids in human health (ISSFAL, Maryland, USA, June 
1995), the views of four leading researchers in this area regarding the desirability to 
ensure, by supplementation if necessary, that the developing human brain is optimally 
supplied with DHA, were discussed in a workshop session. Hornstra et al (1995) 
reported that maternal stores of DHA were dramatically depleted after each pregnancy, 
emphasising that the first child of a given woman has generally a better DHA status than 
that of her following children. This study indicated that the maternal DHA dietary 
intake was not sufficient to guarantee an adequate DHA supply to the fetus. 
Furthermore Morley (1995) compared the developmental performances of premature 
infants fed maternal milk to that fed milk formula. She provided evidence that breast­
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fed children performed significantly better at both 18 months post-term and at 7.5 to 8 
years of age. Crawford (1995) advised that diets of women should be enriched in n-6 
and n-3 long chain PUFA before and during pregnancy, that the milk formula in current 
use for preterm infants is inadequate, with too much emphasis on 18:2n-6, and finally 
that bottle-fed infants had an 8 point IQ deficit at 8 years of age and a significantly 
reduced cortical DHA level compared to that of breast fed children. These studies 
therefore encouraged breast feeding and the enrichment of milk formula in n-6 and n-3 
long chain PUFA. However, Innis (1995) reported several studies where no differences 
in visual acuity or developmental scores were found between term gestation breast fed 
and bottle fed babies. The milk formula used in these studies did not contain AA or 
DHA. This report indicated that information on the potential dietary essentiality of AA 
and DHA for very premature infants is limited and the outcomes are still unclear. DHA 
inclusion in formulas reduced scores on some developmental tests in both premature and 
term gestation infants. Premature infant growth was also slowed. This report 
concluded that AA and DHA supplementations into infant formula should be more 
carefully studied with the knowledge that these fatty acids are potent metabolites which 
may have untoward effects on infant growth and development when fed from sources 
other than human milk. Thus complete consensus in this area remains to be achieved.
In all cases cited above, the role of nutritional therapies was emphasised. In the 
case of the human infant, at least two strategies of n-3 supplementation are available: 
supplementation of the baby's diet during its post-natal life or supplementation of the 
mother's diet during pregnancy. To be able to provide DHA both in a molecular form 
(i.e. TG vs. PL, position of DHA on glycerol backbone, nature of other fatty acids 
present) and at a time during development (e.g. early pregnancy, late pregnancy, 
lactation) which favours the delivery of this fatty acid to the developing neural tissues, 
we need to understand the route and mechanism by which DHA is delivered to these 
tissues. This project was aimed at improving the knowledge of DHA delivery to the 
brain of the developing embryo. The chick embryo appeared to be a suitable model to 
study this subject as all embryonic development occurs in a closed system using lipid 
pre-packaged in the yolk as the sole source of fatty acids. At a later stage in this 
discussion (section 4.2 and Figure 4.1) a hypothesis is presented, based on the results 
described in this thesis, suggesting a unique route by which DHA is transferred from the 
yolk to the brain. Speculations regarding the possible relevance of concepts obtained 
using the chick embryo system to the mammalian and human situations are discussed in 
section 4.5.
167
4.2-TRANSFER OF FATTY ACIDS FROM THE YOLK COMPLEX TO THE
MAJOR ORGANS OF THE CHICK EMBRYO
4.2.1. General aim o f this section o f the study
The rationale behind the experiments described in section 3.1. was, by measuring 
the amounts and proportions of the major fatty acyl components of the lipids of the 
yolk, the whole embryo, the major tissues and the blood plasma throughout embryonic 
development, to provide a detailed picture of the rate of transfer of fatty acyl moieties 
from the yolk and the partitioning of these fatty acids between the embryonic tissues. A 
key aim was to delineate the route and mechanism by which DHA is transported from 
the yolk to the developing brain.
4.2.2. Transfer from the yolk sac membrane to the embryonic circulation
A major advantage in using the avian embryo to study lipid transfer stems from 
the fact that lipids and their constituent fatty acids which are required by the developing 
embryo are supplied "pre-packaged" in the yolk. Moreover, the avian embryo system 
has a very low capacity for the de novo synthesis of fatty acids from carbohydrate. Thus 
the fatty acids which accumulate in the embryo lipids are almost entirely derived from 
the yolk; the rate of this incorporation will therefore depend on the kinetics of transfer 
from the yolk and the rate of (3-oxidation in the tissues. An additional factor regulating 
the levels of particular fatty acids in the lipids of the embryonic tissues will be the action 
of desaturation/elongation systems. For example, high levels of A6-desaturase are 
expressed in the yolk sac membrane and tissues of the chick embryo and the major 
function of this enzyme would appear to be in the conversion of 18:2 to AA (Noble and 
Cocchi, 1990). Although the synthesis of DHA via A6-desaturase has been 
demonstrated in the chick embryo (Miyamoto et al, 1967), this process may be of 
limited quantitative importance since, as indicated in Table 3.1, the amounts of available 
18:3 substrate in the yolk is very low. The data in Table 3.1 also indicate that the 
amounts of 18:2 in the yolk are 13-16 times higher than the amounts of 18:3, thus 
potentially providing a very effective substrate competition for the A6-desaturase 
enzyme. Experimental evidence for the view that desaturation/elongation of 18:3 does 
not make a significant contribution to the DHA content of the embryo has been provided 
by the studies of Anderson et al (1990) and Lin et al (1991). Thus it would appear that, 
under normal conditions, the DHA present in the yolk lipids is by far the major source of 
DHA for the embryo; a fact which greatly facilitates the interpretation of the data 
presented in section 3.1.
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With regard to the transfer of total lipid from the yolk during embryonic 
development (Figure 3.1), the amount of lipid transferred from the yolk complex prior 
to day 12 of development was very low. However, the period around day 12 marks a 
phase of major metabolic transition, characterised, as illustrated in Figure 3.1, by a 
dramatic increase in the rate of lipid transfer, in agreement with previous work (Noble 
and Cocchi, 1990). Thus, up to more than 80% of the initial yolk lipid content is 
transferred to the embryo between day 12 of embryogenesis and the first day of hatching 
(Figure 3.1). The proportions of the major lipid classes of the yolk complex, TG and PL 
expressed as % (w/w) of total lipid, remained approximately constant throughout 
development in line with the view that the bulk of the lipid is taken up from the yolk by 
the yolk sac membrane by phagocytosis in a relatively non-discriminatory fashion (Noble 
and Cocchi, 1990). However, in one of the experiments (experiment 1), the proportion 
of CE in the yolk complex increased dramatically between days 18 and 22 (Tables 3.4 
and 3.5). Similarly, expression of the levels of the lipid classes in terms of the absolute 
amounts (mg/yolk complex) (Figure 3.2) showed that TG, PL and CHOL were removed 
from the yolk roughly in parallel, whereas the amount of CE in the yolk complex in one 
of the experiment (experiment 1) remained constant or increased. This may be 
explained firstly by the rapid esterification of CHOL to CE within the yolk sac 
membrane (Shand et al, 1993) and consequently by the recycling of CE from the liver, 
via the bile duct and the small intestine, back to the yolk (Noble and Cocchi, 1990). The 
differences between the two experiments may reflect different efficiencies in the 
recycling of CE.
Analysis of the fatty acid composition of the total lipid of the yolk complex 
during development (Tables 3.6 and 3.7 ) revealed, for the most part, a remarkable 
consistency in the relative proportions of the major fatty acids. A singular exception to 
this consistency was exhibited by DHA, whose proportion decreased significantly, by 
more than 50%, during the course of development. Furthermore, it is clear from Tables 
3.8 and 3.9 that this decrease in the proportion of DHA occurs in PL, and not the TG, 
fraction. Presentation of the specific fatty acid content of the lipids of the yolk complex 
in terms of the percentage of the levels initially present in the yolk prior to incubation, 
allows the changes in the amounts of the different fatty acids to be expressed on the 
same scale (Figure 3.3). On this basis, the transfer of 16:0, 18:0, 18:1, 18:2, 18:3 and 
AA followed the same kinetic profile throughout development. In contrast, the transfer 
of DHA followed a different and unique profile, indicating that DHA was being 
preferentially transported from the yolk lipids.
As a consequence of this transfer of lipid from the yolk complex, the amount of 
total lipid in the embryo increased dramatically from day 12 to day 18 and then remained 
approximately constant over the hatching period (Tables 3.13 and 3.14; Figure 3.4). 
Whereas PL was the major lipid class in the embryo during the first half of development,
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the amount of TG in the embryo increased dramatically from about day 13/14 (Figures
3.5 and 3.6). These results may be interpreted in terms of membrane biogenesis and 
thus PL accumulation occurring throughout development, with a major deposition of 
TG in the embryo occurring during the latter part of development, presumably mainly as 
adipose tissue (see section 3.1.3.) and intramuscular fat, in parallel with the period of 
intensive yolk lipid transfer.
The amounts of C16 and C18 fatty acids in the total lipids of the whole embryo, 
expressed as a percentage of the initial yolk value, showed a very similar pattern of 
increase from day 11/12 onwards. In contrast, the incorporation of both AA and DHA 
into the total embryo lipids occurred at a much higher rate, especially during the early 
phase (day 12-16) of the period of intensive lipid transfer (Figure 3.7). In the case of 
DHA, this result is compatible with the preferential transfer of DHA from the yolk at 
this time. The rapid rate of increase of the AA content of the embryo lipids is possibly a 
result of the conversion of 18:2 to AA by desaturation/elongation in the yolk sac 
membrane and the embryonic tissues (Noble and Cocchi, 1990).
The results in Figure 3.7 and Table 3.21 also indicate that only about 20% of the 
mass of the major yolk lipid fatty acids (i.e. the C16 and C18 fatty acids) transferred 
from the yolk complex actually accumulate in the embryo. This suggests that a large 
proportion of the fatty acids transferred are utilised for energy by the (3-oxidation 
pathway. However, in the case of AA and DHA, a greater proportion of the transferred 
fatty acid was recovered in the embryo lipids; presumably this indicates that these long 
chain PUFA are relatively resistant to P-oxidation, possibly because they are 
preferentially incorporated into membrane PL, but the probable synthesis of additional 
AA from 18:2 complicates the interpretation for this fatty acid.
The fatty acid compositions of the major lipid classes of the whole embryo 
changed in a distinctive fashion during development, particularly with regard to AA and 
DHA (Tables 3.15 and 3.20). In both the experiments shown, the DHA proportion (% 
w/w of total fatty acids) in PL was relatively high at the earlier development stages and 
decreased only slightly at the later stages. Similarly, the AA proportion in PL remained 
fairly constant throughout development. Relatively high levels of DHA (approx. 10% 
w/w) were present in total embryo TG at the earlier stages but this proportion decreased 
dramatically to approx. 1% by day 22. Whole body CE was also characterised by a high 
proportion of DHA at the earlier stages, but with a much reduced DHA proportion later 
in development.
The partitioning of DHA between PL and TG of the whole embryo also 
exhibited some distinctive features (Figure 3.8). Whereas the amount (mg/embryo) of 
DHA in PL increased steadily from day 12 to 22, the amount of DHA in TG increased 
dramatically up to day 15 and then remained fairly constant until day 19; during this 
period, the amount of DHA in TG was approximately twice as much as the amount in
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PL. Then, over the hatching period, the amount of DHA in TG dramatically declined. 
One interpretation of this result, which will be considered in more detail later in the 
discussion, is that tissue TG may serve as a store of DHA which can be selectively 
mobilised to provide a supply of this fatty acid for specific developmental functions.
To summarise so far, these studies on the gross transfer of fatty acids from the 
yolk to the embryo have revealed a number of interesting features:
(i) DHA is preferentially transferred from the lipids of the yolk; this is a unique feature 
appertaining to DHA and is not shown by any other major fatty acid. Previous work 
(Noble and Cocchi, 1990) has demonstrated that the major proportion of yolk DHA is 
present as a component of PE and that molecular species of PE which contain DHA 
tend to preferentially disappear from the yolk from around day 12. Results from two 
other studies are also compatible with this view (Cherian and Sim, 1992; Lin et al 
1991). It would therefore appear that there is a specific uptake mechanism to 
preferentially transfer DHA-containing species of PE from the yolk to the yolk sac 
membrane. The means by which such a specific process could take place against a 
background of non-specific phagocytotic uptake of yolk components by the yolk sac 
membrane (Lambson, 1970) remains to be established.
(ii) As a consequence of (i), DHA preferentially accumulates in the lipids of the whole 
embryo during the early stages of lipid transfer.
(iii) In the embryo, DHA is incorporated into both PL and TG in a characteristic 
developmental pattern.
4.2.3. The consequences o f differing amounts o f initial yolk lipid
The use of eggs of different sizes and therefore of different initial lipid contents 
(Table 3.1) provides a simple opportunity to study the effects of different "nutritional" 
regimes on the development of the embryo. The two experiments described in this 
section utilised batches of eggs which differed by 1.5- fold in their initial yolk lipid 
content. Thus, in relative terms, these experiments may be taken to represent conditions 
of nutritional stringency versus nutritional excess for the embryo.
The fact that the total amount of lipid which accumulated in the embryo was 
significantly less in the "small" egg experiment (Figure 3.4) is not surprising. More 
interesting are the effects of initial yolk lipid content on the relative proportions of the 
major lipid classes in the embryo. A striking feature of the final week of embryogenesis 
is the deposition of large amounts of TG in the embryo in levels proportional to the 
initial yolk lipid content (Figure 3.6). Thus the TG accumulation is relatively restricted 
in the embryos which develop under conditions of comparative nutritional stringency. In 
contrast, the PL content of the newly-hatched chick was relatively unaffected by the 
initial amount of yolk lipid (Figure 3.6). It is likely that, at least within ranges of egg
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sizes used here, the amount of PL in the embryo is determined by the demands of the 
inherent developmental programme of membrane biogenesis, whereas the accumulation 
of TG in the embryo is more dependent on substrate supply.
The results in Table 3.21 suggest that both DHA and AA are relatively resistant 
to P-oxidation in the embryo, possibly because of preferential incorporation of these 
fatty acids into membrane PL. This relative resistance was less marked for embryos 
which developed within the larger eggs, probably due to the greater excess of these fatty 
acids in the initial yolk (Table 3.1) relative to the comparatively unaltered demands for 
membrane biogenesis. Given the important roles of AA and DHA in membrane PL (see 
section 1.4), it is possible that many biological membranes have an optimal fatty acid 
composition that is most compatible with normal function. It may be proposed that 
once this optimal composition has been achieved, any excess AA and DHA supplied 
from the yolk will be exposed to the possibility of P-oxidation, having being denied 
"sanctuary" in the membrane PL. Thus development within the larger eggs containing 
correspondingly greater amounts of AA and DHA in the yolk, will be characterised by 
the P-oxidation of a greater proportion of the initial AA and DHA content. It is of 
interest that similar conclusions have been made by Lin et al (1991) who compared the 
fatty acid composition of the whole newly-hatched chick with that of the initial yolk. 
Firstly, they found that greater proportions of the initial yolk AA and DHA content were 
recovered in the newly-hatched chick in comparison with the major C16 and C18 fatty 
acids; thus AA and DHA were relatively resistant to P-oxidation. Secondly, by 
comparing eggs with differing initial AA and/or DHA contents, they were able to show 
that this relative resistance to p-oxidation was inversely proportional to the initial 
amounts of these fatty acids in the yolk. Thus, if an egg contained a high initial amount 
of DHA, a greater proportion of this DHA would be P-oxidised.
Additional consequences of differences in initial yolk lipid content are illustrated 
by the results in Table 3.22, in which the amount of TG and PL in the newly-hatched 
chick were compared with the respective amounts of TG and PL in the initial yolk. In 
both experiments, generally less than a quarter of the initial amount of yolk TG or PL 
was recovered in the day-old chick in the form of TG and PL respectively. A reasonable 
explanation for this finding is that a large proportion of the fatty acyl components of 
both TG and PL are metabolised by p-oxidation. A greater proportion of the initial TG 
content was recovered as TG in the day-old chick when development occurred within 
the larger eggs; presumably this reflects the formation of adipose tissue from these fatty 
acids which are surplus to the energy needs of the embryo. Under the more stringent 
conditions within the smaller eggs, a greater proportion of the fatty acyl content will be 
required for energy purposes, leaving less available for adipose tissue formation. In the 
case of PL, a greater proportion of the initial content was recovered in the day-old 
chicks which originated from the smaller eggs. The explanation for this is similar to that
172
advanced in the previous paragraph for individual fatty acids; that is, once the acyl 
group requirement for membrane biogenesis has been satisfied, the remaining fatty acids 
will be susceptible to P-oxidation; the amount of fatty acids in excess of requirements 
for PL synthesis will be lower in the smaller eggs. The above discussion does not, 
however, imply that fatty acids recovered from embryo TG necessarily originate only 
from yolk TG, or that tissue PL fatty acids are derived only from yolk PL; in fact it is 
likely that some "mixing" or cross incorporation occurs. This is evident, for example, 
from the observation that DHA, which is mainly present in yolk PL, is extensively 
incorporated into tissue TG (Figure 3.8).
4.2.4. Transfer from the yolk sac membrane to the embryonic circulation.
The concentration of total lipid in the plasma of the embryo increased 
progressively from day 12 of development resulting in very high plasma lipid levels just 
prior to hatching at days 18 and 19 (Table 3.23). The plasma lipid concentration then 
decreased after hatching. These results are similar to those of Yafei and Noble (1990) 
and are in accordance with the changes in the rate of lipid transfer from the yolk to the 
embryo (Figure 3.1). At the beginning of the period of rapid lipid transfer (days 12-14), 
TG was the major plasma lipid component, but the later stages were characterised by 
decreasing proportions of TG and a predominance of CE. It is not possible to 
accurately interpret these changes in the absence of data on the proportions of the 
lipoprotein classes (e.g. very low density lipoprotein (VLDL), VLDL-remnants, low 
density lipoprotein (LDL), high density lipoprotein (HDL)) and their lipid compositions 
and, indeed, such studies would be difficult given the small amounts of plasma 
obtainable from the embryos. However, it may be suggested that the plasma TG is 
largely present as a component of VLDL secreted by the yolk sac membrane whereas 
the increase in plasma CE content may partly result from an accumulation of VLDL- 
remnants in the circulation (i.e. if the rate of remnant production is greater than the rate 
of remnant uptake by the liver). An additional source of plasma CE could be HDL; i.e. 
as a result of transfer of surface components including CHOL from VLDL to HDL 
during LPL action and the subsequent conversion of this CHOL to CE via the 
lecithin:cholesterol acyltransferase (LCAT) reaction (Brown et al, 1981; Dolphin, 1985; 
Mahley et al, 1984; Nilsson et al, 1980). A major finding of this study was the presence 
of high levels of DHA in the TG fraction of the plasma, particularly between days 12-15 
when proportions of DHA as high as 14% (w/w of total fatty acids) were detected 
(Tables 3.26 and 3.30) in this fraction. In contrast, the plasma PL contained only low 
levels of DHA but much higher (up to 20%) proportions of AA (Tables 3.27 and 3.31). 
Thus the proportions and distribution of AA and DHA in the plasma are strikingly 
different from that displayed by their precursors in the yolk. The DHA of the yolk is
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mainly present as a component of PL where it comprises 6-8% of fatty acids (Table 3.3) 
whereas only trace levels of DHA (0.2-0.4%) are detected in yolk TG (Table 3.2). Thus 
it may be proposed that, following uptake from the yolk into the yolk sac membrane, 
DHA is hydrolysed from PL and re-esterified into TG. It may be surmised that this 
newly assembled TG containing high levels of DHA is then incorporated into lipoprotein 
particles to be secreted from the yolk sac membrane into the embryonic circulation. So 
far, therefore, DHA transport from the yolk to the target tissues has displayed two 
unique features: firstly, the preferential uptake of DHA-containing PL species from the 
yolk into the yolk sac membrane, and, secondly, the translocation of DHA from PL to 
TG within the yolk sac membrane with the result that DHA is released into the 
circulation as a component of lipoprotein TG. It should also be noted that the 
proportion of AA in plasma PL is much higher than in the initial yolk PL (Table 3.3 cf. 
Tables 3.27 and 3.31). This probably reflects the functioning of the 
desaturation/elongation system in the yolk sac membrane resulting in the synthesis of 
additional AA from 18:2 (Noble and Cocchi, 1989, 1990).
A major consequence, therefore of the lipid re-arrangements which occur in the 
yolk sac membrane is that the long chain PUFA of the n-6 and n-3 series show distinct 
patterns of partitioning between the lipid classes of the secreted lipoproteins. Thus 
DHA is selectively diverted into lipoprotein TG whereas AA is preferentially 
incorporated into PL.
The situation described here regarding the processing of yolk lipids within the 
yolk sac membrane has similarities with the partitioning of fatty acids in the PL and TG 
of chylomicrons during absorption of lipid by the mammalian intestine. Thus dietary 
DHA and other n-3 fatty acids (Anderson and Connor, 1992; Li et al, 1992; Nilsson et 
al, 1992) are preferentially incorporated into chylomicron TG whereas AA is 
preferentially incorporated in chylomicron PL (Nilsson et al, 1992; Nilsson and Melin, 
1988). For example, Li et al (1992) reported that, following oral administration of 
[l^CJDHA to weaning rats, 92% of the radioactivity incorporated into plasma 
chylomicrons was associated with the TG fraction. This differential partitioning of AA 
and DHA in both the avian and mammalian systems may result from the substrate 
specificity of the relevant acyltransferases and probably reflects the outcome of 
competition between the various fatty acyl species for these reactions (Nilsson and 
Melin, 1988; Nilsson et al, 1987; Rubin and Laposota, 1992).
The subsequent metabolic fate and tissue-specific uptake of the acyl components 
of the plasma lipid released from the yolk sac membrane will be profoundly influenced 
by their distribution between the lipid classes in the lipoprotein (Nilsson et al, 1992; 
Nelson and Ackerman, 1988). Furthermore, DHA is ultimately incorporated into the PL 
fraction of the brain; thus it is striking that this fatty acid initially present in the yolk PL 
is transferred to the TG fraction in the yolk sac membrane prior delivery to the embryo.
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4.2.5. Delivery o f lipid moieties to the tissues from the plasma.
The next stage to consider is the fate of the lipoproteins which are released from 
the yolk sac membrane into the circulation. Of particular interest is the partitioning of 
specific lipid components of the lipoproteins between different tissues. The results of 
Speake et al (1993) suggest that the tissue-specific expression of LPL is of primary 
importance in this regard. Thus the high activity of LPL in the embryo's adipose tissue 
will favour the diversion of a significant proportion of the circulating TG-fatty acids into 
the adipocytes for storage as TG droplets. Lower, but significant, levels of LPL in the 
heart and skeletal muscles will enable these tissues to obtain fatty acids, hydrolysed from 
plasma TG, to be used for (3-oxidation and membrane formation. Following the 
hydrolysis of a large proportion of the lipoproteins' TG content by the action of LPL, 
the resultant remnant particles consisting mainly of CE are deposited in the liver. As a 
consequence, very large amounts of CE are deposited in the liver as development 
proceeds (Shand et al, 1994).
The action of LPL on the plasma lipoproteins not only determines the amount of 
fatty acid supplied to specific organs but also to some extent, influences the composition 
of the fatty acids which are delivered (Speake et al, 1993). A number of studies have 
indicated that TG species which contain C20 and C22 PUFA exhibit a degree of 
resistance to LPL action (Melin et al, 1991, Nilsson et al, 1987; Ridgeway and Dolphin, 
1984). These studies showed that the FFA released from plasma chylomicrons by LPL 
action contained a lower proportion of C20 and C22 PUFA than were present initially in 
the chylomicron TG. Also, the TG remaining in the resultant remnant particles were 
enriched in polyenoic C20 and C22 acyl groups. Speake et al (1993) proposed that this 
substrate specificity of LPL could explain some of the striking features of tissue lipid 
fatty acid composition in the chick embryo. Thus the high proportion of DHA in plasma 
TG (approx. 14%, Tables 3.26 and 3.30) is only partially reflected in the composition of 
adipose TG where DHA forms about 6% of fatty acids (Table 3.37). However, it may 
be proposed that the residual TG of the lipoprotein remnant will be further enriched in 
DHA; since the remnant are taken up by-the liver, this would explain the very high 
proportions of DHA in liver TG (approx. 18%; Table 3.40). [The above values for the 
% of DHA in TG are based on the results at days 12-14],
The above discussion has described the likely mechanisms by which lipids may 
be delivered to adipose tissue, heart, muscle and liver of the embryo. The key question 
is the mechanism by which the developing brain obtains its lipid requirements. Thus far, 
two mechanisms of tissue-specific lipid uptake have been described: (i) via the localised 
action of LPL situated in the capillaries permeating specific tissues; (ii) via the (receptor- 
mediated?) uptake of lipoprotein remnants. However, LPL activity was not detected in 
the chick embryo brain at any stage (Speake et al, 1993). As regards the second
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possibility, recent studies have provided evidence that cells of the mammalian central 
nervous system express receptors for LDL, HDL and the lipoprotein remnants 
(Handelman et al, 1992; Pitas et al, 1987). The expression of such receptors in the 
brain of the chick embryo, enabling neural uptake of lipoprotein remnants, would 
provide an extremely efficient means of supplying the developing nervous system with 
DHA, since, as proposed above, it is likely that such remnants are especially enriched in 
DHA. Such a mechanism would also provide a supply of cholesterol for myelination, 
and it is of interest that the receptor-mediated uptake of lipoproteins by foetal rabbit 
dorsal root ganglion cells was found to promote neurite growth, extension and 
branching (Handelman et al, 1992). However, a recent study from this Department 
indicating that large amounts of vitamin E accumulate in the chick embryo's liver, 
apparently as a result of remnant uptake, whereas only extremely low levels of this 
vitamin are detected in the brain (Gaal et al, 1995) suggest that uptake of lipoprotein 
remnants by neural tissues may not be a significant process in this system. Also, it 
appears that the brain of the chick embryo obtains its myelin cholesterol requirements by 
de novo synthesis of cholesterol as opposed to uptake from plasma lipoproteins (Noble 
and Cocchi, 1990).
It is possible, therefore, that the developing chick brain does not directly obtain 
its PUFA requirements from the yolk sac-derived lipoproteins or their remnants. 
Although the proportion of DHA in adipose TG is somewhat lower than in the 
circulating lipoprotein, the absolute amount of DHA deposited in the tissue (i.e. mg 
DHA/depot) is relatively very high (Figure 3.13) due to the large amount of lipid in this 
tissue. An opposite, but equally interesting, situation appertains to the liver TG; the 
absolute amount of DHA in liver TG (mg DHA/liver) is much lower than in the adipose 
tissue but, DHA forms a very large proportion of total TG fatty acids in the liver (Table 
3.40 and Figure 3.17). These observations raise the possibility that adipose tissue 
and/or liver may somehow mediate the delivery of DHA to the brain. The following 
sections discuss the changes in the fatty acid composition of the lipid of adipose tissue 
(section 4.2.6.) and liver (section 4.2.7.) during development in order to provide a 
background for such speculations. The fatty acid compositions of the lipid of the heart 
(section 4.2.8) and finally the brain itself (section 4.2.9.) are also considered.
4.2.6. Fatty acid profile o f  adipose tissue TG during development
The accumulation of TG in the subcutaneous adipose depot of the embryo 
between days 12 and 19 was dependent on the amount of initial yolk lipid (Figure 3.10) 
and on the amount of lipid transferred from the yolk at any given time (Figure 3.11). 
However, the linear relationship between yolk lipid transfer and adipose tissue growth 
completely broke down over the hatching period (Figure 3.11). Thus although
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approximately 37% of the total lipid transfer occurred between days 19 and 22, there 
was no further growth of adipose tissue during this period. This may reflect a decrease 
in LPL activity in the tissue at this time (Speake et al, 1993) coupled with an increase in 
the sensitivity of the adipocytes to lipolytic agonists (Langslow, 1972).
Whereas the amounts (mg fatty acid in TG/depot) of the major C l6 and C18 
fatty acids in the tissue TG changed essentially in parallel with the profile of TG 
accumulation in the depot (i.e. a continuous increase between days 12 and 19, then 
remaining constant or slightly decreasing over the hatching period, Figure 3.12), a 
totally different and unique pattern of change was found for DHA (Figure 3.13). 
Instead of increasing continuously until day 19, the amount of DHA in the depot 
reached a plateau level by day 16 with little or no further increase prior to hatching. 
More dramatically, the amount of DHA in adipose TG decreased precipitously over the 
hatching period.
Firstly, it is clear that adipose TG in the embryo represents a substantial store of 
DHA. In fact, between days 14 and 19, considerably more DHA was present in the 
lateral thoracic adipose depot alone than in the total brain PL (Figure 3.13 cf Figure 
3.14). Secondly, the dramatic and specific decrease in the DHA content of the adipose 
depot during hatching suggests that this fatty acid may be preferentially mobilised from 
the tissue TG. Additionally, the relatively constant amount of DHA in the depot from 
days 16 to 19 may represent a balance between incorporation of the fatty acid from 
plasma lipoprotein via LPL action and this specific mobilisation of DHA from the tissue.
These results are consistent with the possibility that adipose tissue may function 
as a mediator of DHA transport from the yolk to the brain. The preferential 
mobilisation of DHA from adipose TG will result in this fatty acid being released into 
the circulation in the FFA form, presumably bound to serum albumin. As mentioned in 
the Literature review (section 1.4.5.) there is considerable evidence that the brain can 
take up PUFA, in the FFA form, from the plasma. These points are considered in more 
detail later in this discussion (section 4.5.2.).
4.2.7. Fatty acid composition o f the liver lipids during development
The lipid composition of the liver during the latter half of avian development is 
largely a consequence of the uptake of lipoprotein remnants which consist mainly of CE 
(predominantly as cholesteryl oleate) with some residual TG which contains high levels 
of DHA and also PL enriched in AA (Noble and Cocchi, 1990; Shand et al, 1994). The 
results in Tables 3.39 to 3.43 and Figure 3.15 are clearly consistent with the previous 
studies on liver lipid composition in the chick embryo (Noble and Cocchi, 1990).
The results shown in Figure 3.16 indicate that significant amounts of both AA 
and DHA accumulate in the total lipids of the liver, reaching maximal levels just prior to
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hatching. Thus the liver may also be considered as a "store" of DHA in the embryo. 
Clear evidence that the liver also functions as a mediator of DHA delivery to the brain 
(i.e. by mobilising the stored DHA) is not directly forthcoming from this data. 
However, these results do suggest that during the hatching period DHA may be 
transferred from TG to PL in the tissue. Firstly, between days 19 and 22, the proportion 
(% w/w of total fatty acid) of DHA in liver TG decreased sharply in parallel with a 
marked increase in the proportion of DHA in PL (Tables 3.40 and 3.41). Secondly, 
Figure 3.17 illustrates that the amount (mg DHA in lipid class/liver) of DHA in liver TG 
decreases dramatically over the hatching period in parallel with an equivalent increase in 
the amount of this PUFA present in the PL fraction. Furthermore, this transfer between 
TG and PL appears to be specific for DHA and is not exhibited by any other fatty acid; 
another unique feature of DHA transport.
Investigations into the mechanism of DHA transport to the brain and retina of 
neonatal rodents have suggested a major role for the liver in the mediation of this 
process (Li et al, 1992; Scott and Bazan, 1989). In these studies, DHA was apparently 
transferred from TG to PL in the liver, and was secreted in this form as a component of 
VLDL for subsequent delivery to the target tissues. The observation in the present 
study regarding the selective increase of DHA content of PL in the liver of the chick 
during hatching (Figure 3.17) may reflect a switch from the putative adipose tissue 
mediated mechanisms of fatty acid delivery suggested above (section 4.2.5. and Figure 
4.2) to a liver mediated process, similar to that suggested for neonatal mammals.
4.2.8. Fatty acid composition o f the heart lipids during development
The heart can not be considered as a major site of lipid accumulation during 
embryonic development (Table 3.44). PL is the major lipid class in this tissue and is 
characterised by a high content of AA (Table 3.47). The TG of the heart contains a 
significant proportion of DHA, particularly at the beginning of the final week of 
embryonic life (Table 3.45). This presumably results from the action of heart LPL on 
the DHA-rich TG of the plasma lipoproteins (Speake et al, 1993). In terms of the 
absolute amount of DHA in the heart, less than 20 fig of DHA were present per heart in 
the TG fraction with about 5-times this amount per heart present as a component of PL 
(Figure 3.18). These amounts remained approximately constant throughout the final 
week of embryogenesis.
Thus, unlike adipose tissue and liver, the heart is not, in quantitative terms, a 
major destination for the DHA transferred from the yolk; nor is there any evidence that 
this tissue plays a role in mediating DHA delivery to the brain. However, the PL of the 
heart does display a characteristic composition and important roles for both AA and 
DHA in heart function can not be ruled out.
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4.2.9. Fatty acid composition o f brain PL during development
The period of rapid lipid transfer from the yolk to the embryo (i.e. the last week 
of development is also a period of rapid brain growth. For example, in the experiment 
described in Table 3.50, the brain fresh weight increased by 7.2-fold and the amount of 
total lipid per brain increased by 11.3-fold between days 12 and 22. PL was the major 
lipid class in this tissue throughout embryogenesis with CHOL composing most of the 
remainder. For the experiments described in Tables 3.49 and 3.51, the proportions of 
PL and CHOL remained fairly constant prior to hatching. However, the experiment in 
Table 3.49 was continued for 4 days after hatching, and at this stage a decrease in the 
proportion of PL and an increase in the proportion of CHOL was observed.
The fatty acid composition of brain PL, measured in 3 separate experiments, did 
not show any major changes between days 11 and 25 (Tables 3.49, 3.50 and 3.51). In 
two of the experiments, some decrease in the proportion of 16:0 did occur, particularly 
after hatching. However, a key feature was that the proportions of AA and DHA 
remained remarkably consistent throughout the second half of embryonic development 
and during the first few days after hatching. At most stages, DHA was the second most 
abundant fatty acid (after 16:0) comprising up to 22% (w/w) of the total, with AA 
comprising 8-10%.
The development of the central nervous system of the chick begins as early as 
the first week of incubation with the formation of the neural plate and by day 4 most of 
the basic forebrain structures have formed (Romanoff, 1960; Rogers, 1995). Prior to 
the period of rapid lipid transfer, brain development at the cellular level is mainly 
characterised by rapid cell proliferation with the peak rate of neurogenesis occurring at 
day 8 (Freeman and Vince, 1974; Rogers, 1995; Sobue and Nakajima, 1978). The next 
phase of brain development is characterised by neurite outgrowth, axonal extension and 
dendritic branching, ultimately resulting in synapse formation with the peak rate of 
synaptogenesis occurring at day 15 (Rogers, 1995; Sedlacek, 1972). The maturation of 
the synaptic connections and the formation of myelin sheaths then continues into post­
hatch life (Rostas, 1991). The developmental period studied in the present work 
(essentially from day 12 to day 22), therefore, encompasses the stages of neurite 
outgrowth and synaptogenesis which, in developing mammals, have been shown to be 
characterised by the accumulation of DHA in PL of the neuronal membranes (Dobbing 
and Sands, 1979; Neuringer et al, 1988). The DHA content of myelin PL of the chick 
embryo brain is very low (Alejandre et al, 1984) consistent with the view that DHA is 
incorporated largely into the neuronal membranes. The fatty acid compositions of the 
brain PL reported here are consistent with previous studies carried out on the brain of 
the newly-hatched chick (Anderson et al, 1989, 1990; Cherian and Sim, 1992; Lin et al, 
1991). Rizzo et al (1995) have made a more detailed study of brain PL composition
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during chick embryo development. They reported minor differences in the AA and 
DHA levels between different regions (i.e. cerebral hemispheres, optic lobes, cerebellum 
and brainstem) and also between the left and right hemispheres.
The absolute amount of DHA in the brain PL (mg DHA/brain) increased in a 
continuous fashion throughout the second half of the embryonic period (Figure 3.19). 
Thus the brain has an ongoing requirement for an adequate supply of DHA during this 
period. The amounts of 16:0 and AA (Figure 3.19), and indeed of all the major fatty 
acids, increased in a fashion parallel to the changes in DHA content, reflecting the 
relatively unchanging proportions of the major fatty acids (Tables 3.49 to 3.51) during 
development.
4.2.10. Summary o f this section
This study of the amounts and relative proportions of the major fatty acids in the 
lipids of the yolk complex, whole embryo, blood plasma and key tissues throughout 
development has revealed one striking feature: the unique behaviour of DHA at almost 
every stage of the transport process. These characteristics are reflected in unique 
patterns of distribution of DHA between tissues and between lipid classes and are 
generally not displayed by the other major fatty acids. These aspects of DHA transport 
are listed below:
(i) DHA is preferentially taken up from the yolk by the yolk sac membrane.
(ii) Within the yolk sac membrane, it appears that DHA is selectively translocated from 
yolk PL into lipoprotein TG. Thus DHA enters the embryonic circulation as a 
component of plasma TG. The chief consequence of this will be that DHA will become 
susceptible to hydrolysis from the lipoprotein by the action of LPL, since TG, not PL, is 
the preferred substrate for this enzyme (Olivecrona and Bengtsson-Olivecrona, 1987).
(iii) As a consequence of the especially high LPL activity expressed in the adipose 
tissue, a large amount of DHA is incorporated into adipose TG.
(iv) As a consequence of the substrate specificity of LPL, the residual TG of the 
lipoprotein remnant will be especially enriched with DHA; as a result of remnant uptake 
by the liver, this tissue will accumulate TG which, although low in amount compared 
with adipose tissue, contains a very high proportion of DHA.
(v) The changes in the amount of DHA present in adipose TG during development 
suggest that DHA may be preferentially mobilised from this tissue. This would result in 
the release of DHA as the FFA into the circulation; it is suggested that, in agreement 
with the work of other authors (Dhopeshwarkar and Mead, 1973; Anderson and 
Connor, 1988), this DHA may be taken up by the brain from the plasma in the FFA 
form. Thus it is suggested that adipose tissue may play a key role in mediating DHA 
transport to the brain.
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(vi) In the liver, over the hatching period, DHA is apparently selectively translocated 
from TG to PL. The significance of this is not clear but it may represent the early stages 
of a role for the liver as a mediator of DHA supply to the brain in the neonatal bird.
(vii) Both DHA and AA appear to be relatively resistant to P-oxidation in the embryo. 
Similar findings for the chick embryo have also been reported by Lin et al (1991). It is 
also of interest that differential rates of oxidation of saturated and polyunsaturated fatty 
acids were also observed in the developing rat (Leyton et al, 1987).
The fact that DHA, which in quantitative terms is a relatively minor fatty acid of 
the initial yolk lipids, exhibits such a range of unique and specialised features during its 
transport through the embryonic system, suggests strongly that this fatty acid is of 
crucial importance for the development of certain embryonic structures and functions. 
This view is consistent with the evidence for the importance of DHA, particularly in the 
development of the neural tissues, as described in section 1.4 and 4.1. It is perhaps 
somewhat surprising, therefore, that the one tissue in this study which, at least from the 
compositional data, does not display any unique features regarding DHA incorporation, 
is the brain itself. The proportion of DHA in brain PL remained approximately constant 
throughout the period studied (Tables 3.49 to 3.51) and, as a consequence, the amount 
of DHA in the tissue (mg DHA/brain) increased in parallel with the other major fatty 
acids (Figure 3.19). However, in order to directly assess the question of preferential 
uptake, a knowledge of the acyl composition of the pool of fatty acids which serves as a 
precursor for uptake into the brain (e.g. the plasma FFA fraction) plus studies on the 
differential rates of uptake and incorporation of the various fatty acids into brain PL 
using radioactive tracer studies, are also required. It is of interest that plasma FFA
fraction in this study contained very high proportions of DHA (up to 17%, w/w; Tables
3.29 and 3.33), at least between days 12 and 16 of development. This result is 
consistent with the view that DHA may be being preferentially mobilised from adipose 
TG into the plasma FFA fraction and would also seem to obviate the need for any 
preferential uptake of DHA by the brain at this stage.
The selective uptake of a particular fatty acid by the brain could involve
differential transfer across the blood-brain barrier (Alberghina et al, 1993, 1994; 
Anderson et al, 1993; Spector, 1988), specific uptake mechanisms into the neurons 
based on the specificity of fatty acid binding proteins (Abumrad et al, 1989; Schoentgen 
et al, 1989) or the fatty acyl specificity of the acyltransferases in the brain cells 
responsible for the esterification of fatty acids into PL (Esko and Raetz, 1983). In 
mammals, there is considerable evidence for the preferential uptake of DHA by the 
neural tissues, as studied in vivo and in vitro. For example, Anderson and Connor 
(1988) found that DHA was taken up into the brain more rapidly than were other fatty 
acids following injection of the radioactive tracer FFA into functionally hepatectomised 
rats, whereas Sarda et al (1986) reported the selective incorporation of injected DHA
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into different brain regions of the rat. In addition, Onuma et al (1984) reported the 
selective incorporation of DHA into brain lipids following intracranial injection. 
Furthermore, in vitro studies have demonstrated the preferential uptake of DHA into 
lipids of the retina of monkeys and humans (Rodriguez et al, 1990). In contrast, 
isolated brain cells of the juvenile turbot did not show any preferential uptake of DHA 
(Tocher et al, 1992). The results of the present study may be taken to suggest that the 
chick embryo system is more similar to the fish than the mammal in terms of the 
apparent lack of preferential DHA uptake by the brain. However, the evidence is at 
present circumstantial, based solely on the compositional data; more direct studies are 
therefore needed to test this view.
The question arises as to the need for the preferential transfer from the yolk to 
the embryo at the beginning of the period of rapid lipid transfer (approx. day 12 to day 
15; Figure 3 .3) since the proportion of DHA in brain PL does not increase during this 
period (Tables 3.49 to 3.51) and the rate of increase in the absolute amount (mg 
DHA/brain) is actually slightly lower than that at the later stages (Figure 3.13). Also, of 
course, preferential transfer at an early stage means that there is less DHA available for 
transfer at the later stages. It should be noted that this preferential transfer of DHA has 
a profound effect on the fatty acid composition of the embryo's lipids, particularly of the 
TG fraction. Thus, at around day 12 high proportions of DHA are present in the TG 
fraction of the whole embryo (Tables 3.15 and 3.18), the plasma (Tables 3.26 and 3.30), 
adipose tissue (Table 3.37), liver (Table 3.40) and heart (Table 3.45). A common 
feature of all these examples is that the proportion of DHA in the TG subsequently 
decreases as development proceeds, due to the dilution of the DHA by other incoming 
fatty acids. Thus, by the time of hatching, the proportion of DHA in these TG fractions 
is generally quite low. In contrast, the proportion of DHA in the PL fractions of the 
whole embryo (Tables 3.16 and 3.19), plasma (Tables 3.27 and 3.31), liver (Table 3.41) 
and brain (Tables 3.49 to 3.51) either decreases only slightly or remains fairly constant 
as development proceeds.
One explanation for the selective transfer of DHA to the embryo could be that 
this process would allow the transport of this fatty acid to be partially uncoupled from 
the gross energy needs of the embryo. This may be necessary in order to enable the 
supply of adequate levels of DHA to the brain prior to the period when lipid utilisation 
for energy purposes is maximal. An alternative explanation is that preferential transfer 
of DHA from the yolk promotes the accumulation of DHA in adipose TG at an early 
stage; in fact from the time of the initial formation of the tissue. Thus the adipose tissue 
becomes "pre-loaded" with DHA which is subsequently preferentially mobilised to 
supply the needs of the developing brain.
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4.3.BRAIN PHOSPHOLIPID CLASSES AND THEIR FATTY ACID
COMPOSITION.
4.3.1. Significance o f the compositional data fo r  the PL classes.
The HPLC method devised by Christie (1985) was found to be very suitable for 
the isolation of the major PL fractions (Figure 3.20) in a highly purified form as assessed 
by HPTLC. As regards the PUFA distribution between the different PL classes of the 
brain, a consistent pattern was observed in both the chicken and the duck (Tables 3.52 
to 3.60). Thus, although PC was the most abundant class of PL in the embryonic brain, 
it contained only minor proportions of both DHA and AA. The second most abundant 
PL class, PE, was the major molecular site of PUFA accumulation in the brain, 
containing up to 40% (w/w) DHA with lower (around 12%) proportions of AA. The 
PUFA content of PS was similar to that of PE, but with a lower proportion of AA. In 
contrast, the quantitatively minor class, PI, contained up to 45% AA but only low levels 
of DHA. These results are very similar to those reported for the developing mammalian 
brain (Green and Yavin, 1993; Neuringer et al, 1988).
A number of studies have investigated the incorporation of radioactively-labelled 
fatty acids into different PL classes of the neural tissues during mammalian development. 
Anderson and Connor (1988) noted that whereas labelled 16:0, 18:2 and 18:3 were 
mainly incorporated into PC, labelled DHA was preferentially recovered in the PE 
fraction, following injection into young rat. Similarly, Gazzah et al (1995) also 
demonstrated that labelled DHA, injected into young rats, was specifically incorporated 
into the PE fraction of the brain. However, following intracranial injection of DHA into 
neonatal rats, the label was approximately equally distributed between PC and PE 
(Onuma et al, 1984), suggesting that the route of injection may affect the subsequent 
partitioning. Delton et al, (1995) reported that labelled AA and DHA were differentially 
incorporated into the lipid classes of cultured pineal cells, with AA largely partitioning 
into PC whereas more DHA was recovered in PE. These results suggest that the 
distribution of PUFA between the PL classes may differ in particular brain regions. This 
same paper (Delton et al, 1995) also investigated the effect of stimulation by nor­
adrenaline on the distribution and release of PUFA by the pineal cells and provided 
evidence that both AA and DHA may be involved in the signal transduction process 
leading to the release of the pineal hormone melatonin. The studies of Tocher et al 
(1992) using brain cells isolated from the developing turbot indicated that labelled DHA 
was incorporated into both PC and PE in this system.
It is well established that PI (in the PI-4'5-biphosphate form) has a major role in 
the signal transduction pathways associated with many aspects of brain development and 
function (Furuichi and Mikoshiba, 1995). Furthermore, the activation of specific
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isoforms of protein kinase C via the PI pathway is associated with the differentiation of 
astrocytes in the cerebrum and cerebellum of the chick embryo brain (Mangoura et al, 
1995a, 1995b). The high level of AA present in the PI fraction of the brain may be of 
functional significance since the release of this fatty acid from PI and other PL classes 
following appropriate stimulation and phospholipase A2 activation results in a range of 
regulatory effects on brain cell function (L'hirondel et al, 1995; Peterson et al, 1995; 
Williams et al, 1995).
Since most of the brain's DHA is present in PE, it would appear that this lipid 
class has important roles in those aspects of brain development associated with a 
requirement for DHA. For example, it may be proposed that PE species containing 
DHA exhibit some, as yet unspecified, role in the neurite extension process. A recent 
study by Calderon et al (1995) has indicated a preferential sorting of PL and glycolipid 
species to the membrane of the growing neurite during neuronal differentiation but 
unfortunately the fatty acids compositions of these species were not measured.
4.3.2. Comparison between the chicken and the duck
The amounts of AA and DHA in the initial yolk of the duck eggs were very 
different from those in the chicken eggs (Table 3.57). Thus the chicken eggs contained 
nearly 6-times more DHA (in terms of mg DHA/yolk) than the duck eggs although the 
latter were more enriched in AA. To some extent, these differences were reflected in 
the subsequent fatty acid compositions of the PL classes. For example, just prior to 
hatching (day 18/19), the proportion of DHA in the PE fraction was more than twice as 
high in the chicken than in the duck (Table 3.54 cf Table 3.59). However, the extent of 
the differences in brain fatty acid composition was much less than in the fatty acid 
contents of the initial yolks, between the two species. This suggests that the transfer of 
DHA from the yolk to the brain was more efficient in the duck than in the chicken, thus 
partly compensating for the low level of this fatty acid in the duck eggs. An extra 
source of DHA for the duck embryo could be 18:3, as the duck yolk had more than 2- 
times more 18:3 than the chicken egg. This suggests that elongation/desaturation 
systems may provide a source of DHA in the duck embryo.
4.4-PREFERENTIAL MOBILISATION OF LONG CHAIN PUFA DURING IN 
VITRO INCUBATIONS OF ADIPOSE TISSUE PIECES.
There is a great deal of information available relating to the mechanism and 
regulation of the mobilisation of fatty acids from adipose tissue TG and the release of 
these fatty acids into the circulation (Fain and Garcia-Sainz, 1983; Newsholme and
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Start, 1973; Vernon and Clegg, 1984). In brief, the binding of lipolytic hormones such 
as adrenaline and glucagon to specific receptors on the plasma membrane of the 
adipocyte triggers a cascade of events in the cell which result in the activation of 
Hormone-sensitive lipase (HSL). Hormone binding induces a conformational change in 
the receptor causing it to interact, via an intermediary G protein, with the enzyme adenyl 
cyclase. The subsequent activation of this enzyme results in the production of cyclic 
AMP which in term activates protein kinase A. This phosphorylates and activates HSL 
which in turn hydrolyses fatty acyl groups from adipose TG. Complete hydrolysis of TG 
to release glycerol and FFA from the cell requires the participation of diacylglycerol- 
and monoacylglycerol lipases but it is HSL which catalyses the rate limiting step. 
Mobilisation is inhibited by insulin and glucose which promote the re-esterification of 
the released FFA; and by adenosine which de-activates adenyl cyclase via an inhibitor G 
protein. Some of these aspects are illustrated in Figure 4.1.
Although many of the above details were elucidated using adipocytes isolated 
from the rat, adipose tissue from the adult chicken has also been used extensively in this 
work (Belffage et al, 1984). The sensitivity of adipocytes to glucagon-stimulated 
mobilisation has been studied in chickens at various post-natal ages (Oscar, 1991, 1992, 
1995). Changes in the sensitivity of chicken adipocytes to various lipolytic agonists 
during embryonic and early post-hatch life have been reported by Langslow (1972).
Almost all the investigations on the mobilisation of adipose lipid in both 
mammalian and avian systems have been concerned with the non-specific release of fatty 
acids from the fat cells in order to provide energy for other tissues. Relatively few 
studies have focused on the composition of the mobilised fatty acids. A series of reports 
in the 1960's on the release of fatty acids from adipose tissue both in vivo and in vitro 
failed to provide any evidence for differential mobilisation of the various fatty acids 
(Nakamura et al, 1966; Rothlin et al, 1962; Spitzer et al, 1966; Stein and Stein, 1962). 
However, also in the 1960's, Meinertz (1963) demonstrated that 18:1 was selectively 
retained in adipose TG during in vitro incubation whereas Hollenberg and Angel (1963) 
showed that unsaturated fatty acids were mobilised to a greater extent than their 
saturated counterparts. It was not until the 1990's that these studies were extended to 
consider the mobilisation of the C20 and C22 PUFA from adipose TG. Gavino and 
Gavino (1992) reported that cultivated pre-adipocytes challenged with nor-adrenaline 
preferentially released the n-6 and n-3 PUFA and retained the saturated fatty acids. In 
the same paper, these authors also showed that rat epididymal fat pads perfused with 
nor-adrenaline preferentially released AA and 18:3 but tended to retain 18:1 and 18:2. 
Perhaps the most detailed study in this area is that of Raclot and Groscolas (1993) who 
evaluated the mobilisation of 52 fatty acids from adipocytes isolated from fish oil-fed 
rats and incubated with nor-adrenaline. In particular, they found that AA and EPA were 
preferentially mobilised from the TG of the cells and the main general conclusion from
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this was that mobilisation increased with increasing unsaturation but decreased with 
increasing chain length. Crucially, DHA was not selectively mobilised in this study, the 
effect of high unsaturation being cancelled out by the effect of long chain length.
In the present thesis, the results in Figure 3.13 illustrating the changes in the 
amount of DHA in adipose TG of the chick embryo at various stages of development 
suggest that DHA may be preferentially mobilised from the tissue. In order to test this 
possibility, a series of experiments were carried out in which adipose tissue pieces were 
incubated in vitro and the composition of the FFA released into the incubation medium 
was compared with that of the tissue TG. The results (Tables 3.61 to 3.70) agreed with 
those of Raclot and Groscolas (1993) in that the PUFA 18:3, 20:4, 20:5 and 22:5 were 
found to be preferentially released from the tissue into the medium whereas the major 
fatty acids of the tissue TG, 16:0 and 18:1, were selectively retained. However, in 
contrast to Raclot and Groscolas (1993), DHA was also found to be significantly and 
consistently preferentially mobilised. This preferential mobilisation of DHA occurred at 
all developmental stages, during both lh and 24h incubations, in the absence and 
presence of glucagon and in experiments using adipose tissue from the embryonic 
pheasant as well as from the chicken.
The difference between the results with adipose tissue from the embryonic 
chicken as opposed to the adult rat may reflect a specific feature of embryonic life with 
the need to supply DHA, as the plasma FFA, to the developing neural tissues. This 
implies that the substrate specificity of HSL may differ according to the needs of 
particular stages of development. Gavino and Gavino (1992) showed that partially 
purified preparations of HSL from adipose tissue preferentially cleaved 18:3, but not 
18:1, from an artificial TG substrate, suggesting that differential mobilisation was due to 
the substrate specificity of the enzyme. On the other hand, Raclot and Groscolas (1993) 
suggested that the more polar TG species (i.e. those containing short-chain unsaturated 
fatty acids) would be preferentially localised at the periphery of the TG droplet and thus 
more accessible to the enzyme. Therefore properties of both the enzyme and the 
substrate have been involved to explain preferential mobilisation.
In summary, the results from the in vitro studies support the supposition that 
DHA (and other PUFA) may be preferentially mobilised from adipose tissue stores, thus 
releasing the fatty acid into the plasma in a form suitable for uptake by the brain.
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Figure 4.1: Mechanism of fatty acid release from adipose TG. Lypolitic 
agents, such as the hormones adrenaline and glucagon bind to the membrane 
receptors of the adipocyte. This start a cascade reaction in the cell: 
adenylcyclase transform ATP to cAMP which activates protein kinase A. The 
active form of protein kinase A phosphorylates and activates the mobilising 
lipase (i.e. HSL), thus triggering fatty acid hydrolysis from adipose TG. 
Mobilising lipase hydrolyses fatty acid in sn-1 or sn-3 positions. Complete 
hydrolysis will be ensured by di- and mono-acylglycerol lipases. Three 
molecules of free fatty acids which become bound to albumin and one molecule 
of glycerol are released into the blood circulation. Phosphodiesterase is 
antagonistic to this process by removing cAMP.
Adrenaline / Glucagon
Adenyicyclase
Receptor
cAMP
P K active\
AM P
^  3 FFA +
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4.5 COMPARISON OF AVIAN AND MAMMALIAN SYSTEMS
4.5.1, Studies in mammalian systems
There is currently no clear consensus in the literature as to the means by which 
DHA is supplied to the developing mammalian brain. The investigations of Scott and 
Bazan (1989) and Li et al (1992) in the postnatal rat suggest that DHA from dietary 
sources is not transported directly from the intestine to the neural tissues but instead the 
liver plays a major role in mediating this process. Their results suggest that DHA is 
incorporated into liver PL which is then secreted, presumably as VLDL, and delivered in 
this form to the brain. The question still outstanding from these works is the mechanism 
of uptake by the brain since the studies of Dhopeshwarkar and Mead (1973) and 
Rapoport (1995) indicated that PUFA can not be taken into the brain whilst in the PL 
form. Also, even though the neonatal mammalian brain may transiently express LPL 
activity (Ben-Zeev et al, 1990), PL is a very poor substrate for this enzyme. The study 
of Burdge and Postle (1994) has focused on the increased synthesis in the maternal liver 
of PL species containing DHA and the secretion of these species into the maternal 
plasma during pregnancy. However, the question arises as to the means by which the 
DHA of these PL species could be transported across the placenta since it appears that 
only the FFA form is amenable to transplacental uptake (Crawford et al, 1981; Noble 
and Cocchi, 1989, Kuhn and Crawford, 1986). An alternative mechanism of DHA 
delivery to the brain was suggested by the studies of Dhopeshwarkar and Mead (1973), 
Anderson and Connor (1988) and Rapoport (1995) which claimed that the main or even 
sole, source of PUFA for the brain are plasma FFA bound to albumen or a-fetoprotein. 
Thies et al (1992, 1994) provided evidence that, although FFA bound to plasma 
albumen are taken up by the brain, a preferred source may be lyso-PC bound to albumin.
Although there may be some variation between species it is generally believed 
that provision of the developing fetus and neonate with “pre-formed” DHA is a far more 
efficient means of enhancing the PUFA status of the developing brain than by supplying 
18:3 as a DHA precursor (Crawford, 1993). For example, Sinclair (1975) demonstrated 
that pre-formed C20-PUFA are incorporated into the developing rat brain at a 10-fold 
greater efficiency when compared to their C18 precursors. In the human, the 
conversion of 18:3 to DHA is very low in the fetus (Crawford et al, 1981) and 
apparently non-existent in the placenta (Kuhn and Crawford, 1986). The synthesis of 
C20-PUFA from their C l8 precursors also appears to be very low in the human neonate 
(Cockbum, 1994). However, the postnatal rat liver does have some ability to synthesise 
DHA from 18:3 (Nouvelot et al, 1986; Scott and Bazan, 1989). Voss et al (1991) 
reported that the rat liver synthesises DHA via the elongation/desaturation of 18:3 to 
24:6 which is then retro-converted to DHA. Pawlosky et al (1994) reported a highly
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24:6 which is then retro-converted to DHA. Pawlosky et al (1994) reported a highly 
specific pathway of elongation/desaturation in the feline where 18:3 is metabolised to 
EPA in the liver and then EPA is transferred to the brain for conversion to DHA. There 
is also some evidence that the capillary endothelium of the brain can synthesised DHA 
from 18:3 via elongation/desaturation and retro conversion steps (Moore et al, 1993). 
Recent work has shown that neurons themselves can not synthesise DHA but that they 
can avidly take up DHA which has been synthesised and released from neighbouring 
glial cells (Moore et al, 1991).
4.5.2.Mechanism o f DHA delivery to the brain in the chick embryo.
The results of the present study do not allow a definitive description of the 
mechanism by which DHA is transferred from the yolk to the brain to be made. 
However, a hypothesis can be suggested which is consistent with these results and with 
mechanisms which are known to operate in other systems.
One of the major findings of the study is that, whereas DHA is present both at its 
"starting point" in the yolk and at its final destination in the brain in the form of PL, it is 
apparently transported into the embryonic circulation in the plasma TG. Presumably 
such a drastic, unique and almost total translocation of DHA between these two lipid 
classes, apparently occurring in the yolk sac membrane (Figure 4.2), must be of major 
relevance to the mechanism of transport of DHA to the neural tissues. A major 
consequence of this translocation will be that the DHA content of the plasma 
lipoproteins will become susceptible to hvdrolysis by LPL, since TG and not PL is the 
primary substrate for this enzyme (Olivecrona and Bengtsson-Olivecrona, 1987). 
However, the brain of the chick embryo has no detectable LPL activity (Speake et al, 
1993); thus any uptake of DHA by the brain following the localised hydrolysis of this 
fatty acid from plasma TG is unlikely. On the other hand, the adipose tissue of the 
embryo contains very high levels of LPL activity (Speake et al, 1993); as a result, 
relatively large amounts of DHA are incorporated initially into adipose TG. The 
evidence, both from the changes in the amount of DHA in adipose TG in vivo and from 
the mobilisation of DHA from tissue pieces in vitro, suggests that this fatty acid is 
preferentially mobilised from the tissue TG and released into the circulation as the FFA. 
It is suggested that the brain is able to take up DHA, in the FFA form, from the plasma 
in agreement with Dhopeshwarkar and Mead (1973), Anderson and Connor (1988) and 
Rapoport (1995). Thus it is proposed that adipose tissue mediates the transfer of DHA 
from the yolk to the brain. It is to be noted that the major period of DHA accretion in 
the brain, from day 12 to after hatching, is co-incident with the period of the initial 
formation of adipose tissue.
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An additional possible mechanism, also involving events occurring at the adipose 
depot, may be suggested. Several studies in mammalian systems have indicated that, 
although the primary result of LPL action on plasma TG is to release FFA for uptake by 
the adjacent tissue (Speake et al, 1985), a considerable proportion (30-50%) of the fatty 
acid released may be carried away by the circulation and thus become generally available 
to tissues distal from the site of LPL action (Cryer, 1987; Karpe et al, 1992; Vernon and 
Clegg, 1984). Thus events occurring in the capillaries of the adipose tissue may result in 
DHA, again in the FFA form, being delivered to the brain. There is, however, no direct 
evidence that such a process may be occurring in the chick embryo; the high proportion 
of DHA in the plasma FFA fraction at certain developmental stages is compatible with 
both the "LPL theory" and the "preferential mobilisation theory" and of course, these 
two putative mechanisms are not mutually exclusive.
As a consequence of the substrate specificity of LPL, the remnant lipoproteins 
resulting from LPL action contain residual TG consisting of a very high proportion of 
DHA. Thus remnant uptake by the liver results in the hepatic accumulation of TG 
which is highly enriched in DHA. During the hatching period, this DHA is apparently 
translocated from TG to PL in the liver. It is tempting to suggest that this DHA- 
enriched PL is subsequently secreted from the liver in the form of VLDL and delivered 
to the brain as suggested by Scott and Bazan (1989), Li et al (1992) and Burdge and 
Postle (1994). The results of Tarugi et al (1994) indicate that the liver of the chick 
embryo synthesises and secretes apoB-containing lipoproteins. Thus it is conceivable 
fhat DHA transport is mediated by adipose tissue in the embryo and then by the liver 
after hatching. These concepts are summarised in Figure 4.3 and await testing by 
appropriate experiments.
4.5.3. The chick embryo as a model system fo r  PUFA transport.
In order to be useful as a model system, in addition to being convenient for 
experimentation, it is desirable that work with the chick embryo produces concepts of 
more general application. A key concept from the present study is the potential role of 
adipose tissue as a mediator of DHA transport to the brain. In the human, maternal 
adipose tissue accumulates during early pregnancy and is extensively mobilised at the 
later stages to provide fatty acids for the fetus (Crawford et al, 1989). The possibility 
that DHA may be preferentially mobilised from the maternal adipose tissue to be 
released into the plasma in the FFA form, able to cross the placenta and be taken up by 
the fetal brain, may be worthy of investigation.
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4.6.SUGGESTIONS FOR FUTURE WORK
ii
! A major outcome of this study is the highlighting of the role of adipose tissue in
the mediation of DHA delivery to the embryonic brain. Future experiments to confirm 
the preferential mobilisation hypothesis may be suggested based on the incorporation 
and release of radioactively-labelled fatty acids by adipose tissue pieces or cells cultured 
in vitro. For example, following pre-incorporation of [14C] 16:0 and [3H]DHA into the 
TG of adipose tissue in vitro, changes in the 14C / 3H ratio of both the tissue TG and the 
medium FFA during the subsequent chase incubation would provide a further test of the 
theory that DHA is preferentially mobilised from the tissue. The Hypothesis presented 
in Figure 4.3 is dependent on the view that the plasma FFA pool is the source of PUFA 
for the brain. Therefore a crucial test of this theory would depend on the provision of 
evidence that the brain of the chick embryo can take up FFA from the plasma. 
Experiments involving the injection of radiolabelled DHA into the main chorioallantoic 
vessel of the embryo and the subsequent measurement of incorporation of radioactivity 
into brain PL, and also in vitro experiments to investigate the uptake of labelled fatty 
acids by the brain cells in culture may be suggested.
In order for this work to have any practical value, it is necessary to extend these 
studies to mammals and in particular the human. For example, studies on the accretion 
of DHA into maternal adipose TG and the subsequent mobilisation of DHA to provide 
for the needs of the fetus would provide a background for the rational design of 
supplementation programmes to maximise the neurofunctional potential of the human 
infant.
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Figure 4.2: Lipid uptake from the yolk and biochemical 
modifications within the yolk sac membrane (YSM). Yolk lipids are taken up by 
the YSM during embryonic development. It is not clear if all fatty acids 
incorporated are hydrolysed from their initial yolk lipid fraction (i.e. is AA 
hydrolysed from yolk PL form to be re-esterified in PL in YSM ?). DHA is 
hydrolysed from PL and reesterified in TG fraction. A proportion of 18:2 is 
hydrolysed and is elongated/desaturated to AA which is then mainly reesterified in 
PL. Cholesteryl esters are synthesised from yolk free cholesterol in YSM. The 
enzyme responsible for this esterification is acylCoA:cholesterol acyltransferase 
(ACAT). The newly formed lipid fractions are then assembled to very low density 
lipoprotein prior release in the embryonic circulation for subsequent delivery to 
the target organs. The fatty acid proportions are based on the situation at about 
day 12 of development.
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Figure 4.3: A scheme for the delivery of DHA to the brain of the 
chick embryo. TG contained in lipoproteins are partially hydrolysed by 
lipoprotein lipase (LPL) situated mainly the blood vessels of adipose tissue. The 
major part of the FFA released in that way are then incorporated in adipose TG. 
It is unclear what proportion of this FFA remains in the plasma. The lipoprotein 
remnant is enriched in DHA since TG containing long chain PUFA are relatively 
resistant to LPL action; the remnant is taken up by the liver. The presence of a 
hepatic lipase (HL) in the embryonic liver may also release some DHA as FFA into 
the plasma. The present study has shown a preferential release of long chain 
PUFA from adipose TG which may then become available for the developing 
brain. A role for the liver in DHA delivery to the brain may also be considered 
since DHA is transfered from liver TG to PL and then possibly released into 
embryonic circulation in the lipoprotein form. The fatty acid proportions (% 
values) shown in the diagram are based on the values at around day 12 of 
development.
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